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Introduction 
Proteus mirabilis is one of the most frequent bacterial agents that can induce infection stone 
formation1 by urease production. In recent years the influence of Proteus mirabilis on stone 
formation in enterocystoplasties has been primarily related to the presence of urease. Usually the 
definition of a symptomatic infection: “The multiplication and maintenance of pathogenic 
bacteria, fungi, parasites or viruses after contamination, causing local inflammation or systemic 
disease of the host”, was overlooked. Often the symptom “bacteriuria” was evaluated rather than 
the disease “symptomatic urinary tract infection” or “cystitis” which are correlated with stone 
formation in enterocystoplasties. Symptomatic infection assumes an initial interaction between 
bacteria and the bladder epithelium, followed by a cellular reaction that is associated with 
cellular, urinary and bacteriological factors. As an objective parameter for infection, bacteriuria 
or a nitrite test are usually regarded as a sufficient clinical indication of infection. The strong 
correlation between bacteriuria and cystitis in the normal bladder fuels misinterpretations of 
scientific data on the effect of treatment and of the definition of disease in enterocystoplasties by 
clinicians and scientists alike. Bacterial adherence to epithelial surfaces is important for starting 
the infection2 and may be a target in prevention.  
 
Swarming behavior is a typical characteristic of Proteus strains, although non-swarming wild 
types also occur. Swarming behaviour3 and flagellation4 have been regarded as motility 
enhancing traits that play a role in ascending urinary tract infections. Motility enhancing traits 
indeed facilitate ascending urinary tract infections but are not necessary for urinary tract 
infection with P.mirabilis5.  P.mirabilis can adhere to different epithelial6 surfaces and invade 
numerous cell types. Adhesion of P.mirabilis to epithelium depends upon bacterial 
characteristics and on epithelial adhesion molecules. It is not related to other adhesion molecules 
such as the glycosphingolipids Ù Type I fimbriae interaction in Escherichia coli, the most 
common urinary pathogen7. These interactions are most critical in cystitis in the early stage of 
infection8. 
 
In the normal bladder the epithelial lining responds with cytokines (interleukin (IL)-6, IL-8, 
platelet-derived growth factor (PDGF) and tumor necrosis factor-alpha, but not IL-1 beta, IL-2, 
IL-4 and IL-10)9 . The epithelial lining acts as a barrier and exfoliation of epithelial cells will 
render adhering bacteria harmless10. Nevertheless in most cases exfoliation will not stop the 
bacterial infection. Bacterial invasion of epithelial cells may occur, providing a safe haven from 
antibiotic therapy and causing persistent infection10, 11. 
 
In the enterocystoplasty bacterial adhesion to the intestinal epithelial lining can furthermore 
persist due to absence of the normal bladder defense mechanisms and presence of factors that 
stimulate adhesion of bacteria and persistence of the bacterial infection. The intestinal epithelium 
in the bladder will change histologically to resemble urothelium12 but to what extent this change 
influences the bacterial- host interaction is still unclear. Epithelial changes also occur in the 
catheterization channel due to catheterization although some of these abnormalities may have 
been there at the time of construction14. 
 
Consequently, antibiotic treatment is clinically less effective13. Bacterial infection in 
enterocystoplasties is thus often regarded as colonization of the intestinal segment13 . In contrast, 
the infections in neurogenic bladders are often an indication for surgical treatment15. Whereas for 
the latter antimicrobiological therapy is preferred, colonization immunity can be achieved to 
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some extent by Lactobaccilus or E.coli strains 16 to prevent symptomatic urinary tract infection. 
The low level of P.mirabilis adherence may limit the effect of colonization immunity17.  
Effective anti-infection methods in addition to antibiotic therapy require overall insight into both 
the bacterial mechanisms involved in the adhesion of P.mirabilis to epithelial cells and the 
epithelial adhesion factors of enterocystoplasties and the normal bladder. We will describe the 
interactions of epithelial cells, P.mirabilis and crystals in relation to lower urinary tract infection 
and stone formation. 
 
Enterocystoplasties as continent urinary diversions 
Bowel segments have been used for more then a century in urologic surgery. Ileal reservoirs, 
ileocystoplasties, have become a more acceptable alternative for urinary diversion than the 
standard ileal conduit (Fig.1.) since their introduction and refinements in the 1950’s and 
1960’s18.  Patients usually evacuate their bladder by clean intermittent catheterization, usually 
prior to augmentation.  
 
   
Fig.1. 
Ileocystoplasty constructed according to the Goodwin Cup-Patch Technique 65: 
An ileal segment is isolated and opened along the anti-mesenteric border. A patch is 
formed to resemble a W, and both sides are connected to form a pouch. The pouch is 
anastomosed to the opened bladder. This was the first, but now historic suggestion of a 
continent reservoir.  
 
  
The indications for bladder augmentations using intestinal segments differ for adults and 
children. In children most common bladder augmentations are ileocystoplasties and 
colocystoplasties, often to enlarge a small non-compliant bladder15, usually neurogenic bladders 
in meningo-myelocoele patients, bladder extrophies or cloacal malformations. Sometimes auto-
augmentations or gastrocystoplasties are constructed. These can be converted into 
ileocystoplasties if complications occur. In adults enterocystoplasties are often orthotopic 
bladder replacements constructed to completely replace the original bladder as part of the 
surgical treatment of bladder, prostatic and other tumors. They have their own indications and 
complications.  
Alternative methods are under development such as epithelial ablation methods19 that result in 
the removal of intestinal epithelium for urothelial overgrowth and methods that rely on in-vitro 
grown urothelium or smooth muscle regeneration in e.g. bladder acellular matrix graft20. Stone 
formation is still frequent in all cases. It becomes more relevant when the patient is young at the 
Pouch formed from a 
ileal segment 
Remaining part of the original 
bladder with the bladder trigonum 
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age of augmentation and undergoes concomitant continence enhancing surgical procedures. 
Stone formation is often related to urease producing bacteria such as P.mirabilis1as presented in 
Fig.4. Bacteriuria has thus been regarded as one of the problems in enterocystoplasties although 
at present it is advised not to treat bacteriuria in enterocystoplasties unless symptomatic urinary 
tract infection occurs14.  
 
A number of considerations fuel this opinion that bacterial infection in enterocystoplasties 
should not always be treated as a complication, but as normal and a logical result of the use of 
intestinal tissue14,15. These are: the bacterial colonization of the intestinal segment before the 
construction of the enterocystoplasties, the absence of symptomatic urinary tract infection in 
many cases and the relatively small effect of antibiotic prevention or treatment on these 
infections13,24,66. In contrast, community acquired urinary tract infections in these patients have 
antibiotic resistance profiles resembling nosocomial infections which indicate frequent exposure 
to antibiotics and a possible explanation for the findings described above.  
 
Regarding factors like bacterial adhesion, bacteriuria, electrolyte disturbances and stone 
formation, gastrocystoplasties are less likely to develop infection stones then ileocystoplasties21. 
The differences in epithelial surface and pH between ileocystoplasties, colocystoplasties, 
autoaugmentation, gastrocystoplasties and the normal bladder lead to specific bacterial 
interactions24 and are expressed in the bacteriuria in these patients. A low pH level in 
gastrocystoplasties could be responsible for less stone formation. However, gastrocystoplasty 
patients have other complications such as the hematuria-dysuria syndrome21. Tumor formation is 
also more likely at epithelial junctions of gastrocystoplasties and ileocystoplasties22. Bacterial 
colonization or infection may contribute to this complication by the production of nitrosamines23.  
 
In non-infected enterocystoplasties, a relatively high average pH of 6.5 is present25. This rise in 
pH level may be attributed to urea uptake, which also decreases the available nitrogen for 
bacterial growth and correlates with the type and size of the intestinal segment in 
enterocystoplaties25. In infected enterocystoplasties urease activity further increases the pH. By 
concomitantly increasing the ammonium concentration it also increases the drive for formation 
of triple phosphate stones. In acidic solutions mucins precipitate according to turbity 
measurements26, while formation and aggregation of crystals will occur at high pH levels that 
also insure the availability of free mucin molecules to enhance aggregation27. E.coli seems to be 
able to inhibit urease28. Apart from anti-adhesion effects, this feature of colonization by E.coli 
could give the augmented bladder protection from more pathogenic urease producing urinary 
pathogens such as P.mirabilis. Urinary acidification may also have a beneficial effect. 
Acidification and concentration of infected urine is more likely after inactivation of bacterial 
urease. Reduced fluids intake and lower clean intermittent catheterization frequency may be 
preferred by patients to prevent the increasing pain from the urinary tract infection, but they 
enhance urinary stasis, vesico-ureteral reflux and infection.  
A diagram of the stone formation process with several patient related factors is presented in 
Fig.1.  
 
In most cases the formation of a detectable stone will lead to a second surgical procedure to 
remove the stone. In children and adults with an enterocystoplasty this means either open surgery 
or stone extraction in most cases. Removing the stone as a whole prevents the formation of 
numerous smaller fragments that may form the nidus of the next stone.   
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Bacterial adhesion to epithelium 
Symptomatic bacterial infection of enterocystoplasties requires the capacity to survive in urine 
and to adhere to the intestinal epithelium or the small amount of urothelium that may be left. 
Common uropathogens meet the requirements of survival in urine. Selection of the most 
prevalent infection must be determined by additional factors to explain the difference in 
bacteriological profile between normal bladders and enterocystoplasties. Possible additional 
factors are: the presence of intestinal-derived mucus and mucins, the abundant use of antibiotics, 
catheterization and urinary stasis and urine alkalinisation. 
 
A number of bacterial fimbriae and pili may be responsible for bacterial adhesion to epithelial 
cells at a molecular level. Several of these adhesion molecules, such as UCA32 (uroepithelial cell 
adhesin) specifically target the urothelium. NAF33,34 (non-agglutinating fimbriae) and several 
MR/P33 (Mannose Resistant fimbriae/ Proteus-like) are present on most Gram-negative bacteria 
found in urinary tract infections, such as P.mirabilis. 
 
pH elevationNH4+
pH 7.3
 
 
Fig2.  
A proposed relationship between risk factors involved in stone formation. Broken lines 
indicate the involvement of mucins MUC2 and MUC5AC in the process. The checkered 
areas indicate hypothesized relations based on epidemiological data and literature. 
White areas indicate proposed relations based on literature and clinical experience. 
Suture materials and problems with Clean Intermittent Catheterization (CIC) are 
proposed as risk factors, based on correlations between respectively concomitant 
surgical procedures and consultation requiring catheterization problems with the 
incidence of bladder calculi. Bacterial colonization or infection with urease producing 
bacteria over longer periods of time due to bladder outlet procedures inducing urinary 
stasis15 and the formation of concrements on suture material29 and other foreign objects 
in the bladder also contribute to enterocystoplasty stone formation. Finally, both long-
term histological and clean intermittent catheterisation problems 30,31 due to retention 
or pain  contribute. The formation of a stone itself may in turn also lead to some of its 
own risk factors31.  Therefore, the most common measures are to catheterize regularly, 
to use absorbable suture material in the bladder and be vigilant for stone formation and 
urease producing pathogens. 
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Host defense mechanisms 
It has been reported that bacterial adhesion decreases when P.mirabilis is cultured in urine34. 
This may be the result of urinary proteins that block the adhesion of bacteria at the cellular 
surface, as is the case for Tamm-Horsfall protein and uroplakin Ia and Ib of E.coli35. Similarly an 
interaction between Tamm-Horsfall or mucins and the bacterial capsule of uropathogens may 
occur due to other bacterial-urine interactions such as crystallization on the bacterial capsule of 
P.mirabilis, Fig. 2. The effect of Tamm-Horsfall as an anti-adherence molecule is decreased by 
an increase in calcium, which induces precipitation of calcium salts35. Precipitation of calcium 
phosphate can occur on the bacterial capsule, as we visualized using scanning electron 
microscopy imaging36.  
 
It seems that bacterial calcification would only enhance the chance of infection stone formation 
after the bacteria have already adhered to the cellular surface or if they have formed a substantial 
mass by agglomeration. Non-adhered calcified bacteria are most likely washed out. Crystal 
precipitation on bacteria could thus be a host defense against infection with urease producing 
bacteria. On the other hand, it may also be a virulence factor, shielding the bacteria from 
antibiotics and is possibly involved in the increased resistance against antibacterial therapy in 
infection stones. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3. 
Interacting bacterial and host factors in 
bacterial adhesion to the 
enterocystoplasty surface, relevant for 
the formation of an enterocystoplasty 
infection stone. The unknown factors are 
presented as part of the bacterial capsule 
or capsule associated proteins These will 
be discussed in chapter 4 and 7. 
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Fig.4. The formation of infection stones according to experimental in-vitro data from Grenabo e.a., Hedelin 
e.a. and Petterson e.a. by the action of urease in urine. Urease in the bladder is generally produced by 
bacteria, usually gram-negative rods in a fashion described and reviewed in detail by H.M Mobley 
Bacterial adhesion factors 
Adhesion may involve (glyco)protein Ù (glyco)protein (glyco)protein Ù polysaccharide or 
(glyco)lipid Ù (glyco)protein interactions and often includes cellular proteins described as 
lectins, such as galectins37. The bacterial adhesion molecules enhance bacterial infection and 
pathogenicity and are therefore classified as virulence factors.  One of the cellular proteins 
involved in the interaction with Proteus mirabilis, NAF, was identified on MDCK cells as 
galectin 3 38. Galectin 3 has regions rich in tyrosine, glycine and proline which are very similar 
to the tandem repeats found in mucins in that they are the carbohydrate binding domains of the 
molecule38 and that the bacterial capsule interacts with sugar moieties on the molecule39. Typical 
for Galectin 3 is also the possibility for multimerisation, transforming a 36 kDa monomer into a 
high molecular weight glycoprotein. Mucin interacting molecules also include GroEL (Hsp60), a 
heat shock protein which acts as a protein folding molecule. GroEL has been established as an 
intracellular molecule that is sometimes found at the bacterial surface of Legionella 
pneumophilia40 Haemophilus41 strains or Clostridium difficile42. GroEL seems to interact with 
intestinal mucins. It is not yet clear when an intracellular molecule would migrate to the bacterial 
surface, but increased expression of Hsp60 (Cpn60) in a hostile environment and altruistic lysis 
of single bacteria may benefit the survival of a colony. 
 
Epithelial adhesion factors 
Bacteria-cell interactions take place at the surface of the cell, which is often covered by high 
molecular weight substances (glycocalyx and mucus layer) rich in sugar residues that protect the 
cellular surface. These surface molecules may act as a barrier to external chemical or 
biochemical or microbiological processes, isolate the cell to preserve cellular function or act as 
receptors or signal molecules. All surface molecules are possible targets for bacterial adhesion. 
The most prevalent molecule for a certain tissue type is a likely microbiological target for 
adhesion and infection, even when they were produced by the cell to resist bacterial adhesion. A 
surface glycoprotein target in enterocystoplasties is mucin, the most important structural 
component of the mucus layer.  
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The large amount of intestinal tissue incorporated in enterocystoplasties produces and secretes 
either MUC2 or MUC5AC. It seems from interaction studies that addition of sialic acid and 
reduction of mucin sugar-O-rings decrease bacterial interaction with MUC2 and MUC5AC43. 
Therefore the interaction probably involves the sugar residues common in both mucins and 
galectin 3 although other interactions including three-dimensional recognition cannot be 
excluded.  
 
Mucins 
The many different mucins differ in size and three-dimensional shape but share sequence and 
glycosylation similarities. Before achieving a MUC designation, mucins are usually described by 
their function, mucin-like or mucoproteins. To date there are approximately 16 mucin types 
(MUC1-13, and MUC16-18) of which 14 have been approved by the Human Genome 
Organization Gene Nomenclature Committee (http:/www.hugo-international.org/hugo/). MUC1 
carries a number of other names such as episialin, or epithelial membrane antigen. The gene 
sequences of MUC1-7 have been determined and partial gene sequences are available for all 
mucin types including endomucin (MUC14). MUC1- MUC7 are the best studied so far. 
 
Mucins are high molecular weight o-glycosylated glycoproteins with galactose, fucose, Gal-Nac, 
Glc-Nac, sulfated sugars or sialic acid and unique carboxylated ends and tandem repeats often 
called mucin domains or PTS regions, high in Proline, Threonine, and Serine (20-50% of amino-
acids, 50-80% of molecular weight). They contain at least 50 weight% O-glycans in their mucin 
domains and often show additional N-glycosylation. They are found in epithelial mucous 
membranes of the gastro-intestinal, respiratory and urogenital tract, on endothelial cells and on 
leucocytes.44 They share several domains including a Von Willibrand factor domain which is 
expressed in both MUC2 and MUC5AC.  
However, most of these domains are not restricted to the mucin family. MUC4 and MUC1 are 
the most dominant mucin types in the genitourinary tract. In one third MUC3 is also expressed45. 
MUC4 is also present next to MUC2 and MUC5AC in the normal epithelium of the respiratory 
tract46. MUC2 is the most common mucin type in ileum and colon47, whereas MUC5AC is 
typical for epithelial stomach tissue48 and otherwise only markedly present in the duodenum, 
bladder trigonum, or in case of a bladder tumor. MUC6 can also be found in the antrum of the 
stomach, but is produced by the glandular tissue48. The secretory MUC2, MUC5AC, MUC5B 
and MUC6 seem to have similar and unique cysteine rich domains and are encoded on the 11p15 
chromosomal locus. Since a similar cluster of mucin genes can be found on the 7q22 
chromosomal gene locus,  restructuring of the mucin family results in tentative subgroups of 
11p15 mucins and 7q22 mucins.  Restructuring of the mucin family tree could clarify the 
relationship within the mucin family between the different mucins and explain how mucins and 
mucin candidates with varying characteristics can be classified. This subject was eloquently 
addressed elsewhere49.  Many of these glycoproteins are highly sulfated and contain sialic acid to 
produce a relatively large rigid structure by absorbing water to form a viscous solution in their 
hydrated form.  
 
Mucins in enterocystoplasties 
After incorporating the intestinal segment in the bladder, mucin expression changes. Up-
regulation of MUC1 and MUC4 expression occurs in transposed ileal segments resembling the 
mucin excretion pattern of normal bladder epithelium, whereas ileal segments in clam 
enterocystoplasty showed an up-regulation of MUC2, 3, 4 and 5AC expression towards the site 
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of anastomosis with the ileal segment46. These changes, some of which may be due to the 
exposure to urine, coincide with a change from ileal sialomucins to colonic sulfomucins by a 
change in glycosylation50. The mucins bind calcium and may form a template resembling the 
crystal structure on which crystals are formed and grow, as has been described for gallbladder 
stones51 .  
 
 
On the surface of the epithelial cells lining the bladder and intestine different mucins are 
expressed. MUC2 and MUC5AC are characteristic mucins along the gastro-intestinal tract. They 
form a barrier against the microbiologically colonized intestinal lumen but also supply the 
intestinal flora with a growth surface. When transposed to the bladder these mucins are still 
produced. In the lung and bladder mucins have a protecting function and the mucus blanket is 
discarded with any adhering bacteria. P.mirabilis overcomes this barrier with UCA, NAF and 
MRP fimbriae to persist in the bladder and lung. 
 
In the bladder exfoliation of the bladder epithelium is a method to remove bacteria when the 
mucous blanket fails52. In addition desquamated epithelial cells may have an antibacterial 
effect53, attributed by some to bladder mucin and glycosaminoglycans54. It is likely that the 
intestinal mucins which act as a barrier and tolerate bacterial colonization function in the same 
manner when transposed to the bladder. In enterocystoplasties, adhesion of P.mirabilis to the 
augmented bladder with its sequela of urease production and pH rise will then make the bladder 
susceptible to stone formation. We have previously shown that these strains thereby bind to the 
most commonly available targets in the enterocystoplasty (MUC2 and MUC5AC) (Chapter 6 
and 7). 
 
Infection prevention by interaction inhibition 
As adherence of bacteria is the pivotal step in the infection process5 and the infection and 
damaging of epithelial surfaces in the bladder with urease producing bacteria is key to the stone 
formation, this has to be prevented. This may be accomplished with relative easy, because most 
of the patients are already on CIC and some experimental success has already been achieved by 
others as discussed in this section From interaction experiments we have concluded that sialic 
acid and MUC3 may prevent bacterial- epithelial interaction. Furthermore we found that intact 
sugar-O-rings were important for the bacterial mucin interaction. This opens some leads to 
prevention of adherence. 
 
Several groups have tested rinsing solution that aim at preventing infection. Several specific 
carbohydrate-bacteria interactions were discovered. One interaction inhibition method using N-
acetylneuraminyl (α2-3) lactose was developed against H. pylori39. Also moderately effective 
rinsing solutions were developed using competing bacteria, such as Lactobacillus, to counteract 
colonization by P.mirabilis16. Sugar solutions containing galactose and fucose were effectively 
used in the treatment of resistant infections with Pseudomonas aeruginosa.55 Pseudomonas 
strains also depend on the presence of sialic acid and specific sugars commonly found in mucins 
for binding to the epithelial cells of the host56 . Other interactions have been described with 
specific mucin types, such as MUC157 . Pseudomonas aeruginosa and E.coli were able to up 
regulate MUC2 and MUC5AC in infected cells by the lipopolysaccharides in their bacterial 
capsule58. In this case bacteria exploit the mucin secretion defense mechanism by the host as a 
cellular adhesion molecule. Asialic derivatives of mucins could act as interactions inhibitors for 
Pseudomonas aeruginosa to host cells59. However, the commercial antibody detection methods 
used to show this seem unreliable and asialic derivatives appear involved in the bacterial 
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interaction in biofilms rather then the bacteria-cell interaction. Mannose and N-acetyl-D-
galactosamine inhibited adhesion of E. coli and P. aeruginosa to epithelial cells, whereas only 
mannose inhibited adhesion of S. zooepidemicus to endometrial epithelium. N-acetyl-D-
glucosamine, D-(+)-glucose, galactose, and  N-acetyl-neuraminic acid had no effect on the 
bacterial adherence of these strains60. Overall, bacterial interactions with host epithelial cells 
depend to a large degree on specific sugar interactions. This makes treatment using specific 
sugars possible. For research purposes the use of pure sugars or glycoproteins is inevitable. 
Unfortunately, treatments using a mixture of these purified sugars could be very expensive 
unless such mixtures are obtained from a natural source. To select the best mixtures, it is 
necessary to study the possible interactions of uropathogens with the epithelial cells in 
combination with interaction studies, to find the best combinations or requirements of interaction 
inhibitors. From the interaction characteristics of bacterial adhesion molecules, the interaction 
inhibiting molecules and their epithelial counterparts a database may be compiled. This database 
and the expression of adhesion molecules on uropathogens could be used to determine the 
correct additives for bladder rinsing solutions, tailored to the patients needs. 
 
The anti-infective effect of glycosaminoglycans support that sugars may be effective in the 
prevention of urinary tract infections. Furthermore anti-adhesion treatment with N-
Acetylcysteine for Streptococcus pneumoniae and Haemophilus influenzae strains was 
effective61 in vitro on oropharyngeal epithelial cells. Mucoprotective substances such as ecabet 
sodium and rebamipide also seem to have a positive therapeutic effect on bacterial adhesion of 
H.pylori to the gastric mucosa62 by creating a protective layer on the gastric epithelial surface, 
shielding the host from the bacterial agent . The haemagglutinins of Bacteroides forsythus strains 
seem to be preferentially inhibited by amino-acids such as L-arginine and L-histidine which also 
inhibit their interaction with polymorphonuclear leucocytes, but this interaction can be altered by 
trypsinisation of the leucocytes63. So other options are available besides sugar compounds which 
may be therapeutically helpful on their own, in synergistic combinations or in combination with 
antibiotics.  
 
Nevertheless, at present sugars seem the best option for effective prevention of urinary tract 
infections and of infections in enterocystoplasties since the sugar binding properties of 
uropathogenic bacteria are well conserved among strains and comparable between several gram-
negative uropathogens. Until now most improvements on bladder irrigation fluids are achieved 
using antiseptics and anti-fungal agents. As a prophylactic, the prerequisite for success is the 
ability of a solution to inhibit the occurrence of bacterial infections and infection stones for a 
lifetime without complications or loss of effect. In light of the bladder rinsing solutions in use in 
urologic practice at present there certainly is a lot of improvement possible using sugar solutions 
which have proven successful in vitro64. Bladder irrigation fluids that would act on the most 
important urease producing bacteria and the most common uropathogens in the augmented 
bladder would greatly improve the urologic success of the enterocystoplasty as a continent 
diversion and should be our aim for the future. 
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Scope of the thesis 
Urinary tract infection is a difficult to treat frequent event in both adults and children. Formation 
of so-called infection stones is a known complication of urinary tract infection. Children with 
enterocystoplasties are especially at risk for both problems. The opinio communis has been that 
infection with urease producing uropathogens like P. mirabilis is the main culprit for this stone 
formation. The exact mechanisms behind both problems and their interrelation are still not clear.  
The purpose of this thesis is to clarify the infection process at the basis of stone formation. The 
hope is that this will add a new perspective to the intervention of enterocystoplasty infection and 
stone formation and that it will contribute to existing prophylactic and therapeutic means. 
 
The working hypothesis for this research project is as follows: 
Bacterial adhesion to mucins precedes invasion into epithelial cells, leading to safe havens 
against antibiotic and other treatment, which results in the formation of infection stones by the 
alkalizing action of urease and inappropriate effect of host defense mechanisms and surgical 
measures. 
 
In this thesis two basic research models are used: enterocystoplasty patients and in-vitro models 
for enterocystoplasties using several strains of P. mirabilis. Enterocystoplasties were chosen as 
model system as they combine a high incidence of urinary tract infections and of infection stone 
formation with the presence of very specific conditions of the bladder milieu that can be 
manipulated in vitro. 
 
In chapter 1 a review is given of the available literature data on urinary tract infection with P. 
mirabilis and stone formation especially in enterocystoplasties.  From this review a working 
hypothesis evolves that describes how the persistence of infection and stone formation depend on 
a number of variables including bacterial adhesion to the epithelial calls in the enterocystoplasty 
bladder, invasion of these cells by the bacteria, urease production and interactions of bacteria, 
bacterial products and cellular products with crystals. In the subsequent chapters the relative 
importance of these variables to the overall processes of infection and stone formation are 
investigated. 
 
In chapter 2 an analysis is given of the clinical risk factors involved in the infection of 
enterocystoplasties in children and the subsequent stone formation. This retrospective study 
shows that both processes are more complicated compared to the normal bladder due to the 
presence of intestinal tissue and their secretions in the bladder. Furthermore the presence of 
suture materials and other foreign materials and the changed flow of urine all may contribute to 
the formation of bladder calculi. Subgroups of patients are identified that are at increased risk for 
infection and stone formation. 
 
The question arises whether all bacterial infections should be treated or whether only certain 
conditions or bacteria should be treated while regarding others as colonization of the intestinal 
patch. In chapter 3 the incidence and nature of bacteriuria and symptomatic infections is 
evaluated for a group of 56 enterocystoplasty patients to answer this question. 
 
The literature review makes it clear that usually bacterial adhesion is required for a symptomatic 
infection. For crystal formation to occur, elevation of the urine pH is a second requirement 
P.mirabilis is regarded as the most important uropathogen involved in infection stone formation 
and is capable of this pH elevation through its production of urease. It is therefore chosen as the 
pathogen of interest in our model systems. In addition to the urease effect, the environment of 
General Introduction 
 25
the bladder and especially the enterocystoplasty bladder contains several factors that may effect 
crystal formation. Urine in a enterocystoplasty thus contains mucins and defoliated cells derived 
from both bladder and intestinal epithelial cells. Finally, formation of a  stone from these crystals 
may require more factors than mere pH elevation. Somehow the crystals must withstand passage 
with normal micturation or in the case of most enterocystoplasties, clean intermittent 
catheterization. Adhesion to the bladder and intestinal epithelium may be required. Overall 
bacterial characteristics, epithelial cell characteristics and urine composition all combined will 
decide whether a stone is formed. The contribution of each factor will be discussed in chapters 4 
to 7. 
Chapter 4 addresses the influence of urine conditioning by cell derived mucins and cellular 
material on crystal growth and the subsequent effect of these mucins on crystal adhesion. 
Bacterial adhesion to cells can be followed by invasion of the bacteria into those same cells with 
intracellular crystal formation. In chapter 5 it is shown that this invasion has consequences for 
the survival of P.mirabilis in the enterocystoplasty and for the therapeutic effect of antibiotics. 
Chapter 6 then addresses the role of mucin mediated cellular adhesion in crystal and stone 
formation. To enable specific inhibition of the clinically relevant infection it is necessary to 
clarify this interaction as the first step of an infection. 
The surface of the enterocystoplasty interacts with the bacterial surface. This implies an 
interaction between epithelial surface molecules and bacterial surface molecules as described in 
chapter 6. This aspect is addressed in detail in chapter 7.  
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Abstract 
 
Purpose:  
To determine the best preventive strategies for bladder calculi in children with an augmented 
bladder, the risk factors and prevention strategies for urolithiasis were evaluated. 
 
Materials and methods:  
The records of 89 patients following augmentation cystoplasty were reviewed to asses the results 
of augmentation cystoplasties and in particular the formation and prevention of calculi. 
 
Results:  
The median follow-up was 4.9 years after augmentation. Most patients had an ileocystoplasty 
(71). Bladder calculi occurred in 14 patients (16%) and recurred in 4 patients. Girls had a higher 
incidence of urolithiasis. Other risk factors were cloacal malformations, vaginal reconstructions, 
anal atresia, CIC problems and retention, bladder neck surgery and symptomatic urinary tract 
infections.  
 
Conclusion:  
Subgroups with cloacal malformations, vaginal reconstructions, ureter reimplantation and 
bladder neck surgery were identified that have an increased risk for stone formation and 
therefore warrant special care in the follow-up after augmentation. This care should include clear 
emphasis on the role of symptomatic urinary tract infections, especially in patients with cloacal 
malformations and vaginal reconstructions. Girls have a higher incidence of bladder calculi. 
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Introduction  
 
The purpose of augmentation cystoplasty is to preserve renal function in case of a small 
noncompliant high-pressure bladder by creating a large low-pressure reservoir and to promote 
continence. Augmentation cystoplasty has become a useful surgical option when CIC in 
combination with anti-cholinergic drugs fails to treat small, noncompliant bladders. However, 
one of the long-term complications of augmentation cystoplasty is urolithiasis 1, 2, especially in 
patients infected with urease producing organisms 3, 4.  
Depending on the surgical procedure used for the cystoplasty, different prevalence  rates of 
bladder calculi are found. In enterocystoplasties one important factor in the formation of bladder 
calculi is the production of mucus by the pouch 5. The mucus may possibly enhance stone 
formation directly by acting as a heterogeneous nucleator or indirectly by facilitating bacterial 
growth and retention in calcium, phosphate and ammonium concentrations in urine in 
combination with alkalinization of urine1,5,6. To avoid the problems of mucus formation and high 
pH, gastrocystoplasty has successfully been used. Indeed, calculi are absent in this procedure7. 
Unfortunately, gastrocystoplasty is hampered by considerable other disadvantages, such as the 
so-called hematuria-dysuria syndrome and perforation of the gastric segment secondary to peptic 
ulceration. Some clinical and experimental evidence suggests an increased cancer risk and 
metabolic complications in gastrocystoplasty and an increased risk for a dumping syndrome after 
gastrocystoplasty 10-15. Overall, weighing the urodynamic advantages, complications and 
limitations, the use of detubularized ileum still seems preferable over the use of sigmoid colon, 
auto-augmentation or ureterocystoplasty 8-15. It is therefore worthwhile to try to minimise the 
complication with stone formation in augmentation cystoplasty. How this should be 
accomplished is not clear yet. Even for prophylactic treatment with antibiotics it is questioned 
whether its effects outweighs its disadvantages. Here we have therefore evaluated which factors 
contribute to the occurrence and prevention of bladder calculi in children following 
augmentation cystoplasty. 
 
Materials and methods 
Between 1987 and 1998, 90 patients underwent surgery in order to obtain a high volume, low-
pressure bladder reservoir by bladder augmentation. The records of 89 patients could be 
reviewed. Augmentation cystoplasty was performed in 38 male and 51 female patients. The 
mean age was 14 years with a mean period of follow-up of 4.9 years. The mean age at 
augmentation was 9.5 years, with a range of 9 months to 24 years. The indications for 
augmentation are mentioned in Table 1.  
Of all patients 44 had a Mitrofanoff type of continent diversion (49%), most often an 
appendicovesicostomy constructed at the time of augmentation. On 5 patients (6%) a Mitrofanoff 
type of continent diversion had been constructed as a secondary procedure at a later stage. 
Continence enhancing surgery at the bladder neck was performed at the time of augmentation in 
45 (57%) of all patients. Concomitant surgical procedures consisted of 21 ureter reimplantations 
(22%), 2 nephrectomies, 11 vaginal reconstructions using bowel segments and 9 pelvic 
osteotomies. The different types of bladder augmentation are mentioned in Table 2. Only 
absorbable sutures were used, Vicryl and in the last 6 years also Monocryl. 
Follow-up consisted of control of bloodgas analysis, electrolytes, and creatinine every 3 months 
during the first year and every 6 months thereafter. A cystoscopy was performed every 2 years 
starting 7 years after augmentation cystoplasty. IVP, ultrasound, urodynamic investigation, and 
voiding cystourethrography were done according to fixed protocols. All but one patient were on 
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clean intermittent catheterization; the one patient had a suprapubic catheter for more than 4 years 
due to reluctance to perform CIC without urolithiasis. Following surgery, all patients were 
instructed to irrigate their bladder with saline at least once a day, but after some months most 
patients followed a more liberal regimen. It was stressed that they should irrigate the bladder 
regularly especially in case of complications, such as pain or infection and large production of 
mucus. Of all patients 82% regularly irrigated their bladder, and 59% irrigated their bladder at 
least once daily, according to patient inquiry. Symptomatic and asymptomatic infections 
associated with bacteriuria were noticed frequently and treated therapeutically in case of a 
symptomatic infection and often prophylactically in patients with frequent or persistent urinary 
infections. Symptomatic infections were defined as infections with symptoms such as fever, 
pain, and production of malodorous urine that require treatment. The occurrence of bladder 
calculi and other complications of bladder augmentation and their recurrence at several intervals 
after augmentation were studied for different indications and surgical procedures. Data were 
analyzed by χ2 analysis and Fisher exact test. 
 
Results 
During the period of follow up 18 stones were found in 14 patients for the first time. In Table 3 
different risk factors are described. In 3 patients more than one type of stone was found at the 
first presentation with bladder calculi. Ammonium urate and calcium apatite stones only 
occurred with struvite stones. None of the stone formers had a history of urolithiasis before 
augmentation. Two patients, who had had stones prior to augmentation cystoplasty, did not form 
stones after augmentation. In one patient stones were detected and removed during bladder neck 
surgery. One patient was known to have recurrent pyelonephritis and developed urolithiasis in 
both bladder and kidney, from which P.mirabilis was cultured. Stone recurrence occurred in 4 
patients in the bladder after a mean period of 1.9 years. Bladder calculi were removed by open 
surgery in 10 cases, by percutaneous litholapaxy in 2 cases, and transurethral stone extraction 
was performed in 3 cases. One patient passed the small stones spontaneously with intermittent 
catheterization. Of the 45 patients who underwent bladder neck surgery 8 of all 10 patients with 
CIC problems using the transurethral passage and19 of all 27 recurrent urinary tract infections 
with 9 of 11 calculi were found after bladder neck surgery. Stomal stenosis, although causing 
CIC problems, was not associated with a higher incidence of stone formation. In 13 patients who 
had experienced either CIC problems or a urinary retention, a higher incidence of ammonium 
urate stone formation was found. In 8 of these patients continence enhancing surgical procedures 
were performed on the bladder neck and 6 also had more bladder neck revisions at a later stage 
of 16 patients with these revisions. Patients with imperforate anus and patients who underwent 
reconstructive surgery of the vagina were also more frequent among stone formers than among 
non-stone formers. There were no differences in faecal soiling with the other groups. Of 11 
Patients with a reconstructed vagina 2 of 3 patients with an acute urinary tract infection and a 
urinary retention were found and 6 of 21 ureter reimplantations were performed.  
There were no statistically significant differences found in the frequency of stones between the 
different surgical procedures for augmentation (Table 2). Frequency of bladder irrigation was 
not related to stone formation. It was not possible to do a reliable evaluation of a Mitrofanoff 
type of continent diversion, of which  85% have been constructed after 1995, considering the 
mean period between augmentation and stone occurrence. 
Urinary infection of every kind combined showed a distinct relationship with stone formation. 
Prophylactic treatment with antibiotics reduced the number of struvite stones compared to 
patients not receiving this treatment, but the total number of stones did not decrease 
significantly. Prophylactic use of antibiotics was not related to the incidence of infection. 
Thirteen girls and 1 boy formed stones, which recurred in 3 girls and the boy. Girls also had 
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more recurrent urinary tract infections (43%), and bladder neck plasties (61%). Of all girls, 10 
had a cloacal malformation. After omitting the girls with a vaginal reconstruction, girls still had 
more recurrent urinary tract infections and formed stones more frequently.  
 
 Number of patients Number of Stones (% 
patients) 
MMC 51 5 (10) 
Extrophy 21 3 (14) 
Posterior urethral valves 4 - 
Cloacal malformation 10 5 (50) 
Other obstructive uropathy 3  1  
 89 14 
Table 1. Indication for augmentation cystoplasty in 89 patients and the occurrence of stones 
 
 Number of 
patients 
Number of patients with 
continent diversion 
Number of patients 
with stones (%) 
Mean time lapse between surgery 
and finding of stones (months) 
ileocystoplasty 71 39 11 (16) 37.6 
Kock pouch 2 1 1 (50) 61 
Indiana pouch 2 1 0 - 
colocystoplasty 9 2 2 (22) 35.3 
auto-
augmentation 
4 0 0 - 
ureterocystoplasty 1 1 0 - 
total 89 44 14 (16) 39 
Table 2. The different types of augmentation cystoplasty in 89 patients and the occurrence of 
stones 
 
Discussion 
Fourteen out of our 89 patients formed 18 bladder calculi for the first time following 
augmentation. Most often we encountered infection stones. It is known that especially urinary 
infection with Proteus mirabilis 16 or other urease producing bacteria can cause bladder stone 
formation by changing urine and bladder mucus composition 5. In addition fimbriae, adhesins 
and the glycocalyx have been implicated to increase bladder stone formation 18-21. In this respect 
measures that remove bacteria from the bladder may be expected to decrease the risk for bladder 
stone formation.   
The frequency of bladder irrigations was not related to stone formation. From other studies on 
concrement formation with continent ileal reservoirs 5 it may be concluded that frequent bladder 
irrigation with a saline solution acts on mucus, bacteria or both, but our data does not support 
this. Because the patients who irrigate their bladder more than once a day do so because of 
infection, large amounts of mucus or pain, we believe that this may have influenced our results 
by revealing no difference in stone formation for different irrigation regimens. A Similar 
explanation of patient selection applies for the use of antibiotics and the absence of infections.  
Over the period of follow-up no reliable measurement could be taken of the volume of irrigation 
fluid used in between consultations. Post irrigation ultrasound was measured at consultations, but 
is not very reliable due to a high number of false negative results. So far we have only used a 
saline solution which has proven to be satisfactory in evacuating mucus, but which might be 
made more effective by adjustments for the bladder volume of the individual child.  
32
Chapter2 
S
to
n
e 
an
al
ys
is
 o
f
th
e 
d
et
ec
te
d
 b
la
d
d
er
st
on
es
S
to
n
e 
an
al
ys
is
 o
f
th
e 
d
et
ec
te
d
 b
la
d
d
er
st
on
es
Total number of patients 
Patients with stones 
Patients without stones 
Struvite 
Ammonium urate 
Calcium Apatite 
Unknown
Total number of patients 
Patients with stones 
Patients without stones 
Struvite 
Ammonium urate 
Calcium Apatite 
Unknown
R.R.
C.I.
95%  
RR
g
ir
ls
 
51
 
13
µ µµµ
38
6
3
1
7
 
B
o
y
s
38
1
37
1
-
-
0
9
.6
8
 
7
1
.1
-1
.3
 
v
ag
in
al
 r
ec
o
n
st
ru
ct
io
n
11
7
µ µµµ
4
4
µ µµµ
2
µ µµµ
-
3
N
o
 v
ag
in
al
 r
ec
o
n
st
ru
ct
io
n
78
7
71
3
1
1
4
7
.0
9
 
1
6
.4
-3
.1
 
cl
o
ac
al
 m
al
fo
rm
at
io
n
10
5
µ µµµ
5
2
1
-
3
N
o
 c
lo
ac
al
 m
al
fo
rm
at
io
n
79
9
70
5
2
1
4
4
.3
8
 
1
0
.5
-1
.8
 
co
n
co
m
it
an
t 
b
la
d
d
er
n
ec
k
 s
u
rg
er
y
45
 
11
 µ µµµ
34
6
3
1
5
N
o
 c
o
n
co
m
it
an
t 
b
la
d
d
er
n
ec
k
 s
u
rg
er
y
44
 
3 
41
1
-
-
2
3
.5
8
 
1
2
.0
-1
.1
 
U
ri
n
ar
y
  
tr
ac
t 
in
fe
ct
io
n
s
47
11
µ µµµ
36
5
3
1
6
N
o
 u
ri
n
ar
y
 t
ra
ct
 i
n
fe
ct
io
n
42
3
39
2
-
-
1
3
.2
7
 
1
0
.9
-1
.0
 
co
n
co
m
it
an
t 
u
re
te
r
re
im
p
la
n
ta
ti
o
n
21
 
7 
µ µµµ
14
4
µ µµµ
2
1
3
N
o
 c
o
n
co
m
it
an
t 
u
re
te
r
re
im
p
la
n
ta
ti
o
n
68
 
7 
61
3
1
-
4
3
.2
3
 
8
.2
-1
.3
 
R
et
en
ti
o
n
, 
C
IC
p
ro
b
le
m
s
13
 
4 
9
2
2
µ µµµ
1
µ µµµ
2
N
o
 R
et
en
ti
o
n
 o
r 
C
IC
p
ro
b
le
m
s
76
 
10
 
66
5
1
-
5
2
.3
3
 
6
.3
-0
.9
 
P
ro
p
h
y
la
ct
ic
 a
n
ti
b
io
ti
cs
58
7
51
2
µ µµµ
1
-
5
N
o
 p
ro
p
h
y
la
ct
ic
 a
n
ti
b
io
ti
cs
31
7
24
5
2
1
2
0
.5
3
 
1
.4
-0
.2
 
T
a
b
le
 3
.
N
u
m
b
er
 a
n
d
 s
to
n
e 
a
n
a
ly
si
s 
o
f 
th
e 
fi
rs
t 
o
cc
u
rr
en
ce
 o
f 
st
o
n
es
 (
n
=
1
8
) 
in
 o
ve
rl
a
p
p
in
g
 p
a
ti
en
t 
su
b
g
ro
u
p
s 
o
f 
8
9
 p
a
ti
en
ts
 w
it
h
 1
4
 s
to
n
e 
fo
rm
er
s.
 T
h
re
e 
p
a
ti
en
ts
 
 f
o
rm
ed
 m
o
re
 t
h
en
 o
n
e 
ty
p
e 
o
f 
st
o
n
e,
 a
m
m
o
n
iu
m
 u
ra
te
 a
n
d
 c
a
lc
iu
m
 a
p
a
ti
te
 o
n
ly
 o
cc
u
rr
ed
 w
it
h
 s
tr
u
vi
te
 s
to
n
es
. 
R
.R
.=
re
la
ti
ve
 r
is
k,
 C
.I
. 9
5
%
R
R
=
 9
5
%
 c
o
n
fi
d
en
ce
 i
n
te
rv
a
l 
o
f
re
la
ti
ve
 r
is
k.
µ µµµ
p
 <
 0
.0
5
A
d
d
it
io
n
a
l 
n
o
te
: 
T
h
e 
re
la
ti
ve
 r
is
k 
fo
r 
st
o
n
e 
fo
rm
a
ti
o
n
 =
 T
h
e 
ri
sk
 f
o
r 
st
o
n
e 
fo
rm
a
ti
o
n
 i
n
 t
h
e 
in
d
ex
 g
ro
u
p
 (
le
ft
)/
T
h
e 
a
b
so
lu
te
 r
is
k 
fo
r 
st
o
n
e 
fo
rm
a
ti
o
n
 i
n
 t
h
e 
re
fe
re
n
ce
 g
ro
u
p
 (
ri
g
h
t)
F
o
r 
ex
a
m
p
le
 i
n
 t
h
e 
fi
rs
t 
ro
w
: 
 1
3
/5
1
=
 0
.2
5
  
1
/3
8
=
 0
.0
3
0
.2
5
/0
.0
3
=
 9
.6
8
Bladder calculi in augmentation cystoplasty in children 
 33
 
Most of the absorbable suture material is used in the pouch or bladder neck area. However, stone 
formation still occurs more frequently after concomitant bladder surgery. Urinary infections are 
related to concomitant bladder neck surgery, which may indicate an intermediate role of urinary 
infections in the formation of stones. Patients with bladder neck plasty may also experience 
difficulty in bladder emptying. Open surgery was preferred to extract the entire stone without 
leaving residual fragments and did not require dilating or damaging the bladder neck. To explain 
the effect of concomitant bladder neck surgery on stone formation, we might have to evaluate the 
effects on the cystoplasty’s mucosa, bacterial adhesion as well as the degradation time of sutures.  
 
The antibiotic treatment has not been changed during the period in which these augmentations 
were performed. Possible emerging resistance of bacteria against antibiotics may have played a 
role in stone formation4. Virtually all patients have infected bladders preceding the augmentation 
procedure. Bacteriuria has been regarded as normal in patients with an enterocystoplasty for 
some time now 22, and the advice has been given not to treat all cases of bacteriuria23. The fact 
that symptomatic urinary infections are significantly more common among stone formers can be 
seen as a confirmation that infection plays a major part in stone formation in enterocystoplasties 
and should redirect our attention to this problem or its effects on urine composition and pH. 
 
In the normal bladder the incidence of bladder calculi has been reported to be higher in boys, 
with a higher incidence of struvite stones. In upper urinary tract infections it is well known that a 
continuous flow can help to wash out bacteria 24. It seems possible that in the lower urinary tract 
such a mechanism may start to fail when voiding is done by CIC. We found more bladder stones 
in girls than in boys, often in association with cloacal malformation and reconstruction of the 
vagina and recurrent urinary tract infections, most of them were infection stones.  
 
It is not clear, whether the operation, tissue damage and damage of the GAG layer and mucosa of 
the enterocystoplasties by CIC have attributed to stone formation similar to a recent theory on 
kidney stone formation 25,  26. CIC has been known to be accompanied by bacteriuria, but is 
usually easily treated and causes no sequellae, however this bacteriuria may also have 
contributed to calculus formation.  
 
In patients with vaginal reconstructions the indication for surgery most often is a cloacal 
malformation, requiring many concomitant procedures and may explain the higher incidence of 
urolithiasis in this group, as does the higher incidence of acute urinary tract infection with 
urinary retention. The relative risk for urolithiasis is higher then that of most other risk factors. 
Mucus secretion by the reconstructed vagina and bacterial tropism 27 for small bowel epithelium 
may have played a role in the increased incidence of urinary tract infection and infection stones. 
So far only uric acid urolithiasis has been reported in patients with a vaginal reconstruction 28. 
Urinary stasis has been identified as an important risk factor for urolithiasis by others and has 
been regarded as a risk factor for stone formation in cloacal malformation in combination with 
infection 29. Considering that patients with an anal atresia or patients with a vaginal 
reconstruction, both related to cloacal malformations, have a higher incidence of stone 
formation, concomitant surgical procedures can not be omitted as a possible explanation for the 
higher incidence of urolithiasis in cloacal malformations. The main prevention method should 
include perineal hygiene and irrigation. 
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Conclusion 
 
Infections of the augmented bladder are not benign. Girls are more prone to develop stones in 
enterocystoplasties, despite CIC. It is clear that concomitant surgical procedures, especially on 
the bladder neck, increase the risk of urolithiasis. Prophylactic use of antibiotics has no effect on 
the total number of stones, but seems to decrease the number of struvite stones. Congenital 
malformations and vaginal reconstructions are an important risk factor and we advise to guard 
against infections. Perhaps by improving the saline solution for bladder irrigation, we may 
reduce the incidence of urolithiasis. Further research into improving rinsing fluids and anti-
microbiological properties, interactions or damaging of urothelium and intestinal mucosa in 
augmented bladders and the influence of suture material is needed, to better understand why this 
gives rise to a higher incidence of stone formation in enterocystoplasties. 
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Additional Comment 
It seems clear that the differences between a normal bladder and an augmented bladder are such 
that stone formation is enhanced in certain conditions. Most prevalent risk factor dominating and 
connecting all the other risk factors seems to be the presence of symptomatic infections. 
However, prophylactic use of antibiotics seems to have little or no effect on the prevention of 
stone formation. Children with a cloacal malformation or a vaginal reconstruction (related to the 
occurrence of a congenital urinary malformation) are at higher risk for stone formation. These 
children are often treated extensively with antibiotics and are often hospitalised. How this effects 
the effect of existing antimicrobial options and stone formation will be discussed in the next 
chapter  

  39
 
Chapter 3 
 
The bacteriology of  infections and bacteriuria in 
enterocystoplasties in children  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R. B. Mathoera, C. M. Verduin, R. J.M. Nijman 
(Submitted) 
 
Chapter3 
 40
Abstract 
Introduction:  
It is not clear to what extent the incidence of symptomatic urinary tract infections represents the 
actual bacterial presence in the enterocystoplasty.  In this follow-up study, symptomatic and 
asymptomatic bacterial infections and their antibiotic susceptibility are evaluated with 
concomitant surgical procedures to identify the relevance of bacteriuria to stone formation. 
 
Patients and Methods: 
56 patients were evaluated for a period of 3 years by urine culture and antibiotic susceptibility 
testing. The complete bacteriological history of the corresponding patient’s symptomatic urinary 
infections were combined with the medical history and asymptomatic bacteriological tests. 
Overlapping subgroups were used to identify risk factors for stone formation, to evaluate 
antibiotic treatment and the relevance of bacteriuria compared to symptomatic urinary tract 
infection in enterocystoplasties. 
 
Results: 
13 patients (23%) developed a bladder stone. Most infections were  with E.coli, but the 
difference between symptomatic and routine culture was clear for P.mirabilis (p=0.011, Relative 
Risk = 2.68). Urease producing strains were more resistant to Amoxicillin, Amoxicillin/ 
clavulanic acid and Trimethoprim/ Sulfamethoxazole. Resistances often occurred for antibiotics 
commonly used in prophylaxis and therapy. Catheterization channels and continence enhancing 
surgery attribute to stone formation and infection, while physical handicaps attribute to  the 
latter. 
 
Conclusion: 
Bacterial infection should be regarded as the result of poorly controlled bacteriuria. Bacteriuria 
are preferentially treated without antibiotics, and eradicated according to a antibiogram. 
Antibiotic guidelines would be useful. Stone formation is a result of the infection in the 
susceptible environment of the augmented bladder, after continence enhancing surgery or the 
construction of catheterization channels. 
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Introduction 
Stone formation in enterocystoplasties is common1 and generally urolithiasis is ascribed to the 
rise in pH caused by urease producing bacteria in the enterocystoplasty2. In children these 
enterocystoplasties are constructed to enlarge the bladder and conserve kidney function in an 
already compromised kidney. In recent years the emphasis of stone prevention has therefore 
been on treatment and prevention of emergence of urease producing bacteria in the 
enterocystoplasty and on urease inhibition. P. mirabilis infection has thus been associated with 
the production of  urease3 and urinary stones4. Usually, urine cultures are obtained in case of a 
symptomatic urinary tract infection. These infections are characterized by foul smelling urine, 
pain and large amounts of mucus, (sometimes accompanied by fever) in the voided 
enterocystoplasty urine. It is to be expected that these infected urines will yield a urinary 
pathogen, which lies at the basis of the symptoms.  
However, bacteriuria is also found in patients with an enterocystoplasty without symptoms. 
These infections have been regarded as benign and rather as a colonisation of the augmented 
bladder than an infection5. Antibiotic prophylaxis does reduce the urine nitrosamine levels, 
which indicates that bacteriuria may have an influence on the incidence of tumours in the 
augmented blader6,7. Especially since colonization is a normal feature of the intestinal tissue 
present in the augmented bladder. This idea is fueled by the observation that antibacterial 
treatment is neither effective in the long run nor significantly prevents the complications caused 
by bacterial infections in the urinary tract. This may be directly attributed to the presence of an 
intestinal section in the bladder as a means of enlarging the bladder or bacterial overgrowth8. 
There have been variable reports about the incidence of bacteriuria in patients with an 
enterocystoplasty5,9. These infections may be retrospectively evaluated by antibody levels10,11. 
Nevertheless, it is not clear to what extent the incidence of symptomatic urinary tract infections 
represents the actual bacterial presence in the enterocystoplasty.  Also, it has not been decided 
whether we can actually regard bacteriuria in enterocystoplasties as a colonisation of the 
incorporated intestinal tissue or if the bacterial presence should still be regarded as a risk factor 
and real infection even in the absence of obvious clinical/physical symptoms. Finally, evaluation 
of risk factors and therapeutic measures is necessary to refine the indication for continence 
enhancing surgical intervention or catheterisation channels, and antibiotic treatment.  To answer 
this we have evaluated both bacteriuria and symptomatic infections in enterocystoplasties. 
 
Materials and Methods 
Between 1999 and 2002 patient urine was collected of 56 enterocystoplasty patients without 
known symptomatic urinary tract infection at the time of investigation at regular follow-up 
consultations. These urine specimens were collected by clean intermittent catheterisation and 
cultured on blood agar and McConkey plates.. Researchers were not aware of the patient’s 
history, symptoms or physical condition at the time of the specimen collection. The urinary pH 
level was measured within 25 minutes after catheterization to ensure reliable measurements. The 
complete bacteriological history of the corresponding patient was gathered from a database to 
evaluate the outcome of cultures from urine samples with the clinical indication of symptomatic 
infections from hereafter referred to as the symptomatic samples. Infections in the patients 
without clinical indication for further bacteriological testing were evaluated from specimens 
gathered at consultation and regarded as significant at >105 colony forming units/ ml, from 
hereafter referred to as the asymptomatic samples. The patients medical history was combined 
with the newly constructed database. Infection rates lower then 103 colony forming units were 
not evaluated. All identified pathogens were tested for antibiotic sensitivity using disk diffusion 
and automated systems. Breaking points for antibiotic sensitivity were acquired from and used 
according to the methods of the National Committee for Clinical Laboratory Standards 
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(NCCLS). Following surgery, all patients were instructed to irrigate their bladder with saline at 
least once a day, but after some months most patients followed a more liberal regimen. It was 
stressed however that they should irrigate the bladder regularly especially in case of 
complications, such as pain or infection and large production of mucus. Follow-up consisted of 
control of bloodgas analysis, electrolytes and creatinine every 3 months during the first year and 
every 6 months thereafter. A cystoscopy was performed every 2 years, starting 7 years after 
augmentation cystoplasty. IVP, ultrasound, urodynamic investigation, and voiding 
cystourethrography were done according to fixed protocols. Symptomatic infections and 
asymptomatic bacteriuria were noticed frequently and were treated therapeutically in case of a 
symptomatic infection and often prophylactically in patients with frequent or persistent urinary 
infections. 
Statistical analysis was performed by χ2 analysis and a Fisher exact test when needed. 
Differences were considered significant for p-values ≤ 0.05 in 2 sided tests. Correlation direction 
and Relative Risks were determined in the SPSS 9.0 software package. 
 
Results 
In the sample group of 56 patients, 13 (23%) developed a bladder stone. In the 665 specimens 
from the 56 patients most infections were due to E.coli. These did not significantly differ 
between the symptomatic and asymptomatic group. A bacteriological profile of complicated 
urinary tract infections could be observed with less frequent bacterial species infecting the 
augmented bladder (Table 1.A).The most prominent difference between the symptomatic 
samples and asymptomatic samples was the incidence of Proteus mirabilis (p=0.011, Relative 
Risk = 2.68,  95% Confidence interval 5.41 – 1.22). only 20 Proteus mirabilis infections (5.3%) 
were found among 553 specimens from symptomatic urinary tract infections based on clinical 
observation. Bacterial identifications and antibiotic susceptibility tests were performed for 378 
specimens. In bacteriuria specimens, 9 (13.6%) of the 112 identifications were positive for 
Proteus mirabilis. Identified strains are presented in Table 1A, antibiotic sensitivity is presented 
in Table 1B. antibiotic resistances of the most frequently used antibiotics closely followed the 
prescription preferences of clinicians (Fig.1). Increased use of cotrimoxazol, augmentin and 
nitrofurantoine was reflected in an increase in antibiotic resistance in the same or following year. 
A cyclic pattern occurred as clinicians switched from one antibiotic to another. The formation of 
bladder calculi was not related to P.mirabilis infection in any direct manner. Stone formation 
was related to urease producing Enterococcus and Providencia strains but not the typical urease 
producing bacteria. Furthermore, stone formation was related to antibiotic therapy for 
symptomatic infections, but mostly to additional procedures to the enterocystoplasty during and 
after the augmentation procedure (Table 2). Medication unrelated to augmentation usually 
consisted of anti-epileptic medication or vitamin C and seemed to have a beneficial effect on the 
reduction of the incidence  of bladder calculi. Many of the additional procedures were related to 
the occurrence of specific antibiotic resistances (Table 3). This could be explained by the 
occurrence of other pathogens rather then the normal uropathogens that have a higher incidence 
following additional surgical procedures. Of these antibiotics Amoxicillin/ clavulanic acid, 
Nitrofurantoin, Ciprofloxacin and Trimethoprim/ Sulfamethoxazole were commonly used for 
therapeutic and prophylactic purposes (Table 4). Many bacterial strains were exposed to these 
antibiotics, most of which were capable of producing urease. The number of patients exposed to 
antibiotic treatment is equally high for patients with symptomatic infections and patient with 
bacteriuria. Infection with urease producing organisms in enterocystoplasties is the most 
prevalent. Bacterial strains, found in urine specimens from either symptomatic infections or non-
symptomatic bacteriuria were more frequent in patients with specific physical disabilities or 
additional surgical interventions (Table 5), while other interventions significantly reduced 
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specific bacterial infections. Lower limb paralysis was defined in this particular group of patients 
as synonymous for the use of a wheel chair, considering the effect of the underlying pathology 
frequently associated with neurological problems. This disability was associated with an increase 
in P.mirabilis infections, which was more relevant in symptomatic urinary tract infections. Other 
afflictions affecting the bladder and bladder function, such as the VACTERL-association and to 
a lesser extent the Arnold-Chiari malformation increased infection with Enterococcus spp. and 
Enterobacter spp. respectively Proteus mirabilis . Surgical interventions to reduce vesico-
ureteral reflux such as ureter reimplantations and subostial Macroplastique® or Deflux ® 
injection were also identified as influencing factors. These factors were related to therapeutic 
interventions at a later stage, presented in Table 6. Many of these interventions were identical to 
the factors correlated to stone formation (Table 2). 
Overlapping groups based on urine acidity (Table 7) correlated with strains and afflictions 
previously identified as related risk factors in Table 5. Although P.mirabilis and 
Pseudomonades are not directly correlated with stone formation, they are correlated with many 
of the factors important for stone formation and could be considered as a confounding factor 
rather then an intermediate factor for stone formation in enterocystoplasties in children. 
Typically, these strains and other urease producing bacteria are found more frequently in patients 
prone to develop resistances to antibiotics used in the urologic field and general practice alike, 
such as Amoxicillin, Amoxicillin/ clavulanic acid, Trimethoprim/ Sulfamethoxazole and 
Nitrofurantoin (Table 8). 
A B C
Fig.1. Antibiotic use and susceptibility 
A. =Number of amoxicillin/ clavulanic acid (Augmentin) and ciprofloxacin prescriptions for each year in 
the period from 1995 until 2002., B = The number of trimethoprim/ sulfamethoxazole (cotrimoxazol) and 
nitrofurantoin prescriptions for each year in the period from 1992 until 2002. C= The resulting antibiotic 
susceptibility in the period of 1996 until 2002 for amoxicillin/ clavulanic acid (Augmentin), ciprofloxacin, 
trimethoprim/ sulfamethoxazole (cotrimoxazol) and nitrofurantoin. The antibiotic susceptibility for the 
separate antibiotics decreases rapidly at the time of highest use. The antibiotic susceptibility was scored as 
1 for resistant and 2 for sensitive strains (including urinary sensitivity), The mean of these scores gives an 
indication of the global fluctuation of antibiotic sensitivity per year.  
 
Discussion 
The profile of treated bacterial strains involved in asymptomatic infection of enterocystoplasties 
is different from the most common strains involved in symptomatic infections. The bacterial 
profile in bacteriuria and symptomatic infection both correspond with a complicated urinary tract 
infection. The difference between the incidence of Proteus mirabilis in asymptomatic bacteriuria 
and symptomatic infection is typical in this particular group and may help to explain the 
incidence of bladder calculi in enterocystoplasties. Except for the Providencia strains, no direct 
correlation with stone formation was found for symptomatic infection with urease producing and 
other bacteriological strains. The formation of stones in enterocystoplasties is probably more 
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complicated in enterocystoplasties then in the normal bladder, due to the formation of mucus, 
additional surgical procedures to enhance continence and ease of catheterisation. Furthermore, 
Hygiene may play a more important role in the bacterial and antibiotic susceptibility profile and 
incidence of infections in patients with complex afflictions requiring bladder augmentation.  
Bacteriological aspects and relevance to antibiotic treatment 
The strains that were treated in case of bacteriuria were most often E.coli or  Enterococcus 
strains and mixed cultures. E.coli was less frequently treated in symptomatic infections, in 
contrast to Enterococcus strains and mixed cultures. The bacterial profile of these patients is 
typical for complicated infections and are similar between the bacteriuria evaluation and the 
symptomatical infections. This leads to the conclusion that the predisposing factors involved in 
the higher incidence of bacterial infections are more likely to be common for most of the 
frequent strains rather than strain specific. Strains that are treated less frequent in asymptomatic 
bacteriuria are more frequent in symptomatic urinary tract infections. Unfortunately many of 
these less frequently treated strains become more resistant to several antibiotics. The increase in 
resistance may lead to more symptomatic infections with the most common pathogens and 
bacteria that have adapted to the urine environment by the production of urease. 
Treatment of urinary infections and bacteriuria is usually by antibiotics such as Ciproxin, 
Amoxicillin/ clavulanic acid, Nitrofurantoin, or Trimethoprim/ Sulfamethoxazole. These last 
three antibiotics have been advocated by general practitioners in The Netherlands as the 
antibiotics of choice in most cases of urinary tract infection12. In most cases antibiotic treatment 
is advised without a bacterial identification or antibiotic resistance testing. Bacterial culture and 
antibiotic resistance testing is only advised by general practitioners in case of complicated 
urinary tract infections or two failures of treatments based on clinical evaluation only. In all 
cases antibiotic treatment is started before test results are final and follow-up deemed 
unnecessary in when symptoms are resolved. This guideline and the failure to recognize 
infections in enterocystoplasties as complicated urinary tract infections may lead to antibiotic 
resistance in these patients and failure of treatment or prophylaxis. In our study the most 
common antibiotics have the highest incidence for resistance, which can be found in several of 
the most common strains. Guided by their request for a clear definition of the subgroups that 
cannot be fitted to the general practitioners’ guidelines13, we therefore propose that preferably 
the group of enterocystoplasty patients with symptomatic infections should receive specific 
antibiotic treatment after bacterial culture and resistance testing of symptomatic infections 
followed by a follow-up urine evaluation of the eradication of the responsible bacterial strain. 
Bacteriuria in enterocystoplasties does not equal a symptomatic infection, although it may lead 
to some complications where vigilant prevention of recurrent or more pathogenic infections can 
be considered. Clearly in these patients the presence of symptoms due to a cellular reaction to 
infection is the indication for testing instead of the presumption that bacteriuria must be 
consistent with a urinary infection. In Western Europe, the most common uropathogen is E.coli 
with 80% of all isolates in normal bladders14 and 50% in augmented bladders6, which is too high 
to fit the profile of bacteriuria. In the more southern regions of Europe E.coli is still most 
frequent, but other bacterial strains such as Proteus, Klebsiella, Enterobacter and Citrobacter 
have a higher incidence14. Prevalence of different uropathogens and antibiotic resistances do not 
resemble that of the general population but are more comparable to those of nursing home 
patient in the same region in The Netherlands15. The prevalence of P.mirabilis in our patients is 
lower, due to vigilance of the urologists and general practitioners alike, although mixed cultures 
may include P.mirabilis. Similar to our patients resistance to Trimethoprim/ Sulfamethoxazole is 
frequent and can be attributed to prescribing habits. 
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However, P.mirabilis was not directly associated with stone formation, but could be correlated 
with several other factors that were correlated with stone formation. Hygiene and catheterisation 
problems could explain a higher incidence of urease producing bacteria. Infection with 
P.mirabilis, Pseudomonas spp. and other urease producing bacteria could be enhanced by lower 
limb paralysis, catheterisation problems or due to urine reflux in the absence of ureter 
reimplantation or other anti-reflux surgery leading to urinary stasis. These infections lead to a pH 
elevation that could induce stone formation. Medication unrelated to augmentation, such as 
vitamin C could have an influence on stone formation. The prescription preferences of clinicians 
influenced the overall antibiotic resistance profile.  
Urological aspects and relevance to treatment 
The most common risk factor for stone formation seems the presence of additional or 
concomitant surgical procedures to the augmented bladder as was previously described16. 
Vaginal reconstructions could not be confirmed in this group as a risk factor of stone formation. 
They could however be related to surgical procedures on the bladder neck which were correlated 
to stone formation. Mitrofanoff appendicovesicostomy could be related to stone formation. This 
should probably be attributed to catheterization problems and additional infections and regarded 
as a concomitant surgical procedure, as described above. The continence enhancing surgical 
procedures could be related to specific antibiotic resistances against common antibiotics such as 
Amoxicillin/ clavulanic acid and Trimethoprim/ Sulfamethoxazole. The continence enhancing 
procedures may enhance the incidence of resistance by creating urinary stasis in a 
prophylacticaly treated patient1. Antibiotic prophylaxis or treatment of patient with or without 
symptomatic infections is very similar and may lead to resistance and treatment failure when 
bacteriuria evolves into symptomatic infection. This could play a role for P.mirabilis infections 
when evaluating the number of symptomatic and asymptomatic infections of P.mirabilis in 
patients with lower limb paralysis. Furthermore, groups of afflictions and surgical procedures 
seem to involve a higher incidence of specific bacterial infections. This could mean a 
predisposition due to a changed anatomical structure on top of the already raised incidence of 
infections. 
The pH level is raised by the presence of intestinal tissue in the bladder but will increase further 
by the presence of urease. We propose that the incidence of stone formation in 
enterocystoplasties in the augmented bladder is not only due to a predisposition to infection but 
also to the smaller difference between the initial urine pH and the pH level needed for struvite 
and brushite precipitation. 
 
Conclusion 
Bacterial infection should be regarded as the result of poorly controlled bacteriuria. Bacteriuria 
should be treated preferentially without antibiotics, but not eradicated unless a clear antibiogram 
is available as for all complicated infections. Clean intermittent catheterization and bladder 
rinsing to prevent urinary stasis may have a more valuable role in this case. Antibiotics for 
enterocystoplasty patients should be separated into antibiotics for clinical treatment and a limited 
number of one or two antibiotics for prophylaxis and regularly evaluated for their efficacy as a 
prophylactic. Stone formation is related to urease producing bacteria  and bacterial infection 
which are related to additional and concomitant surgical procedures. Surgical procedures in the 
augmented bladder are especially a risk for stone formation in case of continence enhancing 
surgery. A more effective method of bacteriuria limitation either by enhancing antibiotic 
effectivity or inhibiting bacterial adhesion and infection to limit antibiotic use may be required to 
decrease antibiotic resistance and stone formation. 
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Identification U.T.I. Cases % of Total Sum % of Identification Identification Bacteriuria Cases
% of 
Total 
Sum 
% of 
Identification 
Unidentified/Negative 175 33.1%  Unidentified/Negative 46 41.1%  
Acinetobacter spp. 1 0.1% 0.3% Acinetobacter spp. 1 0.9% 1.5% 
Acinetobacter baumannii 1 0.1% 0.3%     
Acinetobacter lwoffii 1 0.1% 0.3%     
Aeromonas hydrophila/caviae 1 0.2% 0.3% Aeromonas hydro/caviae 3 2.7% 4.5% 
Burkholderia. Cepacia    Burkholderia. Cepacia 1 0.9% 1.5% 
Chrysemonas lutea     Chrysemonas lutea  1 0.9% 1.5% 
Citrobacter spp. 1 0.1% 0.3%     
Citrobacter amalonaticus 1 0.0% 0.3%     
Citrobacter freundii 11 1.8% 2.9% Citrobacter freundii 1 0.9% 1.5% 
Comamonas acidovorans 1 0.2% 0.3%     
Corynebacterium spp. 1 0.2% 0.3%     
Enterobacter     1 0.9% 1.5% 
Enterobacter avium      1 0.9% 1.5% 
Enterobacter cloacae 8 1.3% 2.1% Enterobacter cloacae 2 1.8% 3.0% 
Enterobacter intermedius 1 0.2% 0.3%     
Enterobacter sakazakii 1 0.2% 0.3%     
Enterococcus spp. 5 1.1% 1.3%     
Enterococcus avium 3 0.6% 0.8%     
Enterococcus faecalis 15 2.4% 4.0% Enterococcus faecalis 1 0.9% 1.5% 
Enterococcus faecium 1 0.2% 0.3%     
Escherichia coli 143 25.1% 37.8% Escherichia coli 21 18.8% 31.8% 
Klebsiella oxytoca 14 2.3% 3.7% Klebsiella oxytoca 2 1.8% 3.0% 
Klebsiella pneumoniae 15 2.0% 4.0% Klebsiella pneumoniae 1 0.9% 1.5% 
Mixed Cultures 35 6.6% 9.3% Mixed Cultures 10 8.9% 15.2% 
Morganella morganii 6 0.8% 1.6% Morganella morgangii 1 0.9% 1.5% 
Ochrobactrum anthropi 1 0.3% 0.3% Orchobacter antropii 1 0.9% 1.5% 
Pantoea spp.    Pantoea spp. 1 0.9% 1.5% 
Pasteurella heamolytica    Pasteurella heamolytica 1 0.9% 1.5% 
Pasteurella pneumotropica    Pasteurella pneumotropica 1 0.9% 1.5% 
Proteus mirabilis 20 2.7% 5.3% Proteus mirabilis 9 8.0% 13.6% 
Proteus vulgaris 2 0.1% 0.5%     
Providencia alcalifaciens 1 0.1% 0.3%     
Providencia rettgeri 3 0.2% 0.8%     
Pseudomonas spp. 5 1.2% 1.3% Pseudomonas spp. 1 0.9% 1.5% 
Pseudomonas aeruginosa 14 1.7% 3.7% Pseudomonas aeruginosa 1 0.9% 1.5% 
Pseudomonas pseudoalc    Pseudomonas pseudoalc. 1 0.9% 1.5% 
Pseudomonas stutzeri 2 0.5% 0.5%     
Serratia marcescens 4 0.7% 1.1% Serratia marescens 1 0.9% 1.5% 
Shigella dysenteriae    Shigella dysenteriae 1 0.9% 1.5% 
Staphylococcus spp. 13 2.5% 3.4%     
Staphylococcus aureus 14 2.8% 3.7%     
Staphylococcus epidermidis 6 0.8% 1.6%     
Stenotrophomonas maltophilia    
Stenotrophomonas 
maltophilia 
1 0.9% 1.5% 
Streptococcus spp. 14 2.8% 3.7%     
Streptococcus bovis 2 0.2% 0.5%     
Streptococcus intermedius 2 0.4% 0.5%     
Streptococcus intestinalis 1 0.3% 0.3%     
Streptococcus mitis 3 0.3% 0.8%     
Streptococcus oralis 2 0.4% 0.5%     
Streptococcus pneumoniae 2 0.2% 0.5%     
Streptococcus sanguinis 1 0.0% 0.3%     
Total identification 378  100.0% Total identification 66  100.0% 
Total 553 100.0%  Total 112 100.0%  
Table 1.A. Bacteriological identification of strains from symptomatic urinary tract infections and bacteriuria specimens in 56 children 
with an enterocystoplasty
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  AUG FUR CIP COT CFX TOB GEN Total 
Acinetobacter spp 1 1 1 1    1 
Citrobacter spp. 1 4  4 2 1 1 7 
Enterobacter spp. 2 2 1 3 1   5 
Enterococcus spp. 2 7 3 4 4 1  12 
Klebsiella spp. 7 7 3 6 2 1  11 
Mixed cultures 4 10 6 9 4 2 2 19 
Proteus spp. 3 4 2 5 1   7 
Providencia spp. 1 2 1 2 2 1 1 4 
Pseudomonas spp. 4 4 2 5 1 1 1 7 
Staphylococcus spp 5 5 5 6 2 2 1 11 
Streptococcus spp. 3 4 3 7 1 2 3 10 
Urease positive I 9 15 6 12 6 3 1 25 
Urease positive II 9 15 6 12 6 3 1 25 
Ba
ct
er
ia
l s
tr
ai
ns
 fr
om
 sy
m
pt
om
at
ic
 u
ri
na
ry
 
tr
ac
t i
nf
ec
tio
n 
Urease positive III 9 13 6 11 5 2  22 
 Total 11 20 10 19 6 5 4 35 
E.coli 6 8 3 8 2 2 2 13 
Mixed cultures 3 2 1 3 2 1 1 6 
Aeromonas hydro/ caviae  1  1    1 
Proteus mirabilis 3 2 2 4   1 5 
Klebsiella spp.   1 1   1 1 
Pasteurella spp. 1   1    1 
Citrobacter spp. 1  1     1 
Pseudomonas spp. 1 1 1 1 1   3 
Ba
ct
er
ia
l s
tr
ai
ns
 fr
om
 
as
ym
pt
om
at
ic
 b
ac
te
ri
ur
ia
 
Other Strains 2 6 2 6 1 2 1 8 
 Total 12 18 7 20 6 4 5 32 
 
Table.4. Antibiotic prescriptions by clinicians.  
Bacterial strains in symptomatic and asymptomatic urinary tract infection for enterocystoplasty patients previously  under 
antibiotic therapy and prophylaxis. Bacterial infections occur despite antibiotic treatment or prophylaxis. Numbers represent 
the number of patients. AUG= Augmentin, FUR= Nitrofurantoin, CIP =Ciprofloxacin, CFX= Cefuroxim, TOB = 
Tobramycin, GEN = Gentamycin. Urease positive I = Urease positive III + Citrobacter spp. +Providencia spp. , Urease 
positive II = Urease positive III + Citrobacter spp. , Urease positive III = Enterobacter spp. + Enterococcus spp. + 
Klebsiella spp. + Proteus spp. + Serratia spp.  
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Additional comment 
From the findings in the comparative study on bacteriological infections of the enterocystoplasty 
and bacteriuria, it becomes clear that community acquired infections should be checked for the 
correct bacteriological strain and treated specifically instead of the empirical treatment, often 
used in general practice. The use of broad spectrum antibiotics and the preferential use of certain 
antibiotics such as cotrimoxazol and amoxicillin (/clavulanic acid) to treat the urinary tract 
infections seen in enterocystoplasties have a tendency to transform the characteristics of a 
community acquired infection into a nosocomial infection due to the increased resistance among 
bacterial strains. Furthermore, the high degree of mixed cultures and low frequency of detected 
P.mirabilis infections may be explained by intracellular infection and increased resistance may 
thus explain the formation of stones; this will be discussed in chapter 4. In the next chapter the 
interaction between the enterocystoplasty and the urine content will be discussed in relation to 
bacterial/crystal adhesion and crystal formation as it seems that infection of the enterocystoplasty 
increases the pH level of the urine content conditioned by the enterocystoplasty, which correlates 
with stone formation The high number of mixed cultures may mask a number of P.mirabilis 
infections. Further research has to be done whether a specific search for urease producing 
bacterial strains among patients with an enterocystoplasty will benefit stone prevention by more 
specific antibiotic therapy of these strains. At this point we can not advocate a specific search for 
urease producing bacteria with current laboratory testing to identify them in mixed cultures, but 
clearly identification of uropathogens should preceed specific antibiotic treatment of  
symptomatic urinary tract infections in enterocystoplasties 
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Abstract 
 
Purpose:  
Cells are a major component of mucus in enterocystoplasties. In this study we evaluated the role 
of secreted mucins on cells and cellular membranes as crystal adhesion and agglomeration 
mediators in infected artificial urine.  
 
Materials and methods:  
Five human intestinal cell lines,  HT29, HT29-18N2, HT29-FU, HT29-MTX, Caco-2 and one 
ureter cell line, SV-HUC-1 were incubated for 3 hours in artificial urine with P.mirabilis 
(ATCC49565) in monolayer and scraped conditions. We isolated Triton X-100 soluble 
membrane proteins from cells to evaluate the effect of MUC2 and MUC5AC as membrane 
associated proteins on crystal formation and crystal adherence. Scanning electron microscopy , 
Light microscopy, Coulter Counter measurements and X-ray Microanalysis (XRMA) were used 
to evaluate crystal formation. 
 
Results:  
Brushite crystals where found adhered to cellular surface sites rich in sulphur as crystal 
agglomerates. Smaller and more numerous crystals were observed in the presence of scraped 
cells. Crystal formation and agglomeration was inhibited by the presence of MUC5AC, whereas 
MUC2  had the opposite effect. Both are present on cellular membranes and are rich in sulphur. 
Cellular invasion by bacteria occurred in all cell lines. 
 
Conclusion:  
Membrane associated cellular secretions such as MUC2 and 5AC are important crystal adhesion 
molecules on cells. The effects of secreted MUC2 and MUC5AC on stone formation by crystal 
adhesion are similar, but different for crystal agglomeration. The effects of MUC2 and 
MUC5AC may explain the high incidence of bladder calculi in enterocystoplasties and 
emphasize the role of cellular surfaces in urine. 
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Introduction 
Calcium phosphate and struvite stone formation is well known in enterocystoplasties. Important 
contributing factors are bacterial colonization and mucus formation1-5. Bacterial derived urease 
production is implicated in making urine conditions favourable for the formation of bladder 
calculi in enterocystoplasties 4,6. Bacterial capsules have been suspected to concentrate and 
induce struvite crystals7. Mucus has been regarded to contribute both by providing a basis for 
bacterial and crystal retention and by effecting crystal formation and growth8-11. Mucus clearance 
has thus been regarded as an important means for prevention of bladder calculi in 
enterocystoplasties5. Urine collected from enterocystoplasties has a high content of mucins that, 
given their biochemical structure, can enhance crystal formation8. In addition there are numerous 
cells, due to the high turn over of cells in the enterocystoplasty and bacterial infection. It is not 
clear how these cells and their membrane proteins influence crystal growth and agglomeration. 
Finally it is not known which of these factors, cells, cell membranes and mucins, are involved in 
the attachment of crystals to the bladder wall in enterocystoplasties. In this study we therefore 
evaluated the influences of cell membranes and mucins on crystal formation, adhesion and 
agglomeration in infected artificial urine in-vitro to determine the role of cells in urine as a major 
component of mucus in enterocystoplasties. 
 
 
Materials and Methods 
Bacterial culture 
One Proteus mirabilis strain was attained from the ATCC (49565) and stored in 15% glycerol at 
-80°C until needed. P. mirabilis was cultured in Luria broth 0.05% glycerol until late lag-phase 
growth before use.  
Cell culture 
We used 5 intestinal cell lines, caco-2, HT-29, HT29-18N2, HT29-FU, HT29-MTX and one 
ureter cell line, SV-HUC-1. Caco-2 and HT-29 were obtained from the ATCC and used within 
15 passages. SV-HUC-1 was obtained from the ATCC and used from passage 30 to passage 34. 
The HT29-FU and HT29-MTX were gifts from Dr.T.Lesuffleur (INSERM U505, Centre de 
recherche Biomédicales des cordeliers, Paris, France), HT29-18N2 was a gift from 
Dr.D.Louvard (UMR 144 CNRS-Institut Curie, 25 rue d'Ulm, 75248 Paris, Cedex 05). All 
intestinal cell lines were cultured on DMEM-high glucose with glutamine, 10% FBS and 5mM 
NEAA. SV-HUC-1 was cultured on Ham’s F12 supplemented with 10% FBS. 
 
Cell Culture and lysed cells infection:  
The cell lines were cultured in 6 wells plates and upon reaching confluency divided in two 
groups. One group was scraped, one left intact. To both groups 3 ml artificial urine was added 
and incubated for 3 hours. After 3 hours both groups were infected with 100µl  bacterial 
suspension, corresponding with 1.7x105 bacteria/ml, and incubated for 3 hours before 
microscopic evaluation.  
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35S Pulse-Chase cell labeling and Immunoprecipitation 
Cells were preincubated for 1 hour with L-glutamine, methionine and cysteine free DMEM 
(Sigma- Aldrich D0422), labeled with 7 MBq/ml Redivue Promix L-[35S] in vitro cell labelling 
mix in culture medium for 45 min, followed by a 2 hour chase with DMEM supplemented with 
10%FBS to label mucin precursors. Membrane proteins were isolated and 100 µl was 
precipitated for 2 hours at 4°C with 100µl 1:4 diluted Goat-anti-mouse agarose in PBS (Sigma-
Aldrich A6531) preincubated for 2 hours with monoclonal anti-MUC-2 (NCL-MUC-2, 
Novocastra Laboratories Ltd.) or anti-MUC-5AC (NCL-MUC-5AC, Novocastra Laboratories 
Ltd.) antibodies. The 35S- labeled mucin precursors were quantified in a liquid scintillation 
counter by measuring the relative 35S contribution of the mucin precursors to the total 35S 
incorporation. Cells were grouped according to mucin production. 
 
Protein isolation 
Cell membranes were isolated from confluent cell cultures to ensure differentiation. Cells were 
washed with ice cold PBS and scraped with a protease inhibitor cocktail (Complete ™, 
Boehringer Mannheim), centrifuged at 3000 rpm for 10 min. The pellet was washed in PBS/ 
protease inhibitor and centrifuged at 2000 rpm for 5 min. For every 107  cells 200 µl RIPA buffer 
was added containing 10mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 
0.1% SDS and 5 mM EDTA. Triton X-100 soluble membrane proteins (TXSP) were acquired to 
contain membrane (glyco)proteins including membrane associated and intrinsic membrane 
proteins. The pellet was resuspended and placed on ice for 15-20 minutes, and centrifuged at 
14000 rpm for 25 minutes at 4°C.  The supernatants were stored at –20°C as 5 mg/ml stock 
solutions. The protein concentration was measured using a protein assay as described by 
Bradford (Bio-Rad), measuring the absorption at 595 nm.  
 
SDS-PAGE 
We used SDS-PAGE to identify pulse chase labeled immunoprecipitates of MUC2 and 
MUC5AC. Ten µl of immunoprecipitated labeled MUC2 and MUC5AC from different cell lines, 
homogenized human colon mucosa and samples of centrifuged and dialysed urine from 
enterocystoplasties was added to 10µl of 2x Laemli buffer. Samples were boiled for 5 minutes 
before analysis on 3% stacking/ 4% separating SDS-PAGE containing glycine. Samples were 
run for 2.5 hours at 100 mV in a mini-protean II dual Slab Cell (Biorad). Some gels were stained 
with Coomassie brilliant blue, Alcian blue -periodic acid Schiff (AB-PAS), or Alcian Blue -
silver to determine the presence of (sulphated) glycoproteins. 
 
Artificial Urine Composition 
Two separate solutions were made to ensure the stability of the solutions. Solution A consisted 
of: 1.3 g/l sodium citrate, 1.3 g/l KH2PO4 , 2.0 g/l sodium oxalate and 25 g/l urea in distilled 
water. Solution B consisted of: 1.3 g/l CaCl2, 1.3 g/l MgCl2, 9.8 g/l NaCl, 4.6 g/l NaSO4, 3.2 g/l 
KCl, 2 g/l NH4Cl and 25 g/l urea in distilled water. Both solutions were combined in equal 
volumes, less than one hour before starting experiments. Artificial urine of pH 6.5 without NaCl, 
NaSO4, and KCl and with 12.5 g/l urea, resulting in a lower osmolarity of 316 mosm, was used 
on cells to prevent artefacts due to high osmolarity. 
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Coulter Counter measurements 
Four dilutions of TSXP-proteins were made in artificial urine, 0.5mg/ml, 0.125mg/ml, 
0.031mg/ml, 0.007mg/ml TXSP, and 100 µl of bacterial solution in Luria broth/0.05% glycerol 
was added. To achieve pH 7.3 and higher, sufficient for precipitation of calcium phosphate and 
struvite, they were incubated at 37°C for 3 hours. Effects on particle size, number and bacterial 
association was evaluated by the distribution at 5%, 1%, and 0.1% cut-off values of controls and 
comparing the area under the curve below and above 3.9 µm in a Beckman Coulter Counter 
Multisizer. To measure crystal formation, the infected solutions were diluted in distilled water 
filtered three times over a 0.2 µm pore size filter. A second measurement after addition of 20 µl 
37% hydrochloric acid to dissolve calcium apatite and struvite crystals served as the background 
measurement containing bacteria, proteins and debris. In addition by selecting an appropriate 
range of 3.90 µm and larger, the bacterial contribution to the particle number was eliminated and 
only true crystal formation and agglomeration effects were studied. All experiments were 
performed in triplicate. Measurements were evaluated by Z* distribution,  Friedman’s test, 
Wilcoxon signed ranks tests, Pearson  and Spearman correlation, and paired samples t-tests 
where appropriate.  
 
Light Microscopy 
Infected dilutions were evaluated at 200x and 400x magnification to identify crystal types and 
crystal formation. A second observer confirmed all light microscopic evaluations of crystals. The 
second observer was not blinded for two observations and blinded for one. One observer did not 
have previous knowledge crystal morphology. Difference in assessment led to re-evaluation of 
samples.  
 
Scanning Electron Microscopy 
Cells were cultured on coverglass until confluency. Infected TXSP-protein solutions were 
filtered over 0.05 µm pore size millipore filters and fixed in 2.5% glutaraldehyde/ 0,15M 
cacodylate pH 7.4 for 2 hrs. Filters and cells were washed in 0.1M cacodylate pH 7.3 twice for 
15 minutes. One percent OsO4 /0.1 M cacodylate pH 7.3 was added and incubated at room 
temperature for 1 hour. Samples were washed overnight in 0.1M cacodylate pH 7.3 at 4°C. One 
percent tannic acid in 0.05M cacodylate pH 7.0 was added and incubated for 1hour at room 
temperature, washed in distilled water for 10 minutes, followed by alcohol dehydration. The 
samples were washed with ethanol 100% and 1ml hexamethyldisilazane (HMDS) and dried 
under 0.5 ml HMDS for optimal preservation of cell morphology. They were mounted on 
aluminium stubs with colloid silver and gold-palladium sputter coated before viewing under a 
JEOL-JSM25 electron microscope with a blinded second and third observer. Two observers had 
no previous knowledge of crystal morphology. The experiment was done twice with cells and 
once with filters. 
 
X-ray micro analysis (XRMA) 
To verify morphological determination of crystal composition and determine characteristics of 
the crystal adhesion site, X-ray microanalysis was performed. Cells were prepared similar to 
SEM samples but were mounted on carbon stubs with colloid silver and coated with carbon 
before viewing under a Philips 525M SEM with an energy dispersive spectrometry system 
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(EDAX-DX4). A Z-MAX light element detector was used for quantification. For the X-ray 
microanalysis (XRMA) with a Voyager XRMA System (NORAN Instruments Inc.) the 
acceleration voltage was adjusted to 10 keV using a point analysis during a live time of 100 
seconds. Elements were identified by X-ray spectra emitted due to changed electron energy 
levels. The used magnifications depended on the size of the target. Measurements were made 
from at least 3 sites with brushite crystals and control measurements of bacteria, cells and 
coverglass in one experiment. A blinded second and third observer confirmed observations. One 
observer had no previous knowledge of crystal morphology. 
 
Confocal Laser Scanning Microscopy (CLSM) 
Cells were cultured on coverglass until confluency. For evaluation of bacterial adhesion and 
invasion, cells were infected with P.mirabilis for 3 hours. Cells were maintained at 37°C and the 
viable stain Syto 16 was applied. The first antibody against P.mirabilis (Biogenesis, Nuclilab) 
was added and incubated for 15 min. A TRITC labeled anti-mouse-antibody was applied and 
incubated for 15 min. For evaluation of mucin location cells were incubated with NCL-MUC-2 
or NCL-MUC-5AC, washed with DMEM, incubated with the FITC labeled secondary antibody 
and washed with DMEM. Incubation steps were 45 minutes in DMEM. Images were made with 
a Zeiss LSM 410 laser scanning confocal microscope (Zeiss, Oberkochen, FRD). A 488 nm Ar-
laser was used to excite the TRITC labeled anti-Proteus mirabilis antibodies. The TRITC signal 
was passed through a 510-540 nm band-pass filter. An overlay of the Syto 16 or FITC signal was 
done using the 488 nm  laser and a 560 nm beam splitter to separate the Syto 16 signal from the 
TRITC signal, showing bacterial infection or mucin location. The experiment was repeated twice 
and results were confirmed on representative samples by a blinded second observer. 
 
 
Results 
Immunoprecipitation and SDS-PAGE 
All the cell lines produce both MUC2 and MUC5AC, but differ in the produced amounts (Table 
1.). SDS-PAGE of immunoprecipitates shows smears of mucin dimers and monomers, larger 
than 250kDa and corresponding to Alcian blue-Silver staining of MUC2 and MUC5AC 
immunoprecipitates from homogenized human colon and patient urine (Fig.1.B) and TXSP’s on 
AB-PAS staining (Fig1.A). Many are sulphated glycoproteins,  mucins or mucin-like, as 
demonstrated by AB-PAS staining of SDS-PAGE and larger than 250kDa. Both MUC2 and 
MUC 5AC contain sulphated groups and sugar residues and are larger than 250 kDa. Two equal 
groups representing MUC2 producing cell lines HT29, HT29-18N2, HT29-FU and MUC2 
negative cell lines were made. Two similar groups were made for MUC5AC producing cell lines 
SV-HUC-1, HT29, Caco-2, and MUC5AC negative cell lines.  
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Fig. 1.A. Alcian b1ue/ Periodic acid-Schiff staining of 10% .SDS-PAGE. Strongest staining of sulphated 
and glycosylated protein precursors above 250 kDa can be found in all cell lines, gastric and colonic 
mucosa. St, border between stacking and separating gel, 1, human gastric mucin. 2, human colonic mucin. 
3, P. mirabilis capsule. 4, Caco-2, 5, HT29-MTX. 6, HT29-FU. 7, HT29-18N2. 8, HT-29, 9, SV-HUC-1 
 
 
 
Fig 1.B. SDS-PAGE of immunoprecipitated MUC2 and 5AC and 35S-Pulse-Chase labeled MUC2 and 
5AC precursors. 1, Caco2. 2, SV-HUC-1 3, HT29 4, HT29-18N2. 5, HT29-FU 6, HT29-MTX 
Left : MUC2 immunoprecipitates of 35S labeled Mucin precursors 
Right :MUC5AC immunoprecipitates of 35S labeled mucin precursors 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig 2, Light microscopy of Caco-2 cells after infection with P. mirabilis, A, Small twinned crystals 
occurred in artificial urine with scraped cells and incubated for 3 hours with P. rnirabilis, B, large crystals 
formed when crystals were not scraped comparable to wells without cells (not shown), Reduced from x400. 
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Fig 3.  
Infected membrane dilution 
series of HT29-FU in artificial 
urine incubated for 3 hours 
A,1/10 dilution: 0.5 mg/ml 
TXSP B, 1/40 dilution: 0.125 
mg/ml TXSP C, 1/160 
dilution: 0.031 mg/ml TXSP, 
1/640 dilution: 0.007 mg/ml 
TXSP.  
Decrease  in transparency can 
be observed due to bacteria, 
with smallest crystals in part 
A and largest crystals in part 
D Reduced from x200 
 
  
Light microscopy 
Lysed and non-lysed cells: 
Light microscopically crystals formed after 2.5 hours in artificial urine at pH values between 7.0 
and 7.5. They appeared as calcium phosphate twinned crystals, and often agglomerated with 
scraped cells. Wells containing scraped cells expressed more and smaller crystals at an earlier 
time than the wells containing adherent cells (Fig. 2). Crystals in wells containing adherent cells 
were similar to crystals without cells. The use of an artificial urine with a lower osmolarity gave 
similar results but with an increased crystallization induction time.  
TXSP- protein dilutions:  
We found larger typically twinned and amorphous crystals at increasing dilutions in most cell 
lines. This was difficult to evaluate objectively by light microscopy and we therefore rely on 
coulter counter data for quantification of TXSP and mucin effect. An increase in bacterial growth 
on the bottom of the wells was observed with increasing protein concentration, microscopically 
as a decrease in transparency (Fig. 3). 
 
  
 
Confocal Laser Scanning Microscopy (CLSM) 
Patches of bacterial biofilm were formed on the non-detached cells and exposed glass surface. 
Bacterial invasion of cells was frequent in all cell lines(Fig4.A.). MUC2 and MUC5AC were 
expressed mainly on the cellular membrane. In cases of high expression of mucins, staining also 
occurred in the cytosol, mainly as granules (Fig.4).  
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EVALUATION 
PURPOSE METHOD 
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BACTERIAL 
INVASION AND 
ADHESION 
C-LSM: Syto16-TRITC (2x) + + + + + + 
Immunoprecipitation of Pulse-Chase labeled 
mucin precursors (35S): MUC-2 measured in 
Liquid Scintillation Counter (CPM/ % of total 35S- 
label) 
551 / 
0.26% 
396 / 
0.08% 
7326 / 
0.64% 
6410 / 
0.39 
2848 / 
0.49% 
2921 / 
0.28% 
Immunoprecipitation of Pulse-Chase labeled 
mucin precursors (35S): MUC-5AC measured in 
Liquid Scintillation Counter (CPM/ % of total 35S- 
label) 
889 / 
0.44% 
2096 / 
0.44% 
3209 / 
0.28% 
2640 / 
0.16% 
981 / 
0.17% 
1749 / 
0.17% 
Ratio MUC2: MUC5AC 0.59 0.18 2.26 2.40 2.90 1.64 
RELATIVE 
MUC2 AND  
MUC5AC 
CONTENT IN 
RIPA 
ISOLATION 
MUC2+ MUC5AC (% of  total 35S- label in 
RIPA) 0.71% 0.51% 0.93% 0.55% 0.66% 0.45% 
QUALITATIVE 
EVALUATION 
OF CRYSTALS 
Scanning Electron Microscopy 
Crystal/ Largest agglomerate size range (µm) 
2.6 / 
36.0 
4.2 / 
17.0 
3.4 / 
17.4 
3.6 / 
23.4 
4.0 / 
13.3 
4.5 / 
58.5 
Average Coulter Counter measurements: Mean 
crystal size (µm) * 
6.6 7.8 8.9 6.6 6.1 7.2 
Average Coulter Counter measurements: Mean 
crystal number in 3.9 to 20 µm range over 70 
channels 
1617 752 994 1213 3353 587 QUANTITIVE 
EVALUATION 
OF CRYSTALS 
Average Coulter Counter measurements: 
Maximum Particle number in 3.9 to 20 µm range° 
17367 17197 9021 11247 18889 20060 
 
Table 1. Individual cellular and crystal characteristics. Coulter Counter *Significantly correlated with (p<0.05) with 
1/mean crystal number °Significantly correlated with counts (CPM) of  35S  in pulse-chase labeled MUC2 and MUC5AC 
Immunoprecipitations (p<0.05) but not with the 35S- count of unprecipitated 35S-labeled proteins 
 
 
TXSP 
(mg/ml) 
1/10 
dilution 
(0.5)++ 
1/40 
dilution 
(0.125) 
1/160 
dilution 
(0.031) 
1/640 
dilution 
(0.007) 
Average number 
of crystals with 
bacteria** 
BSA 
(mg/ml) 
2891 
(0.400) 
3898 
(0.100) 554 (0.025) 
846 
(0.007) 
Average 
number of 
crystals** 
Average 
total crystal 
surface 
(µm2) 
Average 
total crystal 
volume 
(µm3)+++ number % 
Bacterial/ 
crystal 
surface 
area*** (%) 
Caco-2* 76184 74628 257118 66544 118618.5 67012.00 17555402 37442.3 31.57 37.4 
SVHUC-1 107589 86465 103734 84239 95506.75 78382.00 5203390 67866.3 71.06 10.9 
HT29+ 197811 120430 86030 65861 117533.0 105978.0 16737596 74236.0 63.16 8.1 
HT29-
18N2 129186 90700 106909 86279 103268.5 75654.00 24960915 66546.1 64.44 8.1 
HT29-FU* 153222 100545 114213 367040 183755.0 143044.0 10822694 27414.5 14.92 38.4 
HT29MTX 128475 103082 143102 101459 119029.5 72801.00 39714443 23618.5 19.84 40.0 
Average 132077 95974 135183 128069 122825.8 92404.00 3034931 46828.3 38.13 23.8 
 
Table 5.Particle number effect of TXSP’s compared to BSA. Mean total particle number of three measurements. TXSP’s 
from these cell lines all increase the mean total crystal number (Friedman’s two way analysis of variance χ2=15.4 
,p=0.031, mainly due to the second dilution compared to the first and third but not due to variance between cell lines, 
according to Wilcoxon Signed ranks tests) 
**Average numbers represent the mean raw count over the four dilutions corrected for the background  assuming that all 
particles below 3.9µm after subtraction of background are bacteria..***Bacterial surface area is represented as a 
percentage of the crystal surface area, assuming that all particles below 3.9µm after subtraction of background are 
bacteria and correlated to the 35S count from MUC5AC precipitates (p<0.05) +Crystal particle numbers are significantly 
correlated with concentration of TXSP. ++ The 1/10 dilutions (0.5mg/ml TXSP) are significantly correlated with the 
average total crystal surface and MUC2 concentration (p<0.05). All TXSP’s enhance the mean total particle number  
significantly in paired samples t-test except * (p<0.05, all are significant in one-sided paired samples t-test with BSA as 
a negative control). +++Average total crystal volume is correlated with the MUC5AC concentration. 
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Fig.4.A. Confocal Laser Scanning Microscopy image of P.mirabilis infected HT-29 cells 
stained with viable stain (Syto 16, green) and bacteria stained with a primary anti-
P.mirabilis antibody and a secondary TRITC labeled antibody (red).  A) Bacterial colony, 
bacterial patches were found on glass and cellular surface. B) Apoptotic cell, C) Invading 
P.mirabilis, D)cytoplasmatic infection and invasion of HT-29 cell. Reduced from x800 
 
 
A
B
C 
D
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Coulter Counter Measurements 
After dissolution of the crystals by HCl, the bacteria that previously adhered to the crystal mass 
were freed, apparent as a particle number increase between 1.97 to 3.70 µm.  The number of 
liberated bacteria was sufficient to cover an average of 23.8% (sd= 14.8%) /2= 11.9% of the 
original crystal surface, ranging from 0 to more than 100%. This was correlated with the 35S 
count after MUC5AC (p=0.023) but not MUC2 precipitation. 
A concentration dependent effect on particle size and number was observed for the average 
particle numbers for the dilutions of the different cell lines (Fig. 5). A correlation between 
sulphur incorporation and particle size and maximum number (Table 1.) was demonstrated. 
Fig.4.B. CLSM picure of cells 
stained with anti-MUC2 (A) and 
anti-MUC5AC (B) antibodies 
and secondary fluorescein 
isothiocyanate – labelled 
antibody. Staining occurs 
primarily on granules (arrow a) 
and membranes (arrow b). 
MUC2 staining of Caco-2 and 
MUC5AC staining sre more 
diffuse but include cellular 
membrane  1, Caco-2, 2, SV-
HUC-1, 3, HT-29, 4, HT29-
18N2, 5, HT29-FU, 6, HT-29-
MTX 
a 
b 
Fig.5. Average coulter 
counter measurements of all 
protein dilutions. 
Concentration dependent 
effect can be observed for 
distribution of large particles. 
Highest peak corresponds 
with single crystals while 
plateau corresponds with 
crystal agglomerates. Solid 
line indicates 1/10 dilution: 
0.5 mg/ml TXSP. Dashes 
indicate 1/40 dilution: 0.125 
mg/ml TXSP. Dots represents 
1/160 dilution: 0.031 mg/ml 
TXSP. Intermittent dashes and 
dots indicate 1/640 dilution: 
0.007 mg/ml TXSP. 
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MUC2 induced the formation of larger crystals (Table 2.) whereas MUC5AC induced smaller 
crystals (Table 3). The effect of MUC2 and 5AC on the mean particle number over all channels 
in the 3.9 to 20 µm range is presented in Table 4. The concentration dependent effect of TXSP’s 
on the mean total particle number is mainly due to TXSP’s from HT29 (Table 5.), which also 
produces the most MUC2 and 5A 
 
 
Diameter(µm) Concentration MUC2 (mg/100ml) Mean Total Count cut-off value (%)
MUC2+ 
(% outside 95%, 99% and 99,9% distribution of  the Muc2- 
control) 
6.792 5 81.26 11.56 15.44 45.18 
9.081 1 38.22 4.90 6.91 23.59 
14.36 
0.103 104082 
0.1 8.06 0.68 0.48 1.15 
7.101 5 87.00 11.98 16.40 48.83 
10.42 1 31.62 3.75 4.65 16.02 
16.15 
0.0258 88058 
0.1 2.53 0.44 0.17 0.27 
10.01 5 18.32 2.24 2.93 10.14 
12.59 1 9.95 0.85 0.79 2.56 
17.06 
0.0064 167984 
0.1 0.50 0.13* 0.04 0.06 
7.937 5 69.82 8.98 13.09 41.21 
10.81 1 30.58 3.45 4.11 13.97 
M
U
C
2-
 
16.34 
0.0016 83080 
0.1 2.20 0.43 0.16 0.24 
Mean Total Count 160072 103891 102838 173060 
Concentration MUC2 (mg/100ml) 0.253 0.063 0.016 0.004 
Table 2. Coulter Counter measurements of MUC2 effect on crystal size.  MUC2- cell lines: SV-HUC-1, 
Caco-2, HT29-MTX; MUC2+ cell lines:HT-29, HT29-18N2, HT29-FU. Mucin concentrations were 
estimated from to the percentage of 35S incorporation in mucin precursors compared to the total amount of 
incorporated 35S and the measured amount of proteins isolated in RIPA. The mean total count is the 
corrected mean particle count over three measurements. 
All differences are significant (p<0.001 except *, p<0.05) in Z*-distribution. MUC2 enhances the 
formation of larger crystals (Friedman test χ2=26.5, p<0.01) 
 
Diameter(µm) Concentration MUC 5AC (mg/100ml) 
Mean Total 
Count 
cut-off 
value (%)
MUC5AC- 
(% outside 95%, 99% and 99,9%distribution of  the Muc5AC+ 
control) 
9.998 5 24.06 1.80 4.11 16.31 
13.39 1 11.51 0.50 0.72 2.42 
17.49 
0.1939 127194 
0.1 0.39 0.08NS 0.05 0.06 
7.586 5 49.98 5.16NS 13.03 46.50 
11.39 1 26.18 1.51 2.90 11.13 
16.44 
0.0484 93841 
0.1 1.86 0.22 0.14** 0.23 
10.27 5 19.73 1.41 3.12 12.35 
12.73 1 12.15 0.55 0.89** 3.23 
17.3 
0.0121 148960 
0.1 0.42 0.07* 0.05 0.07** 
7.999 5 60.21 5.90 15.06 55.47 
10.52 1 39.74 2.72 5.84 22.95 
M
U
C
5A
C
+ 
15.87 
0.0030 71214 
0.1 4.45 0.37 0.28 0.53 
 Mean Total Count 137000 98109 121400 184900 
 Concentration MUC 5AC(mg/100ml) 0.0834 0.0209 0.0052 0.0013 
Table 3. Coulter Counter measurements of MUC5AC effect on crystal size.  MUC5AC- cell lines: HT29-
18N2, HT29-FU,HT29-MTX; MUC5AC+ cell lines:HT-29, Caco-2, SV-HUC-1. Mucin concentrations were 
estimated from to the percentage of 35S incorporation in mucin precursors compared to the total amount of 
incorporated 35S and the measured amount of proteins isolated in RIPA. The mean total count is the 
corrected mean particle count over three measurements. 
All differences are significant (p<0.001 except*=p<0.05, **= p<0.01 and NS=non-significant) in Z*-
distribution. MUC5AC inhibits the formation of larger crystals (Friedman test χ2=30.3, p<0.01) 
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0.1939 688.6 0.0834 690.6 -2.0 868.7 103.8 -209.1 205.1 0.985 
0.0484 516.1 0.0209 174.1 342.0 787.1 93.4 155.7 528.3 <0.001 
0.0121 1411.2 0.0052 650 761.1 1334.3 157.2 447.5 1074.6 <0.001 M
U
C
 
5A
C
+ 
0.0030 571.3 
M
U
C
 
5A
C
- 
0.0013 3702.5 -3131.2 2585.0 306.8 -3743.1 -2519.4 <0.001 
0.253 1409.3 0.1030 364.2 1191.7 1503.8 179.7 833.1 1550.3 <0.001 
0.063 197.5 0.0258 503.3 -363.0 904.8 107.4 -577.1 -148.8 0.001 
0.016 498.9 0.0064 1491.2 -992.3 1159.5 136.7 -1264.8 -719.9 <0.001 M
U
C
2
+ 
0.004 1685.6 
M
U
C
2
- 
0.0016 515.2 1082.1 939.0 111.4 859.9 1304.4 <0.001 
0.1939 688.6 200.00 382.3 458.2 1057.6 135.4 187.3 729.1 <0.001 
0.0484 516.1 50.00 191.3 363.9 1015.3 125.0 114.3 613.5 <0.001 
0.0121 1411.2 12.50 314.9 1144.4 1707.5 210.2 724.6 1564.1 0.002 M
U
C
 
5A
C
+ 
0.0030 571.3 
B
SA
 
6.25 610.1 917.6 1488.2 317.3 257.8 1577.5 0.038 
0.253 1409.3 200.00 382.3 1439.9 1116.9 144.2 1154.4 1728.4 <0.001 
0.063 197.5 50.00 191.3 3.9 240.0 29.5 -55.1 62.9 <0.001 
0.016 498.9 12.50 314.9 138.9 1021.9 125.8 -112.3 390.1 0.885 M
U
C
2
+ 
0.004 1685.6 
B
SA
 
6.25 610.1 2757.9 1344.5 286.7 2161.8 3354.0 0.003 
0.0834 690.6 200.00 382.3 420.7 363.0 46.9 326.9 514.5 <0.001 
0.0209 174.1 50.00 191.3 -4.0 316.4 39.0 -81.8 73.8 <0.001 
0.0052 650 12.50 314.9 228.2 1402.2 172.6 -116.5 572.9 0.550 M
U
C
 
5A
C
- 
0.0013 3702.5 
B
SA
 
6.25 610.1 6283.3 2168.7 462.4 5321.7 7244.8 0.005 
0.1030 364.2 200.00 382.3 109.2 1130.0 144.7 -180.2 398.6 0.126 
0.0258 503.3 50.00 191.3 394.4 1132.9 139.4 115.9 672.9 <0.001 
0.0064 1491.2 12.50 314.9 1199.6 1868.6 230.0 740.2 1658.9 0.008 M
U
C
2
- 
0.0016 515.2 
B
SA
 
6.25 610.1 861.5 1509.1 321.7 192.4 1530.6 0.0510    
 
Table 4. Coulter Counter measurements of particle number. Mean differences over 70 channels in particle 
number in a 3.9 to 20 µm range evaluated in paired samples t-test. Sd=standard deviation, se=Standard 
error of the mean, C.I.95%= 95% confidence interval. 
 
 
Scanning Electron Microscopy 
Infected cells on coverglass 
Scanning Electron Microscopy showed agglomeration of brushite crystals on cells. This was 
found for all the infected samples. No crystals were found on the non-infected controls. Patches 
of bacterial colonies adhered to the cellular surface of the intestinal and between cells of the 
ureter cell line (Fig. 6). The composition of the crystals was confirmed by XRMA and in 
addition to calcium and phosphorus a relatively high sulphur peak at the site of crystal adhesion 
was observed (Fig. 7) 
Filtered infected protein dilutions 
Scanning Electron Microscopy showed that the larger crystals were all agglomerates of smaller 
crystals. Crystals were similar to the crystals found on the surface of infected cells. In most cases 
no bacteria were found on crystals except on agglomerates. Most large agglomerates were 
composed of flat trapezoid crystals agglomerated to form a rosette, which can appear as an 
amorphous crystal when viewed laterally (Fig. 6.C.). 
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Fig.6. Scanning Electron Microscopy. A) Bacterial adhesion to microvilli on HT29-MTX. Arrow a indicates 
microvilli. Reduced from x 15.000 (bacterial size 1.7 by 0.2 micron). B) crystal adhesion to cellular surface 
as crystal agglomerates. Arrow b indicates crystal agglomerate. Reduced from x 3.000. C)Agglomerated 
crystals (rosette) in 0.5 mg/ml TXSPs from Caco-2 consisting of smaller trapezoid crystals. Reduced from x 
7.000. D) Brushite needles (3 µm) agglomerated by 0.007 mg/ml TXSP from Caco-2. Reduced from 15.000. 
Asterisk indicates bacteria. 
 
Discussion 
In this study we show that bacterial infection first induces the formation of brushite crystals in 
artificial urine instead of struvite, adhered to the cellular surface at sites relatively rich in 
sulphur.  
The effect of smaller and numerous crystals for all scraped cell types, indicates some similarity 
in characteristics. Caco-2 is a colonic epithelial cell line regarded as ileum like for its membrane 
characteristics12. HT-29 is regarded a true colonic epithelial cell type and easily forms mucin 
producing subclones 13-15. SV-HUC-1 can be regarded as a non-MUC2 producing, non-secreting 
cell line stable within 5 passages16, while HT29-18N2 and HT29-MTX produce mucins only in 
certain culture conditions13,15. MUC2 and to a lesser extent MUC5AC, can be found in the entire 
small and large intestine. When secreted, much of the secreted mucins still remain on the cellular 
surface, simplifying isolation of soluble mucins in the TSXP solution with RIPA buffer. These 
mucins are known to contain differences in sulphate groups and O-glycosylated sugar residues17. 
Many of the TXSP’s are membrane associated and integrated membrane proteins from the 
cellular membrane, some are from the cystosol. They are freed from the cell by rigorously 
disrupting the cellular membrane. In cultured cell lines the production of mucins is small, even in 
the so-called mucin producing cell lines, compared to the artificial urine volume. Differences in 
the oligosaccharide chains and the number of tandem repeats cause the main differences in the 
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Fig.7. X-ray microanalysis spectra. Measurements; all had 100 seconds live time. A) Spectrum of 
coverglass without sulphar peak. B) Spectrum of cellular surface of HT29-MTX with a small sulphur 
peak, but no phosphate and small calcium peak. C) Spectrum of bacteria with small calcium peak but 
no sulphar or phosphate. D) Spectrum of crystals adherent to cellular surface, with high sulphar peak, 
high calcium and high phospate. Excitation curve of phosphate slopes and causes phosphate peak to 
overlap with voltages designated to Ytrium ( corrected as P for phosphate). VFS, Vertical full scale. 
molecular weight between MUC2 and MUC5AC. But there are great similarities in the relatively 
large and rigid molecular structure, secreted at the luminal side as dimers with a typical general 
structure of sulphate rich domains to form a gel-like layer18. Considering the characteristics of 
the crystal adhesion sites, the cellular location of mucins and their high sulphur content, we 
choose to quantify these small amounts of mucins by measuring the sulphur incorporation. 
Crystal formation and agglomeration in infected TXSP dilutions was tested in crystallization 
experiments using solubilized membrane components instead of whole membranes to reduce 
background. MUC2 and MUC5AC, which are not only present on the cellular membrane but are 
also present in urine from enterocystoplasties may adhere crystals on the cellular membrane but 
act differently in solutions.  
The isolated TXSP’s of mucin producing cells show a distinct effect on crystal size when 
compared to the TXSP’s of non-mucin producing cells. However, all TXSP’s induce both an 
increase in crystal size and crystal number compared to BSA. This indicates an effect of mucins 
despite the presence of other cellular proteins. MUC2 increases whereas MUC5AC decreases 
particle size. It becomes clear that soluble MUC5AC inhibits agglomeration. This indicates that 
MUC5AC adheres to the calcium phosphate crystals without spanning more than one crystal. 
MUC2 enhances agglomeration and must therefore adhere to more than one crystal. The 
agglomeration of crystals reduces the number of particles, resulting in an inverse correlation of 
the mean particle size with the mean particle number.  
With detached cells, the entire cellular membrane is in contact with the artificial urine and 
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smaller crystals are formed. Both MUC2 and MUC5AC are present on the entire cellular 
membrane in different local concentrations. Molecules capable of adhering to crystals and 
present on the cellular membrane such as MUC2 and 5AC can function as cellular crystal 
adhesion molecules. In ileocystoplasties with similar cellular surfaces, detached cells might thus 
increase the number of crystals adhering on the cell surface and the formation of small crystals, 
while soluble MUC5AC inhibits and MUC2 enhances the formation of large agglomerates. 
Unfortunately the production of MUC2 by ileal and colonic cells is larger than the production of 
MUC5AC and large agglomerates of small crystals may adhere to the cellular surface as in our 
model. From our model we speculate that mucus clearance from enterocystoplasties will be most 
effective if membrane associated MUC2 and 5AC and soluble MUC2 is cleared from the bladder 
whereas soluble MUC5AC would act similar to glycosaminoglycans, protecting the 
enterocystoplasty from stone formation. 
Other attributing factors may be either nucleation or crystal growth into the measuring range and 
bacterial invasion by P. mirabilis and bacterial adherence to the cell surface, which may involve 
MUC5AC as suggested by the correlation with bacterial adhesion to crystals. In the 316 mosm 
artificial urine, decreased urea concentration and absence of NaCl, may have inhibited bacterial 
growth or differentiation20, with a longer crystal induction time. 
In enterocystoplasties where both attached and detached mucin producing cells are present in 
infected alkaline urine and cell turn-over is high, this model may in part explain the high 
incidence of urolithiasis. 
 
Conclusion: Membrane associated cellular secretions such as MUC2 and 5AC may be important 
crystal adhesion molecules in stone formation. These mucins influence crystal agglomeration, 
when present in urine and crystal adhesion when membrane associated. The effect on crystal 
agglomeration depends on the mucin type. These effects may play a role in the high incidence of 
bladder calculi in enterocystoplasties, thus emphasizing the role of cellular membranes in urine. 
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Additional comment 
No hyaluronic rich extracellular matrix as proposed for MDCK cells was considered as an 
explanation for the smaller size of the more numerous crystals, but rejected after consistent 
negative results in initial testing for a shielding extracellular matrix by use of fixed erythrocytes 
in a particle exclusion assay according to Knudson e.a.1  
In intestinal tissue, the classic protective molecules of the epithelium that make up the unstirred 
water layer, are mucins rather then polysaccharides and should be considered the most probable 
interacting molecule. Although some similarities in regard to crystal interaction may exist, the 
effect on crystal number and size is best explained by the effect of molecules, capable of starting 
nucleation in saturated solutions or inhibiting crystal growth. Cellular lysis often occurs with the 
formation of smaller crystals. This will be discussed further in the next chapter. Similar reports 
of altered crystal size have been made for several urinary proteins (THP) and other mucins such 
as MUC1 2. 
 
1. Knudson W., Knudson C.B. Assembly of a chondrocyte-like pericellular matrix on non-
chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular 
matrix. J. Cell Sci. 99: 227-235; 1991 
2. Nagatsuma K., Asakura H., Nakamura S., Murai M., The effect of mucin on the nucleation and 
growth of struvite crystals in vitro. A.L. Rodgers, B.E. Hibbert, B. Hess, S.R. Khan, G.M. 
Preminger, Proceedings of the 9th International Symposium on Urolithiasis 2000 p202-203 
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Pathological and therapeutical significance of cellular invasion by 
Proteus mirabilis in an enterocystoplasty infection stone model. 
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 Abstract 
Proteus mirabilis infection often leads to stone formation. We evaluated how bacterial-mucin 
adhesion, invasion and  intra-cellular crystal formation are related to antibiotic sensitivity and 
may cause frequent stone formation in enterocystoplasties. Five intestinal (Caco-2, HT29, HT29-
18N2, HT29-FU, HT29-MTX) and one ureter cell line (SV-HUC-1) were incubated in artificial 
urine with 5 Proteus mirabilis strains. Flowcytometry (FACS), laser-scanning microscopy and 
electron microscopy evaluated cellular adhesion/invasion, pathological changes to mitochondria 
and P.mirabilis-mucin colocalisation (MUC2/ MUC5AC). An MTT (thiazolyl blue tetrazolium 
bromide)-assay and FACS-analysis of caspase 3 evaluated the cellular response. Infected cells 
were incubated with antibiotics at dosages representing the expected urinary concentrations in a 
10 year old, 30 kg child to evaluate bacterial invasion and survival. All cell lines showed 
colocalisation of P.mirabilis with Human Colonic Mucin i.e. MUC2 and Human Gastric Mucin 
i.e. MUC5AC. Correlation between membrane mucin expression and invasion was significant 
and opposite for SV-HUC-1 and HT29-MTX.  Microscopically, invasion by P.mirabilis with 
intra-cellular crystal formation and mitochondrial damage was found. Double membranes 
surrounded bacteria in intestinal cells. Relative resistance to cotrimoxazol and augmentin was 
found in the presence of epithelial cells. Ciprofloxacin and gentamycin remained effective. 
Membrane mucin expression was correlated with relative antibiotic resistance. Cell invasion by 
P.mirabilis and a mucin and cell type related distribution and response difference, indicate 
bacterial tropism which affects crystal formation and mucosal presence. Bacterial invasion seems 
to have cell type dependent mechanisms and prolong bacterial survival in antibiotic therapy, 
giving a new target for therapeutic optimalisation of antibiotic treatment 
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Introduction 
 
Proteus mirabilis has been designated the most important bacterial agent in the formation of 
infection stones, both in normal and augmented bladders (14, 23, 26). In the period following 
augmentation of the bladder the pH rises and stones may be formed consisting of ammonium 
magnesium phosphate, calcium phosphate and calcium apatite. This stone formation has been 
attributed to the rise in pH as a result of urea splitting by urease (13) or crystal formation on the 
bacterial capsule (9, 10). When urine pH rises crystals will form in vitro in normal human urine 
and in artificial urine above pH 7.3 (11, 16). For crystals to mature into calculi they also must be 
protected against washout from the bladder. Adhesion of crystals and or bacteria to bladder wall 
cells and crystal formation inside invaded cells could be of importance. In addition, adhesion/ 
invasion may be a target in fighting the recurring cycles of infection and stone formation. 
Mucins such as MUC2 and MUC5AC play a part in the interaction between crystals and cells in 
our cellular model and are secreted to the cellular surface (22). Their role in the incorporation of 
bacteria into the cell is as yet unclear. Regular irrigation of the bladder in this respect should 
have a beneficial effect preventing stone formation by clearing crystals, mucus and bacteria. 
However patients on clean intermittent catheterization (CIC) appear to be at risk for bladder 
stone formation (2). Further study of the occurrence of these adhesion/ invasion processes and 
their dependence on cell/bacterial/ crystal characteristics is warranted.  
 Enterocystoplasties in children are well suited for this study. Mucus formation, 
bacteriuria and stone formation in these cystoplasties are common. The cystoplasties are usually 
constructed to enlarge small non-compliant bladders and consist of an ileal or colonic pouch 
attached to the remaining bladder (9). Infecting bacteria will encounter multiple types of 
epithelium that differ in surface characteristics. In girls with both vaginal reconstructions and an 
augmented bladder the incidence of bladder stones is especially high (23). Therefore bacterial 
tropism may play a role in enterocystoplasties and differences in adhesion properties could be 
involved.  P.mirabilis has been noted to invade intestinal INT 407, HCT-8, Caco-2 and HT-29 
cells, Monkey Kidney cells and T24 bladder cells and several other urothelial cell lines in 
culture, which in some cases can be inhibited (3, 25, 32). For the invasive properties of P. 
mirabilis there are many proposed mechanisms and influencing factors among which LPS (17), 
hemolysin and urease in the presence of urea (24). Bacterial invasion may give rise to a relative 
resistance to antibiotics such as aminopenicillins and persistent infection, due to the save haven 
provided by the epithelial cells. Here we used an enterocystoplasty in-vitro model to study the 
complex of: infection with urease producing bacteria, intra and extra-cellular crystal formation, 
adhesion to and invasion of epithelial cells, as well as their influence on antibiotic resistance. 
 
Materials and Methods 
Bacterial culture 
One Proteus mirabilis strain was attained from ATCC (49565) and stored in 15% glycerol at -
80°C until needed. Bacteria where cultured in Luria broth 0.05% glycerol until late log-phase 
growth before use. Four P.mirabilis strains were isolated from patients with an enterocystoplasty 
(AB129, AB474, AB780, AB964) using the API- system of identification (Table 1) and gram 
staining and stored in 15% glycerol at -20°C. Genomic DNA was isolated from the 5 strains 
using the Wizard® Genomic DNA Purification Kit (Promega, Madison WI, USA) and a single 
primer RAPD-PCR to rule out identical strains. The single 10 nucleotide RAPD PCR primer (5’-
GTGGATGCGA-3’) is routinely used in strain identification. PCR was carried out in 50 µl  
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volumes with 5-30 ng genomic DNA, 0.4 u SuperTaq DNA polymerase and SuperTaq buffer 
(Stratech Scientific Ltd), 0.5mM of each deoxynucleoside triphosphate with 0.5µM primer. At 
least 4 fragments were amplified for each sample in a GeneAmp PCR System 9700 thermocycler 
programmed for 5’ 94° and 40 cycles of  94° 30’’, 25° 30’’, 72° 45’’. Amplification products 
were resolved by electrophoresis on a 1.5% agarose gel stained with ethidiumbromide (Fig. 1). 
Cell culture 
We used 5 intestinal cell lines, caco-2, HT-29, HT29-18N2, HT29-FU, HT29-MTX and one 
ureter cell line, SV-HUC-1 to study the interactions most common in enterocystoplasties. Caco-2 
and HT-29 cell lines were obtained from ATCC and have been passaged for an unknown number 
of times but all cells used were within 15 passages. SV-HUC-1 was obtained from the ATCC 
and has been used from passage 30 to passage 34 to ensure stability within the cell line. All 
intestinal cell lines were cultured on Dulbecco’s minimal Eagle’s medium (DMEM)-high 
glucose with glutamine, 10% fetal bovine serum (FBS) and 5mM non-essential amino acids 
(NEAA). SV-HUC-1 was cultured on Ham’s F12 supplemented with 10% FBS. 
 
MTT-assay 
MTT-assay was performed as described by others to asses cellular survival in artificial urine in 
the absence of culture medium by measuring hexosaminidase activity (15,16). Cells were 
cultured in 24 wells plates at 50000 –100000 cells per well for 4 days. The cells were overlaid 
with artificial urine for time periods between 5 hours and 30 minutes, with or without 
conditioned medium from a 3 hours P.mirabilis culture in Luria broth at a 1:5 broth to urine 
ratio. The supernatant was removed and 200µl (MTT) thiazolyl blue tetrazolium bromide 
(Applichem, Darmstadt) was added at 5mg/ml. The cells were incubated for 4 hours with the 
MTT solution. Then the supernatant was removed and dimethyl-sulphoxide added and shaken 
for 5 minutes to extract the formazan formed by the cellular metabolism. The supernatant was 
transferred to a 96 wells flat-bottom plate and light absorption by formazan was measured in a 
BioRad platereader with a 570nm test wavelength and a 690nm reference wavelength. Similarly 
comparisons were made between 3 hour incubation with bacterial secretions in Luria broth 
compared to Luria broth as an artificial urine supplement for 5 strains. All MTT assays were 
performed in triplicate. 
 
Artificial Urine Composition 
Two separate solutions were made and combined at the start of experiments, to prevent 
premature precipitation. Solution A consisted of: 1.3 g/l  sodium citrate, 1.3 g/l KH2PO4 , 2.0 g/l 
sodium oxalate and 25 g/l urea in distilled water. Solution B consisted of: 1.3 g/l CaCl2, 1.3 g/l 
MgCl2, 9.8 g/l NaCl, 4.6 g/l NaSO4, 3.2 g/l KCl, 2 g/l NH4Cl and 25 g/l urea in distilled water. 
Both solutions were combined in equal volumes, less than one hour before the experiments. 
Artificial urine of pH 6.5 without NaCl, NaSO4 and KCl and with 12.5 g/l urea with a lower 
osmolarity of 316 mosm was also used as a control for osmotic effects on the cell lines. 
 
Cell Culture infection 
Cells were cultured in 6 or 24 wells plates and infected after reaching confluency. For 
transmission electron microscopy cells were cultured on 100µm melinex (Du Pont Teijin Films 
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Netherlands BV, Rozenburg, The Netherlands), for confocal laser scanning microscopy on glass 
coverslips, before infection. Artificial urine was added and incubated for 3 hours to rise above 
pH 7.3, infected with 150µl bacterial suspension (2.5-3McF ≈ 105-106 bacteria) for 3ml of 
artificial urine before microscopic evaluation.  
 
Confocal Laser Scanning Microscopy (C-LSM) 
Infected cells were washed three times with DMEM and maintained at 37°C. A rabbit-anti-
Human Colonic Mucin (HCM) or rabbit-anti-Human Gastric Mucin (HGM) antibody was 
applied for 15 minutes and washed three times with DMEM. Anti-HCM and anti-HGM 
characteristics were previously described by Tytgat e.a.(29). Anti-HCM (Human Colonic Mucin) 
is a rabbit polyclonal antibody raised against purified human colonic mucin it recognizes mainly 
the mature, fully glycosylated MUC2. Anti-HGM (Human Gastric Mucin) is a rabbit polyclonal 
antibody raised against purified human gastric mucin it recognizes mainly the mature, fully 
glycosylated MUC5AC. A monoclonal antibody against P.mirabilis (Biogenesis, Nuclilab) was 
added, incubated for 15 min and washed three times with DMEM. A fluorescein-isothiocyanate 
(FITC) labeled anti-rabbit antibody (Caltac laboratories, Burlingame, CA) was applied, 
incubated for 15 min, washed thoroughly with DMEM and followed by a thio-rhodamine-
isothiocyanate (TRITC) labeled anti-mouse-antibody (DAKO A/S, Denmark). Images were 
made with a Zeiss LSM 410 laser scanning confocal microscope (Zeiss, Oberkochen, FRD). A 
488 nm Ar-laser was used to excite TRITC labeled antibodies and a 633 Kr-laser without a filter 
to visualize the reflection of the crystals. The TRITC signal was passed through a 510-540 nm 
band-pass filter. An overlay of the FITC signal was done using the 488 nm laser and a 560 nm 
beam splitter to separate the FITC from the TRITC signal, showing bacterial infection and 
crystal formation. Viable stain Syto16 was used instead of anti-mucin antibodies, omitting the 
last washing step, to show viable epithelial cells and determine bacterial invasion. Experiments 
were performed in triplicate except bacterial invasion assessment, which was performed twice to 
confirm previous findings. A second observer evaluated a representative selection of images. 
 
Transmission Electron Microscopy 
Cells were cultured on melinex sheet to attain transferable monolayers until confluency and fixed 
in 1% glutardialdehyde/4% formaldehyde in 0.1M PBS pH 7.2/ 4˚C for at least 2hrs before 
processing. Detached cells were collected and centrifuged to a pellet before processing. Samples 
were washed in 0.1M PBS pH7.2/ 4˚C for 12 hours followed by a secondary fixation in 1% 
osmium tetra-oxide/ 1.5% K4Fe(CN)6 in 0.1M PBS pH 7.2. Samples were washed twice in 
distilled water for 30 minutes and dehydrated in ethanol 50%, 50%, 70%, 70%, 90%, 90%, 96%, 
96%, for 10 minutes and twice in ethanol 100% for 15 minutes. Samples were impregnated in 
equal volumes of Epoxy resin (LX112) and ethanol 100% for 60 minutes at room temperature 
followed by pure Epoxy resin (112) for 60 minutes at 37˚C. Resin was allowed to polymerize for 
12 hours at 60˚C after which the melinex sheet was removed. 
Sectioning of blocks was performed on a Type LKB IV ultramicrotome at 40 nm and collected 
on a copper 200 mesh grid. Sections were incubated with 6% uranyl acetate for 10 minutes 
followed by lead citrate for 1 minute before viewing under a Philips Morgangi ™ 268 
transmission electron microscope connected to a CCD camera (Mega view II).  
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Gentamycin Invasion Assay 
Cells were cultured in 24 wells plates until confluency, incubated with P.mirabilis in HBSS for 3 
hours. Cells were washed twice with HBSS to remove free bacteria and incubated with 
Gentamycin 0.01% in PBS for 1 hour to kill accessible bacteria. The monolayers were washed 8 
times with PBS, to remove all gentamycine and lysed in poly-L-Lysine (Sigma-Aldrich P1524) 
for 5 min. A 1/10 dilution series was made, plated on blood-agar plates and incubated at 37°C for 
24 hrs. Experiments were performed in triplicate to reveal bacterial survival in epithelial cells. 
 
Relative Antibiotic Susceptibility Assay (RASA) 
The RASA procedure followed the gentamycin invasion assay except for three major changes. 
First the incubation time with the antibiotic was increased from 1 to 18 hours. Second, a panel of 
commonly used antibiotics was applied at concentrations reflecting the calculated expected 
urinary excretions in pediatric urology for a 10 year old child weighing 30 kg. Amoxicillin: 450 
µg/ml, Augmentin: 600 µg/ml Amoxicillin / clavulanic acid 60 µg/ml, Gentamycin: 90 µg/ml 
Cotrimoxazol: 46 µg/ml trimethoprim /230 µg/ml sulfamethoxazole, Ciprofloxacin 300 µg/ml, 
Nitrofurantoin: 50 µg/ml, Metronidazole: 20 µg/ml.  Third, lysates were plated on McConkey 
agar instead of blood-agar to enable colony counting and incubated at 37˚C for 24 hours. For a 
panel of five bacterial strains the resistance against a specific antibiotic (n=8 including DMEM 
control) was tested both in the presence and the absence of a specific cell-line (n=6). Overall the 
number of colony forming units, cfu, was counted for 5x2x6x8=480 different situations. For 
each combination of bacterial strain and antibiotic we calculated the ratio of cfu in the presence 
(cfucell+) and absence of cells (cfucell-), cfucell+/ cfucell-. This ratio was considered to be increased at 
a cut-off point of 10. For the statistical analysis of the differences between the situations cells  
present and cells absent we used the average of the ratio's obtained for the five bacterial strains in 
a paired samples T-test. These stringent conditions answer the questions if bacteria can resist 
antibiotic treatment by invading cells and which antibiotics would still be suitable. 
 
Flowcytometric analysis of infected epithelial cells 
All flowcytometric measurements of Human Colonic Mucin, Human Gastric Mucin, caspase3, 
and bacteria were performed separately using material from the same infected sample. Infected 
cells were incubated in 70% ethanol for 30’ and scraped followed by overnight incubation at 
room temperature in 2% paraformaldehyde/ 2% formaldehyde to fixate cells and bacteria. Fixed 
cells were washed twice with PBS and the first antibody in 0.5%BSA/PBS was applied against 
P.mirabilis, Human Colonic Mucin, Human Gastric Mucin, or caspase 3, and incubated for 1 
hour at 37˚C.  Cells were washed with PBS twice and a secondary FITC labeled antibody was 
applied and incubated for 1 hour at 37˚C after which the cells were washed twice with PBS 
before measurement. After the first measurement Trypan Blue was added to quench an intra-
cellular FITC signal and incubated for 30’ after which cells were washed twice with PBS and 
measured again. The decrease in signal determines the contribution of membrane bound and 
intra-cellular signal. 1:200 antibody dilutions were used. Pearson correlation was used to analyze 
the mean FL-1 count in relation to the RASA.  
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Results 
Bacterial identification 
Bacterial strains with similar API codes (Table 1) were identified as unique strains in RAPD-
PCR (Fig. 1). 
Confocal Laser Scanning microscopy 
In confocal laserscanning microscopy epithelial cells of approximately 7 microns, expanded in 
size after infection with P.mirabilis and a colocalisation of mucins expressed on the cellular 
membrane and bacterial adhesion was demonstrated for Human Colonic Mucin (HCM) and for 
Human Gastric Mucin (HGM) (Fig. 2C, D). Furthermore intra-cellular crystal formation was 
demonstrated for all cell lines and intra-cellular invasion confirmed (Fig. 2A, B). In the intestinal 
cell lines cytoplasmic colonies are observed (Fig. 2B) opposed to single cell invasion in the 
ureter cell line (Fig. 2A). Both HCM and HGM appeared as granules in cells and membrane 
associated mucins on the cells, indicating the mature mucin form (Fig. 2C,D). Colocalisation of 
HCM and HGM with P.Mirabilis occurred in all cell lines and is visible in Fig 2C and D as a 
yellow/ orange signal. For a better assessment of this colocalisation, the single colocalisation 
signal is shown in black for the same section areas are in Fig 2E and F. Large cells were 
observed for HT29-18N2 with a large number of cytoplasmic bacteria.  
 
 
 
 
Fig. 1  
RAPD –PCR products on 1.5% ethidiumbromide 
agarose gel. L=100bp Standard, 1= AB129, 2= 
AB474, 3= AB780, 4= AB964, 5= ATCC49565. 
All strains have different patterns 
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Fig. 2  
Confocal Laserscanning Microscopy Images (all images at 800x magnification). 
Bacteria are always red. A=SV-HUC-1 cell line stained with viable stain Syto 16 with 
reflecting crystals (blue/purple) . B=HT29-MTX stained with viable stain Syto 16 
(green), with reflecting crystals (blue) . The symbols (a), (b), (c), (d), indicate 
extracellular crystals, intracellular bacteria, extracellular bacteria, and intracellular 
crystals respectively. C=HT29-MTX cell line showing HCM in green and colocalisation 
in yellow (*=HCM along the cellular membrane, arrow =bacterial /HCM 
colocalisation). D= HT29-MTX cell line showing HGM in green and colocalisation in 
yellow  (*=HGM without bacterial colocalisation, arrow =HGM with bacterial 
colocalisation).  The yellow colocalisation signal is produced by a simultaneous red 
TRITC and green FITC signal. 
E= the colocalisation signal of P.mirabilis and HCM of C indicated in black. F= the 
colocalisation signal of P.mirabilis and HGM of D indicated in black. (Produced in 
CorelDraw 9.0 for Microsoft ® Windows) 
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 ATCC49656 AB129 AB474 AB780 AB964 
API 0737000 0336000 0737000 0737000 0733000 
Amikacin <=2 <=2 4 <=2 4 
Amoxicillin/  
Clavulanic acid <=8 <=8 <=8 <=8 16 (I) 
Amphicillin >=32 (R) 2 4 >=32 (R) 4 
Cefotaxime <=4 <=4 <=4 <=4 <=4 
Ceftazidime <=8 <=8 <=8 <=8 <=8 
Cefuroxime-sodium <=4 <=4 <=4 <=4 <=4 
Cefuroxime -axetil <=4 <=4 <=4 <=4 <=4 
Cephalothin >=32 (R) 4 4 4 4 
Ciprofloxacin <=0.5 <=0.5 <=0.5 <=0.5 <=0.5 
Gentamycin <=0.5 <=0.5 1 <=0.5 1 
Imipenem <=4 <=4 <=4 <=4 <=4 
Meropenem <=2 <=2 <=2 <=2 <=2 
Nitrofurantoin >=128 (R) >=128 (R) 
>=128 
(R) >=128 (R) 
>=128 
(R) 
Norfloxacin <=4 <=4 <=4 <=4 <=4 
Pipercillin/Tazobactam <=8 <=8 <=8 <=8 <=8 
Tobramycin <=0.5 1 <=0.5 >=0.5 1 
Trimethoprim/ 
Sulfamethoxazole <=10 <=10 
>=320 
(R) >=320 (R) 
>=320 
(R) 
 
Table 1. 
Antibiotic susceptibility of  5 P.mirabilis strains. Resistance ( R) and intermediate 
resistance (I) are indicated. Minimal Inhibitory Concentrations are represented in 
µg/ml 
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Fig. 3.  
Transmission Electron microscopy  
A= crystals on SV-HUC-1 cell surface (2800x), B= bacterial adhesion to the cellular surface of 
HT29-MTX, condition without artificial urine (22000), C= invasion in HT29-FU with double 
membrane (44000x), D= bacterial invasion in SV-HUC-1, without a double membrane 
(14000x), E= crystal formation inside cellular organelle of HT29-FU, probably destroyed 
mitochondrion (18000x).F= Crystal ghost in HT29-MTX , with large cytoplasmatic colony of 
P.mirabilis surrounding the crystal (3000x). Arrows without any symbols indicate bacteria. 
Arrows with a symbol (A) indicate bacterial adhesion to the double membrane. The double 
membrane is indicated by (+), and crystals are indicated by (*). (Produced in CorelDraw 9.0 
for Microsoft ® Windows) 
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Culture and infection conditions 
Evaluation 
parameters Cell line DMEM Artificial urine DMEM +P.mirabilis 
Artificial 
urine+ 
P.mirabilis 
Caco2 - + - + 
SV-HUC-1 - - - + 
HT29 - + - - 
HT29-1 8N2 - - - - 
HT29-FU - - - - 
Crystal adhesion 
HT29-MTX - - - + 
Caco2 - + - + 
SV-HUC-1 - - - + 
HT29 - + - + 
HT29-1 8N2 - - - + 
HT29-FU - + - + 
Intra- 
cytoplasmatic 
crystal formation 
HT29-MTX - - - + 
Caco2 - - - + 
SV-HUC-1 - - - + 
HT29 - - - - 
HT29-1 8N2 - - - - 
HT29-FU - - - + 
Intra- 
mitochondrial 
crystal formation 
HT29-MTX - - - + 
Caco2 - - + + 
SV-HUC-1 - - + + 
HT29 - - + - 
HT29-1 8N2 - - - + 
HT29-FU - - - + 
Bacterial 
adhesion 
HT29-MTX - - + - 
Caco2 - - - + 
SV-HUC-1 - - + + 
HT29 - - - + 
HT29-1 8N2 - - - + 
HT29-FU - - - + 
Bacterial invasion
HT29-MTX - - - + 
Table 2. Transmission electron microscopy results with varying culture and infection conditions. Cell 
pellets and monolayer cultures were used in infected artificial urine conditions, all other conditions were 
evaluated in monolayer conditions. (+=present, -=absent) 
Transmission Electron Microscopy 
Cellular adhesion (Fig. 3B), cytoplasmatic colonies and invasion by P.mirabilis surrounded by a 
double membrane was observed in intestinal cell lines (Fig. 3C) with intra- cytoplasmatic crystal 
formation and crystal adhesion to the cellular membrane. The urothelial cell line showed fewer 
and always single bacteria invaded into the cells without a double membrane  (Fig. 3D)  and 
large crystal deposits on and in the cell (Fig. 3A). Occasionally intra-mitochondrial (Fig. 3E) 
crystal formation was observed. Results are presented in Table 2. Results indicate that bacterial 
infection in artificial urine of 316 mosm. enhances the formation of crystals (intra-cellular and in 
mitochondria) in conjunction with enhanced bacterial invasion. For HT29-18N2 large-scale 
destruction of cells was noted with large cells and bacterial colonies contained by a double 
membrane. Infected epithelial cells showed loss of nuclear staining and density, indicating 
damage. 
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Relative antibiotic susceptibility assay (RASA) and gentamycin invasion assay 
After vigorous washing to remove all antibiotic and free bacteria; viable bacteria were found 
upon cell lysis for all cell lines tested, confirming bacterial invasion. The RASA test showed that 
this cellular invasion provides the bacteria with a relative protection against the antibiotics, 
cotrimoxazol and amoxicillin/ clavulanic acid. DMEM acts as a control for bacterial growth 
without any inhibition in the presence of cells. Amoxicillin acts as a control for the Amoxicillin 
content in Augmentin, to assess clavulanic acid. Amoxicillin does not show diminished 
effectivity in the presence of cells and neither Metronidazole nor nitrofurantoin exhibits a 
significant change in effectivity according to a paired samples T-test, although Augmentin 
(amoxicillin/ clavulanic acid) does. Ciprofloxacin and gentamycin still seem suitable antibiotics 
in the presence of epithelial cells.  
Results of the Relative antibiotic susceptibility assay are presented in Table 3.  
MTT-assay 
Cell survival decreased in time in the presence of artificial urine instead of normal culture 
medium. The hexosaminidase activity dropped to approximately 50% in all cell lines with or 
without the added preconditioned Luria broth in 3 hours. The cells showed a hexosaminidase 
activity at a 3 hour period which was comparable in conditions with (Fig. 4) or without the 
preconditioned Luria broth. (Fig.. 5), although some cell lines with conditioned medium from 
certain bacterial strains showed differences compared to a blank sample without conditioned 
medium. These readings were always higher in the Caco-2, HT29, and HT29-FU cell lines and 
always significantly higher in the HT29-FU cell line, while only significant for the SV-HUC-1 
cell line in combination with the ATCC49565 strain. Significant differences are marked in Fig. 
5. 
Flowcytometric analysis of infected epithelial cells 
On average over all epithelial cell lines 23% of the bacteria were located intra-cellular. 23.2% 
was found in Caco-2, 26.7% in SV-HUC-1, 22.7% in HT29, 0.5% in HT29-18N2, 31.8% in 
HT29-FU, 24.1% in HT29-MTX. The HT29-18N2 values for bacterial invasion were very low 
due to large-scale destruction of the epithelial cells and high permeability for Trypan Blue, 
which shows aberrant results for the AB780 strain only. Results are presented in Fig. 6.  Of all 
Human Colonic Mucin and Human Gastric Mucin expressed by the cells, most was present on 
the cellular surface, only a small fraction was contained as granules in the cell. 60%-95% of 
HCM and HGM was expressed on the cellular surface, but did not show significant differences 
among cell lines. Of the more then 5000 correlations analyzed between flowcytometric data, 
RASA and the MTT-assay, the relevant significant results are presented as a meta-analysis in 
Table 4. Caspase 3 expression was not correlated with hexosaminidase activity, bacterial 
invasion, MUC2 or MUC5AC expression. Hexosaminidase activity was not correlated with 
bacterial invasion. 
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Fig. 4. A) MTT assay of epithelial cells incubated with artificial urine followed in 
time. Error bars represent the Standard error of the mean. 
 
Fig. 4. B) MTT assay of epithelial cells incubated with artificial urine and conditioned 
Luria broth by P.mirabilis ATCC49565 followed in time. Error bars represent the 
Standard error of the mean. 
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Fig. 5. MTT assay of epithelial cells incubated for 3 hours with artificial urine 
supplemented with conditioned Luria broth by 5 P.mirabilis strains for 3 hours compared 
with artificial urine and  unconditioned Luria broth. Incubation with unconditioned Luria 
broth and artificial urine for 3 hours was set as 100%. Values over 100% outside the 
standard error bars are indicated as significant (*). Histograms represent average values 
of three MTT-assays. Error bars represent the Standard error of the mean. 
 
First Factor Second Factor p-value 
 Cell-line 
Direction of 
correlation  Antibiotic  
MUC5AC HT29-MTX negative Bacterial invasion - 0.048 
Human Colonic Mucin HT29-MTX negative Bacterial invasion - 0.023 
MUC5AC HT29-MTX negative Bacterial survival Ciprofloxacin 0.025 
MUC5AC HT29-MTX negative Bacterial survival Gentamycin 0.042 
Hexosaminidase HT29-MTX positive Bacterial survival Metronidazole 0.029 
MUC5AC HT29 positive Human Colonic Mucin - 0.049 
Caspase3 HT29 positive Bacterial survival DMEM 0.007 
Caspase3 HT29 negative Bacterial survival Amoxicillin 0.007 
MUC5AC SV-HUC-1 positive Bacterial invasion - 0.042 
Caspase3 SV-HUC-1 positive Bacterial survival Nitrofurantoin 0.008 
Bacterial invasion SV-HUC-1 positive Bacterial survival Metronidazole 0.032 
Human Colonic Mucin Caco-2 negative Hexosaminidase - 0.038 
Human Colonic Mucin Caco-2 positive Bacterial survival Amoxicillin 0.006 
Bacterial invasion HT29-18N2 negative Bacterial survival DMEM 0.026 
Bacterial invasion HT29-18N2 negative Bacterial survival Amoxicillin 0.027 
Bacterial invasion HT29-18N2 negative Bacterial survival Augmentin 0.027 
Bacterial invasion HT29-18N2 negative Bacterial survival Ciprofloxacin 0.025 
Bacterial invasion HT29-18N2 negative Bacterial survival Metronidazole 0.027 
 
Table 4. Meta-analysis of infection and survival data. Bacterial invasion, Caspase 3 
expression, MUC5AC and Human Colonic Mucin were determined by Flowcytometric 
Analysis. Bacterial survival was determined by RASA and the Hexosaminidase activity 
was determined by the MTT-assay. The meta-analysis of data was performed by Pearson 
correlation. Correlations were significant (p<0,05) in a 2-tailed test. 
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Discussion 
 
Conditions as they exist in the augmented bladder, especially the presence of intestinal cells and 
their secretions in the presence of urine, enhance bacterial infection and invasion. Often Proteus 
mirabilis infection of the augmented bladder is difficult to treat and leads to stone formation. 
P.mirabilis can invade epithelial cells and survive intracellular (3,5,25,32,33,34). It is not known 
if this effects antibiotic effectivity. We studied the effect of bacterial invasion by Proteus 
mirabilis on antibiotic susceptibility and intracellular crystal formation in conditions modeled to 
enterocystoplasties. The relative antibiotic susceptibility assay was developed in artificial urine 
for this purpose. Artificial urine is a useful defined culture medium for the growth of  P.mirabilis 
(4). The meta-analysis of a number of control parameters for bacterial survival in cells including 
the MIC values help to evaluate the data gathered from our relative antibiotic susceptibility 
assay. The data allow us to propose the scheme for bacterial invasion/ survival shown in Fig 7. 
Interventional studies must be performed to test the validity of the scheme 
 
In this study artificial urine enhances invasion of bacteria and intra-cellular crystal formation. 
The presence of crystals in cellular organelles i.e. intra-mitochondrial crystals confirms their 
intra-cellular origin. The large Ca2+ stores in mitochondria and the endoplasmatic reticulum 
(21,31) may explain the cellular location of crystals when the pH level rises above 7.3 and the 
solubility of calcium phosphate is exceeded. Mitochondrial damage may then lead to increased 
cytosolic calcium levels and precipitation at other cell sites. Bacterial activity and mechanical 
damage by crystals eventually leads to nuclear destruction and a disruption of calcium levels 
(12,21) with a more diffuse distribution of crystals throughout the epithelial cytoplasm as was 
observed in electron microscopy. The rise in pH level was caused by urease producing P. 
Mirabilis strains. These strains invaded the cells and formed a micro-environment, which 
supported the formation of crystals. 
 
We hypothesized that micro-colony formation inside epithelial cells protects against antibiotic 
treatment. Especially for antibiotics which have a concentration dependent activity, a low 
membrane permeability or for which P.mirabilis has already acquired a relative resistance. In 
vivo epithelial invasion would create a bacterial pool from which the next cycle of infection can 
originate. An additional double membrane surrounded bacteria in the intestinal cell lines 
providing an extra barrier for antibiotics to pass in addition to the cellular cytoplasm, suggesting 
that P.mirabilis was better protected inside intestinal cells. The RASA test (where extracellular 
bacteria were removed) shows that intracellular bacteria better survive treatment with the 
antibiotics cotrimoxazol and amoxicillin/ clavulanic acid, for which one or more strains were 
already (relatively) resistant. Invasion was confirmed in flowcytometric data. On average 23% of 
the bacteria were located inside intact cells for all cell lines tested accept HT29-18N2, that 
showed massive cell destruction. This may be beneficial for the epithelial cells as increased cell 
membrane permeability makes P.mirabilis lose their safe haven, as in HT29-18N2.   
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Fig. 6 A) Flowcytometric analysis of caspase 3 expression in epithelial cells infected with 5 
P.mirabilis strains. Error bars represent the Standard error of the mean. 
 
Fig. 6 B) Bacterial adhesion (quenched) and total bacterial infection of epithelial cells. 
Bacterial invasion was regarded to be the difference between the quenched (extra-cellular) 
data and the total P.mirabilis infection. Error bars represent the Standard error of the mean. 
Chapter 5 
96
Self-destruction could be a way for the cells to deprive the bacteria of their protection. In 
infected cells mitochondrial swelling and destruction was visible. This suggests an apoptosis 
mechanism involving the radical oxygen species (ROS) Æcytochrome c Æcaspase 9 Æcaspase 
3 pathway (28).  
Expression of caspases due to infection would decrease bacterial survival for amoxicillin in 
HT29 but according to our data does not significantly increase bacterial invasion. Only in control 
antibiotics and DMEM did caspase 3 correlate with increased bacterial survival. This suggests 
that cellular membrane permeability is increased. Overall neither a significant effect of apoptosis 
on RASA or a direct correlation between caspase 3 and bacterial invasion was found. It may be 
that P.mirabilis counteracts the effect of apoptosis as it produces an iron dependent superoxide 
dismutase that handles radical oxygen species (ROS). Also, caspase 3 can promote nuclear 
membrane permeability without increasing cellular permeability (12) as is observed in 
electronmicroscopy. 
The presence of artificial urine and absence of normal culture medium affected the cellular 
metabolism and increased the invasion of epithelial cells. However bacterial secretions that 
constitute a stress-situation for the cell only marginally effected the metabolism of epithelial 
cells. When invasion is very efficient, like for the HT29-18N2 cell line, there is rapid cell 
destruction. Thus we investigated the cellular reaction to invasion, using hexosaminidase activity 
as a marker for cellular survival and metabolic activity (6, 8). Hexosaminidase, a detoxification 
enzyme (15) in the lysosomal degradative pathway, may be activated by proinflammatory stimuli 
(27). When hexosaminidase function was enhanced, lysosomal degradation and bacterial 
survival with Metronidazole increased. 
  
Epithelial mucins have a dual effect in the invasion of P.mirabilis, depending on the cell line. In 
HT29-MTX bacterial invasion is decreased by MUC2 and MUC5AC and colony formation 
occurs, which could indicate phagocytosis of the cellular membrane with the bacteria in which 
the mucins act as a bacterial barrier. In the ureter cell line SV-HUC-1 bacterial invasion occurs 
as single bacteria and is positively correlated with MUC5AC expression indicating a receptor 
function. Mucins such as MUC-2 could also function as a barrier to antibiotics such as 
amoxicillin in Caco-2. Bacterial secretions seem to induce metabolic activity in the cells, which 
may help the destruction of P.mirabilis and detoxification of antibiotics. It seems that excretions 
from P.mirabilis induce a cellular response in certain HT29 cell lines that requires a higher 
metabolic activity of the epithelial cell. The HT29, and HT29-FU subclones and Caco-2 that are 
activated in the presence of bacterial secretions are known to produce relatively more MUC2 and 
MUC5AC (22). Mucin production may be involved as a defense mechanism against interaction 
with P.mirabilis LPS as has been reported for other bacteria (21) and may be regulated similarly 
(19). Recycling of the cellular membrane, unrelated to the bacterial agent incorporates 
substances from the cellular membrane such as mucins, as described for MUC1 (1). On the other 
hand mucins may inhibit phagocytosis by polymorphonuclear leukocytes in the lung (30). It is 
not clear from this study how different mucin types interact at a molecular level with bacteria, 
but there seems to be a difference in the invasion capability of P.mirabilis according to the type 
of epithelium i.e. urothelium or intestinal epithelium related to mucin expression. 
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Fig. 7 Schematic presentation of our interpretation of the data and meta-analysis. The 
diagram shows bacterial adhesion and invasion of epithelial cells with possible 
mechanisms of influencing factors on the outcome of the relative antibiotic 
susceptibility assay. Both bacteria and crystals can start apoptosis by inducing 
cellular stress. Bacterial invasion is either inhibited or enhanced by adhesion to HGM 
or HCM. Bacterial invasion and apoptosis may enhance antibiotic effectivity by 
increasing the permeability of the cellular membrane after increasing the 
permeability of the nuclear membrane. Mitochondrial damage will enhance the 
bacterial induced apoptosis of the epithelial cell.  P.mirabilis will invade the cell and 
form microcolonies, protected from antibiotics in the cytoplasm by the 
microenvironment formed within the double membrane formed in intestinal cell lines. 
In SV-HUC-1 single bacteria are found without the protection of a double membrane 
(left), whereas in the intestinal cell lines a double membrane was found surrounding 
invaded P.mirabilis bacteria and microcolonies (right). 
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Conclusion 
 
The overall interpretation of our data is depicted in Fig. 7. Bacterial invasion in epithelial cells is 
enhanced by the enterocystoplasty environment with urine, mucin and intestinal cells. The 
invasion into urothelial and intestinal cells show different aspects, resulting in a single 
membrane respectively double membrane protection. This protection induces a relative 
resistance of P. mirabilis to the antibiotics Cotrimoxazol (TMP/SMX) and Amoxicillin/ 
clavulanic acid. Gentamycin and ciprofloxacin are the best antibiotics in the presence of 
epithelial cells and nitrofurantoin also seems more effective in the presence of cells. P.mirabilis 
thrives better inside the cell when there are antibiotics in the culture medium and better outside 
the cell when there is no selection pressure from antibiotics.  Resistance to Cotrimoxazol and of 
course nitrofurantoin are also often found clinically (7). Resistance to Amoxicillin/ clavulanic 
acid and ciprofloxacin is less frequent. P.mirabilis appears to interact with mucins such as 
MUC2 and MUC5AC in the adhesion to epithelial cells preceding invasion, but is not 
necessarily internalized with these mucins. These mucins act differently according to the origin 
of the cell type and may relate to the different microbiological function of intestinal and urinary 
epithelium. Human Colonic Mucin is equivalent to the mature form of MUC-2 and Human 
Gastric Mucin is equivalent to the mature form of MUC-5AC (29). P.mirabilis appears to 
reproduce more effectively in intestinal cells than in ureter cells by the formation of cytoplasmic 
colonies. This may help explain the persistence of P.mirabilis in enterocystoplasties under 
antibiotic therapy. The infection stones in the augmented bladder may start as intra-cellular 
crystals (approximately 7 microns according to CLSM) at the surface of the bacterial capsule. 
These crystals are protected from wash out by voiding and also enhance bacterial survival when 
they reach a larger size, according to the generally accepted safe-haven theories for biofilms and 
urinary calculi. 
Further research, e.g. on interactions of bacterial molecules with MUC2 and MUC5AC, must 
show if fighting cell invasion can provide a more effective treatment of P.mirabilis infection. 
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Additional comment 
The invasion of epithelial cells and cellular stress may be involved in a number of cellular 
reactions which can enhance the production of mucins and thereby increase the effect of crystal 
adhesion. The effect on antibiotic resistance may play an important role in the persistence of an 
infection and requires a first step of bacterial adhesion in the process of invasion. How mucins 
are involved in this process will be further discussed in the next chapter. 
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Chapter 6 
 
Mucin mediated cellular adhesion and crystal formation by Proteus 
mirabilis in an enterocystoplasty infection stone model. 
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Abstract 
Introduction:  
Proteus mirabilis infection of the surgically augmented bladder is a well known event leading to 
stone formation. We evaluated how bacterial adhesion may be involved in stone formation using 
an enterocystoplasty tissue model.  
 
Materials and methods:  
Intestinal and bladder tissue cultures were infected to resemble an early P.mirabilis infection. 
Paraffin sections were double stained to evaluate bacterial, mucin and crystal colocalisation. 
Scanning Electron Microscopy (SEM) and Von Kossa staining  evaluated phosphate salt 
precipitation on bacteria. Far-Western analysis of mucin adhesion to the P.mirabilis capsule was 
done for 8 augmented bladder strains and 8 normal urinary strains. Enterocystoplasty urine 
untreated, or treated with neuraminidase or periodate was used in Far Western analysis or 
preceded by a sialic acid, or MUC3 block. 
 
Results:  
Correlations between tissue type, bacterial adherence to MUC2 producing cells and crystal 
formation were found. Bacterial/mucin colocalisation could be clustered according to tissue type. 
All strains bound Human Gastric Mucin (HGM) and Human Colonic Mucin (HCM). Far-western 
analysis showed sialic acid dependent binding of HCM and HGM. Furthermore HCM adhesion 
depended on intact sugar O-rings. Von Kossa staining of sections and SEM showed phosphate 
salt precipitation on the bacterial surface in intestinal crypts. 
 
Discussion:  
Bacterial adhesion in enterocystoplasties is specifically mediated by HGM (mainly consisting of 
MUC5AC) and HCM (mainly consisting of MUC2) presence. P.mirabilis strains derived from 
enterocystoplasties prefer HCM instead of HGM binding. This may lead to an increased risk for 
bladder stone formation in enterocystoplasties. Bacterial adhesion can be blocked by other 
mucins and sialic acid. 
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Introduction 
 In recent years several attempts have been made to either confirm or reject the 
hypothesis that mucins are adhesion molecules for Proteus mirabilis. Some aimed at 
chemotaxis22, others at the interaction between epithelial cells and Proteus mirabilis in general 
and enteric binding and endocystosis of bacteria32,35,37,38,39,40, but most have focused on bacterial 
pili and fimbriae29. As P.mirabilis is the most important bacterial agent in the formation of 
infection stones, both in normal and augmented bladders16,20,29, it is important to establish the 
presence or absence of this interaction as it relates to the production of certain mucin types by  
intestinal tissue. It has been suggested that not only urease10 but also the bacterial capsule9 could 
play an important role in the formation of stones by acting as a template for the crystallization of 
ammonium magnesium phosphate. Similar claims, that they can serve as crystallization 
templates have been made for several mucins,17, ,28,31,34. This crystal/mucin interaction explained 
crystal agglomeration in a previous study21. A possible bacterial/mucin interaction may have 
similar agglomeration enhancing characteristics. GroEL, present on the bacterial capsule, may 
play a role in this interaction13,12,15,. This was previously described for other bacteria after 
exposure to salts or other stressors5 and found in P.mirabilis in a previous study19.  When the pH 
of urine rises, ammonium magnesium phosphate, calcium phosphate and calcium apatite crystals 
will form in vitro in normal human urine and calcium phosphate crystals in artificial urine above 
pH 7.3 10,14,18,23 . For the formation of bladder calculi, often called infection stones or triple 
phosphate stones, it is necessary that the pH level reaches such high levels in order for these 
crystals to form and that these crystals remain in the bladder and mature into detectable bladder 
calculi. Bacterial adhesion and invasion of epithelial cells may be elemental in this 
crystallization and adhesion process. We have previously shown that bacterial adhesion and 
invasion may lead to a relative antibiotic resistance and to the formation of small crystals on and 
in the epithelial cells. Many of these crystals initially share the same size as P.mirabilis and 
could be the result of calcium precipitation on the bacterial capsule. Adhesion prevention may 
thus be a target in stone and infection prevention in enterocystoplasty patients; it may also 
enhance antibiotic treatment or even replace antibiotic prophylaxis strategies.  
The incidence of symptomatic urinary tract infection correlates with the incidence of urinary 
stones in enterocystoplasties20. In complicated urinary tract infections, the number of unusual 
urinary pathogens increases. It is not clear however, why the incidence of induced stones is 
directly correlated with the relatively low incidence of P.mirabilis infections despite the fact that 
other (urease producing) pathogens cause the majority of infections. This would imply that 
P.mirabilis infections lead to stone formation more effectively compared to infections caused by 
other bacteria. Further study of the adhesion/ invasion process for P.mirabilis is therefore 
warranted. Most of the enterocystoplasty patients are burdened by bacteriuria and multiple 
urinary tract infections, mucus and stone formation. Thus, enterocystoplasties in children are 
well suited for this study by supplying a situation where infection stone formation is more 
frequent than in the general population and easily studied. In children the cystoplasties are 
usually constructed to eleveate small non-compliant bladders. They consist of an ileal or colonic 
pouch attached to the remaining bladder 8,16,20. These epithelia differ in surface characteristics 
and are represented in our model systems. Here we used an in-vitro enterocystoplasty model, to 
study bacterial/epithelial interaction.  
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Materials and Methods 
Bacterial culture and preparation  
One Proteus mirabilis strain was obtained from the ATCC (49565), a O:6 serotype strain and 
stored in 15% glycerol at -80°C until needed. Bacteria where cultured in Luria broth 0.05% 
glycerol until late log-fase growth before use. Seven P.mirabilis strains were isolated from 
children with an enterocystoplasty (AB129, AB142, AB364, AB474, AB520, AB780, AB964) 
and identified using the API- system of identification. In addition seven strains were isolated 
from adult patients with normal bladders (U101, U103, U124, U238, U366, U530, U679) and 
stored in 15% glycerol supplemented Luria broth at -20°C until needed. One strain was obtained 
from a patient with a bladder stone in an enterocystoplasty (S468). The origin of the bacterial 
strains used including their biochemical profiles (API-codes) are given in Table.1.  
 
Bacterial FITC labelling 
Bacterial FITC labeling and incubation protocols were adapted from a previously published 
protocol for H.pylori 11 . All P.mirabilis strains were cultured overnight on bloodagar after which 
the bacterial cells were collected in Eppendorf tubes from both the swarming edge as well as the 
center of the colonies and suspended in sterile water, transferred to Eppendorf tubes and pelletted 
to approximately 1 gram pellets. The pellets were resuspended in 1ml of 0.15M NaCl/ 0.1M 
sodium carbonate pH 9.0 supplemented with 10 µl of a 10 mg/ml flourescein isothiocyanate 
(FITC, Sigma) solution and incubated for 1 hour at room temperature in the dark. The bacteria 
were recovered by centrifugation at 3000 x g and washed for 5 times in PBS/ 0.05% Tween 20. 
The intensity of 10 µl spots of labeled bacterial suspensions was checked under a fluorescence 
microscope. Undiluted labeled bacterial strains were stored at -20°C as a stock solution. 50µl 
aliquots were diluted in 1 ml PBS before use and only refrozen once to serve as a working 
dilution. 
Bacterial Capsule preparation 
Bacterial capsules were isolated from an overnight culture of P.mirabilis grown in Luria broth at 
37°C. Bacteria were collected by centrifugation at 1500x g for 10 minutes at 4˚C in an 
Eppendorf 5804R centrifuge and transferred to 25 ml 1 M TRIS-HCl pH 7, for every 100 ml 
broth. The bacteria were sonicated for 3 minutes at a peak to peak amplitude of 9 micron in a 
Soniprep sonicator. After sonication, bacterial capsules were separated from intact bacteria by 
differential centrifugation at 500x g rpm for 20 minutes, removing the bacterial pellet, followed 
by centrifugation at 1700x g for 1 hour to isolate the bacterial capsules. The capsular rich 
material was resuspended in 1 ml PBS.  
 
In-vitro  enterocystoplasty infection model 
Bladder and ileal tissues were taken peroperatively and frozen at -80°C until use. For each 
experiment tissue cultures from enterocystoplasty tissues were cultured on solidified 0.5% low 
melting point agar (Gibco) in DMEM supplemented with 20% FBS and overlaid with DMEM 
for 24-48 hours. Functionality of the tissues was indicated by the discoloration of the agar 
without microbiological overgrowth. Intestinal and bladder tissue cultures were thus prepared 
and subsequently infected with a 1:10 dilution of a 18 hour Proteus mirabilis (ATCC 49565) 
culture in Luria broth that was centrifuged and resuspended in centrifuged patient urine. Tissues 
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were thus incubated with bacteria in urine for 4 hours at 37°C. In this manner intestinal and 
bladder tissues from 7 and 7 patients respectively were infected with a single strain of 
P.mirabilis (ATCC49565). In addition, sections of ileal tissue from a single patient was likewise 
infected with all P.mirabilis strains. Following infection with P.mirabilis tissue cultures were 
fixed in 4% formaldehyde for 2 days and paraffin embedded.  
  
Immunohistochemistry 
Lipopolysaccharide (LPS) - Alcian Blue (AB) staining of infected ileal sections 
Tissues were sectioned at 5 µm and deparaffinized in xylene and dehydrated in alcohol for 10 
minutes before endogenic peroxidase blocking in methanol /3% H2O2 and antigen enhancement 
in 0.05 M pH 6.0 citrate buffer using a microwave at 700W for 15 minutes. Sections were 
washed in PBS for 5 minutes and blocked in 30 minutes in 1x Teng-T made from a 10x stock 
solution in warm water (100 mM Tris, 50 mM EDTA, 1.5M NaCl, 2.5% gelatin, 0.5% Tween 
20) and adjusted to pH 8.0 . Blocked sections were  rinsed 3 times in PBS/ 0.1% Tween 20 
(PBST) and once in PBS. The primary polyclonal sheep antibody against the LPS core region 
(Nuclilab, Biogenesis, 5684-1000) was applied  in 5% BSA / PBST for 1 hour at a 1:80 dilution 
and washed 3 times with PBST. A indirect immunostaining protocol was used to stain the core 
region of the bacterial LPS as a general bacterial staining method. A rabbit-anti-sheep-HRP 
antibody was applied for 30 minutes at a 1:50 dilution in 5% BSA/ PBST and washed 3 times 
with PBS. Sections were incubated for 15-20 minutes with AEC (3-amino-9-ethylcarbazole) as 
chromogen. Sections were washed 2 times in PBS and once in distilled water. Alcian Blue 8GX 
1% in 3% acetic acid was applied for 20 seconds and rinsed with tap-water for 30 seconds. 
Sections were washed in 3% acetic acid for 10 minutes and 2 times in distilled water for 5 
minutes, air-dried and mounted with pertex. 
Proteus mirabilis –Mucin specific staining of infected ileal sections 
Proteus mirabilis and mucin specific staining was used to evaluate and count specific 
interactions. Tissues were sectioned at 5 µm and deparaffinized in xylene and dehydrated in 
alcohol for 10 minutes before endogenic peroxidase blocking in methanol /3% H2O2 and antigen 
enhancement in 0.05 M pH 6.0 citrate buffer using a microwave at 700W for 15 minutes. An 
alkaline phosphate staining procedure was used to stain MUC2 or MUC5AC at 1:80 primary 
antibody dilution for 1 hour. Followed by three times 5 min. washing with PBS/0.1% Tween20 
and application of an alkaline phosphatase secondary labeled antibody for 45 min. at a 1:50 
dilution. Followed by three times washing with PBS and staining using Fast-Blue RR (Sigma-
Aldrich) as a chromogen. Slides were blocked using goat-anti-mouse- immunoglobulins (DAKO 
A/S) at a 1:50 dilution for 30 minutes. A peroxidase-anti-peroxidase protocol was used to stain 
the Proteus bacteria using a 1:100 dilution of the first anti-Proteus mirabilis-antibody 
(Biogenesis, Nuclilab) overnight at 4˚C, an anti-mouse antibody (DAKO) at 1:50 dilution for 30 
minutes, 1:300 dilution of the PAP complex (DAKO A/S) for 30 minutes and AEC (3-amino-9-
ethylcarbazole) as a chromogen. Anti-MUC2 and anti-MUC5AC monoclonal antibodies were 
NCL-MUC-2 and NCL-MUC-5AC respectively (Novocastra Laboratories Ltd, Newcastle upon 
Tyne, UK) and specific for the respective precursor protein. Correct staining was verified by 
staining positive control sections of stomach and colon and comparing staining patterns with a 
known MUC2 specific monoclonal antibody (We9) on control sections28. Washing steps in 
between antibodies were done using PBS/ 0.1% Tween 20 and a last washing step with PBS 
prior to staining with the AEC chromogen. Slides were air-dried and mounted with pertex. Slides 
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were evaluated at 400x and 1000x magnification with and without polarization filters. In each 
section the number of bacteria associated or unassociated with MUC2 and MUC5AC stained 
cells were counted in 10 high power fields (1000x). Similarly the number of bacteria in the 
mucosa and the submucosa were counted.  
Von Kossa staining 
Following in-vitro infection, infected ileal sections were stained according to an adaptation of 
the Von Kossa staining procedure for phosphate salts to show calcium and magnesium salt 
precipitation26 as an antibody independent bacterial staining method. Deparaffinized 5µm 
sections were hydrated to distilled water and placed in a 5% silver nitrate solution. Sections were 
stained for 30-45 min. under a UV-light source. Sections were washed three times in distilled 
water and placed in a 5% sodium thiosulfate solution for 5 min. after which sections were 
washed in distilled water three times and counterstained with nuclear-fast Red for 5 minutes and 
washed in distilled water. Sections were dehydrated in an alcohol gradient and after clearing in 
xylene mounted with pertex. 
 
Adherence of FITC-labeled bacteria on deparaffinized ileal tissue sections 
Bacterial hybridization experiments were conducted according an abridged version of a method 
described for Helicobacter pylori by Falk e.a. in order to evaluate bacterial adhesion to 
undisturbed epithelial cells and the effect of sialic acid and MUC3 blocking on epithelial cell 
adhesion.  
Uninfected fresh ileal tissue from patients was embedded in paraffin and sectioned at 5 µm on 3-
aminopropyltriehoxysilane (APES) coated slides after which the sections were deparaffinized in 
xylene for 10 minutes and alcohol for 10 minutes. Slides were coated after cleaning the slides 
with detergent for 30 minutes and washing in tap-water for 30 minutes followed by two washing 
steps in distilled water and 2 washing steps in 95% alcohol of 5 minutes each. Slides were coated 
by immersion in a fresh 2% 3-aminopropyltriethoxysilane in dry acetone for 5 seconds. Slides 
were washed twice in distilled water and dried at 42 °C overnight in an incubator. Sections were 
rehydrated by serial incubation in 70%, 50% alcohol , distilled water and PBS for 5 minutes 
each. Sections were blocked for 15-30 minutes in 0.2 % Bovine Serum Albumin /0.05% Tween 
20 in PBS. Sections were incubated for 1 hour with 200 µl labeled bacteria in a 1/20 working 
dilution, covered with parafilm slips in a humidified chamber at 37°C.  The 200 µl FITC-labeled 
bacterial suspensions were either used directly or pre-incubated with a 1mg/ml solution of sialic 
acid (Sigma Aldrich, N-acetylneuraminic acid, A9290) or 10 mg/ml MUC3 for 1 hour and 
washed with PBS. After incubation the sections were washed in PBS for 6 times for 3-5 minutes 
and air-dried. Sections were checked for a FITC signal under a fluorescence microscope and 
washed another 2-4 times after which the sections were covered in Vectashield ® (Vector 
Laboratories, Inc., Brunschwig) mounting medium supplemented with 0.2 mg/ml 4 , 6-
diamidino-2-phenylindole, dihydrochloride (DAPI) to visualize epithelial cell nuclei. Blocked  
sections were evaluated in comparison with unblocked sections. 
 
Far-Western Analysis 
Far Western analysis was used to evaluate specific bacterial capsule-mucin interactions, sialic 
acid and MUC3 blocking. The bacterial capsules were analyzed on a 4% stacking/ 10% 
separating SDS-PAGE by staining with Coomassie Brilliant Blue or transblotted. The gels were 
transblotted at 100 mV for 1 hour to a nitrocellulose transfer membrane (Protran® BA 85,  
Schleicher&Schuell), washed in PBS/0.1%Tween 20 three times and blocked for 1 hour in PBS/ 
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0.1%Tween 20/ 2% skimmed milk. A second blocking step with 1mg/ml MUC3 (Sigma Aldrich 
M1778, partially purified powder) or 1mg/ml purified sialic acid  (Sigma Aldrich, N-
acetylneuraminic acid, A9290) for 45 minutes was used to test sialic acid specific binding in two 
separate series. The transfer membrane was overlaid for 45-60 minutes with 5 ml PBS/0.1 % 
Tween 20/ 2 % skimmed milk supplemented with 5 ml patient urine after centrifugation at 1500x 
g for 10 minutes. Urine was used either untreated or pre-treated with either 0.002u /ml 
neuraminidase (Sigma-Aldrich) or 1% periodate for 30 min. at 37˚C. After washing the 
nitrocellulose membrane 3 times for 10 minutes in PBS/0.1 %Tween 20/ 1 % skimmed milk the 
first antibody was applied. Rabbit polyclonal antibodies against HCM or HGM in PBS/0.1 
%Tween 20/ 2% skimmed milk at a 1:1000 dilution were used and incubated for 1 hour. Anti-
HCM and anti-HGM characteristics were previously described by Tytgat et.al.33. Anti-HCM 
(Human Colonic Mucin) is a rabbit polyclonal antibody raised against purified human colonic 
mucin. It recognizes the mature, fully glycosylated MUC2. Anti-HGM (Human Gastric Mucin) 
is a rabbit polyclonal antibody raised against purified human gastric mucin it recognizes mainly 
the mature, fully glycosylated MUC5AC. The first antibody must be able to recognize the 
mature protein, therefore anti-HCM was used to show MUC2, and anti-HGM was used to show 
MUC5AC. After that the membrane was washed 3 times in PBS/0.1 % Tween 20/ 1 % skimmed 
milk and the second HRP labeled anti-rabbit-antibody was applied in PBS/0.1 % Tween 20 / 2 % 
skimmed milk and incubated for 45-60 minutes. Horse radish peroxidase labeled antibodies were 
visualized by chemiluminescence using BM Chemiluminescence Blotting Substrate (POD) 
(Roche Diagnostics GmbH, Mannheim) and exposure to film. The prestained Seeblue molecular 
weight standard (Invitrogen) provided a positive control to which both MUC2 and MUC5AC 
would adhere. 
 
Western Blotting analysis of bacterial strains for GroEL 
Western Blotting was used to evaluate GroEL (Cpn60) in different strains. Gel electrophoresis 
and transblotting and blocking was performed similar to Far-Western Blotting. Rabbit-anti-
GroEL (Hsp60/ Cpn60) antibody (Sanbio BV, Stressgen) was used as a primary antibody  in 
PBS/0.1 %Tween 20/ 2% skimmed milk at a 1:1500 dilution and incubated for 1 hour. After that 
the membrane was washed 3 times in PBS/0.1 % Tween 20/ 1 % skimmed milk and the second 
HRP labeled anti-rabbit-antibody was applied in PBS/0.1 % Tween 20 / 2 % skimmed milk and 
incubated for 45-60 minutes. Horse radish peroxidase labeled antibodies were visualized by 
chemiluminescence using BM Chemiluminescence Blotting Substrate (POD) (Roche 
Diagnostics GmbH, Mannheim) and exposure to film. 
Statistical Analysis 
Statistical analysis was performed using SPSS 9 software. The association between bacteria, 
mucins and crystals was analyzed using Pearson and Spearmann correlation, and hierarchical 
cluster analysis was performed for the infected bladder and intestinal tissues using median 
clustering by squared Euclidean distance. Far-Westerns were evaluated by binomial tests and 
Pearson and Spearmann correlation, Wilcoxon signed rank, Mann-U-Whitney and Mc Nemar 
tests. 
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Results 
Adherence of FITC-labeled bacteria on deparaffinized tissue sections 
P.mirabilis adheres to goblet cells and to some extent to enterocytes. P.mirabilis does not adhere 
to the lamina propria. After sialic acid blocking specific adhesion to goblet cells disappeared but 
increased on enterocytes at the top of the intestinal villi. Bacterial adhesion to Paneth cells in the 
intestinal crypts also disappeared. MUC3 blocks all specific interactions with ileal epithelial 
cells. Results are presented in Table 1 and Fig.1.E, F, G, H.. 
 
Immunohistochemistry of in-vitro infected tissues 
In Fig.1 A,B sections are doublestained for respectively MUC2 and MUC5AC respectively and 
P.mirabilis. Infected and damaged epithelia show bacterial adhesion/ invasion in the mucin 
producing epithelial cells. Fig. 1.C shows salt precipitation on bacteria in the intestinal crypts.  
 
Falk’s bacterial-hybridization P.Mirabilis 
strain 
Origin API-code 
Unblocke
d 
Sialic acid 
block 
MUC-3 
block 
Alcian Blue 
/ LPS 
staining 
AB129 Enterocystoplasty 0336000 - - - + 
AB142 Enterocystoplasty 0735000 +/- - - + 
AB364 Enterocystoplasty 0737000 +/- - - +/- 
AB474 Enterocystoplasty 0737000 + - - +/- 
AB520 Enterocystoplasty 0737000 +/- - - + 
AB780 Enterocystoplasty 0737000 + + - +/- 
AB964 Enterocystoplasty 0733000 + - - +/- 
S468 Enterocystoplasty 
Infection Stone 
0736000 +/- - - + 
U101 Normal Bladder 0737000 + - - + 
U103 Normal Bladder 0334000 + - - - 
U124 Normal Bladder 0735000 + - - +/- 
U238 Normal Bladder 0337000 +/- - - + 
U366 Normal Bladder 0736000 - - - - 
U530 Normal Bladder 0737000 + - - + 
U679 Normal Bladder 0757000 + - - +/- 
ATCC Normal Bladder 
Infection Stone 
0737000 + - - + 
Table 1. P.Mirabilis origin of strains and Falk’s bacterial-hybridization with fresh ileal tissue 
sections and immunological staining of infected ileal tissue sections. Sections were scored for 
association of Proteus mirabilis with goblet-cells in the ileal sections (+=strong colocalisation 
with goblet-cells, +/-= association with goblet-cells and some other cell types, -= no typical 
association with goblet-cells). Strong co-localization with enterocytes was also observed in all 
sections (especially after sialic acid blocking) except in the MUC-3 blocked hybridization 
experiments. LPS-Alcian Blue staining of infected tissue sections showed bacterial localization in 
the goblet-and enterocytes.    
In binomial tests the LPS-Alcian Blue staining and unblocked hybridization experiments were 
significantly positive (+ or +/-, p=0.004) and the sialic acid blocked (p=0.001) and MUC3 
blocked (p<0.001) hybridization experiments were significantly negative for goblet-cell adhesion 
/ infection 
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G
F
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Fig.1. Histochemistry and Immunohistochemistry 
A) Immunohistochemical staining of ileum indicates bacterial colocalisation (orange-
black) with MUC2 stained epithelial cells B) Immunohistochemical staining of ileum 
indicates bacterial colocalisation with MUC5AC producing cells. C) Bacterial 
localization between intestinal villi, bacteria stain positive for phosphate salts in Von 
Kóssa staining.  D) Bacterial colocalisation with epithelial cells in ileal villi. red= 
bacterial LPS Proteus mirabilis, blue = sulfated mucins. Reduced from x 800 
Bacterial Hybridization of tissue sections with FITC-labeled bacteria. E) DAPI/ FITC 
fluorescent microscopy image of  hybridization with ileal tissue (800x), F) 
hybridization after Sialic acid blocking (400x), G) hybridization after Sialic acid 
blocking (800x), H) hybridization after MUC3 blocking (800x). 
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A) Intestinal and bladder tissue infection with P.mirabilis ATCC49565 
P. mirabilis has a different adhesion pattern to MUC2 and MUC5AC producing epithelial cells 
in bladder and bowel tissues. The total number of bacteria influences the number of bacteria in 
the lamina propria and epithelium. The total number of bacteria correlates with the number of 
bacteria that are free from MUC2, which correlate with the number of bacteria in the lamina 
propria and epithelium. Pearson correlations are presented in Table.2A. Colocalisation of 
bacteria with MUC2 becomes clear in a group of sections with an equal amount of bladder and 
ileal sections where more MUC2 and bacteria are found in the ileal sections (Table 2.B). 
However bacteria with MUC5AC and without MUC2 are also correlated. The number of 
bacteria in the lamina propria correlates with the number of bacteria that are free from MUC2. 
The adhesion of P.mirabilis to MUC2 seems to be limited and dependent on MUC2 expression. 
Invasion and loss of the mucosal barrier function occurs with decreasing fraction of MUC2 
adherent P.mirabilis, apparent with increasing number of bacteria.  
  
   Pearson 
correlation 
p-value 
Total number of bacteria vs. Bacteria without MUC2 P = 0.801 p = 0.0009 
Bacteria in epithelium vs. Total number of bacteria P = 0.891 p = 0.043 
Bacteria in epithelium vs. Bacteria without MUC2 P = 0.597 p = 0.031 
Bacteria in epithelium vs. Bacteria in lamina propria P = 0.559 p = 0.047 
Bacteria in lamina propria vs. Total number of bacteria  P = 0.874 p = 0.009 
Bacteria in lamina propria vs. Bacteria without MUC2 P = 0.827 p = 0.0004 
Bacteria with MUC5AC vs. Bacteria without MUC2 P = 0.629 p = 0.028 
 
Table 2A. Colocalisation in Immunohistochemical doublestaining for 13 infected tissue sections 
(7 bowel and 6 bladder). Only significant correlations are presented. ‘Crystals with MUC5AC’ 
were not presented since the significant correlations were similar to values for ‘crystals without 
MUC5AC’ . Correlations are significant  at the p<0.05 level. 
 
B) Intestinal tissue with different P.mirabilis strains 
In only ileal tissue sections bacterial adhesion to MUC2 producing cells was significant on the 
epithelial surface, but not in the lamina propria. The number of bacteria associated with 
MUC5AC producing cells and with non-MUC5AC producing cells were related and both were 
found preferentially in the epithelium. Correlations are presented in Table.2.C. LPS-Alcian blue 
staining showed colocalisation of bacteria with the basolateral part of goblet-cells and the apical 
part of enterocytes in the mucin filled inter-villous space, but not in the ileal crypts, the lamina 
propria or any other part of the ileal tissue. Results are presented in Table 1. and Fig.1D. 
 
Far-Western Analysis 
In Far-Western analysis a binding capability was shown for proteins in the bacterial capsule to 
MUC5AC and MUC2 in all cases. Adhesion was effective enough to deplete the 
enterocystoplasty urine from mucins. This capability disappeared after periodate treatment in the 
case of MUC2 and remained in the case of MUC5AC, destroying the sugar-O-rings in the 
glycosylated tandem repeats. Furthermore, sialidase treatment of enterocystoplasty urine used in 
the Far-Western showed a inverse relation between sialidase pre-treated MUC2 and MUC5AC. 
This procedure digests sialic acid in mucins to load the enterocystoplasty urine with a large 
amount of both sialic acid and a more accessible protein backbone. Most of the enterocystoplasty 
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strains of P.mirabilis showed the ability to adhere to MUC2 despite sialidase pre-treatment and 
lacked the ability to adhere to sialidase treated MUC5AC. The strains isolated from normal 
urinary bladders were able to bind to MUC5AC, but not MUC2 in sialidase treated 
enterocystoplasty urine. These (glyco)proteins involved in the binding of MUC2 and MUC5AC 
are approximately similar in size and can be separated on a non-reducing SDS-PAGE. (Fig.4.) 
MUC3, neuraminidase treated MUC3 and sialic acid solutions before the application of 
enterocystoplasty urine in Far-Western analysis was able to block the adhesion of HCM and 
HGM to the bacterial capsules, Table.3  
 
 
t-test for Equality of Means 
Group Statistics 
t df Sig.  (2-tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
 TISSUE Mean Sd SEM      Lower Upper 
Bowel 30.71 14.49 5.48 Bacteria with 
MUC2 Bladder 4.17 6.52 2.66 
4.36 8.60 0.002 26.55 6.09 12.67 40.42 
Bowel 12.71 5.82 2.20 Bacteria without 
MUC2 Bladder 28.83 21.61 8.82 
-1.77 5.62 0.13 -16.12 9.09 -38.73 6.50 
Bowel 16.14 12.38 4.68 Bacteria in 
lamina propria Bladder 27.00 18.19 7.43 
-1.28 11.00 0.228 -10.86 8.51 -29.58 7.87 
Bowel 39.14 11.75 4.44 
M
U
C
2 
Bacteria in 
epithelium Bladder 33.00 22.02 8.99 
0.64 11.00 0.534 6.14 9.57 -14.91 27.20 
Bowel 12.67 8.96 3.66 Bacteria with 
MUC5AC Bladder 36.17 14.08 5.75 
-3.45 10.00 0.006 -23.50 6.81 -38.68 -8.32 
Bowel 12.50 4.81 1.96 Bacteria without 
MUC5AC Bladder 12.83 6.62 2.70 
-0.10 10.00 0.922 -0.33 3.34 -7.77 7.10 
Bowel 25.17 12.58 5.13 Bacteria in 
epithelium Bladder 49.00 17.84 7.28 
-2.67 10.00 0.023 -23.83 8.91 -43.69 -3.98 
Bowel 29.67 20.39 8.33 
M
U
C
5A
C
 
Bacteria in 
lamina propria Bladder 11.00 33.72 13.76 
1.16 10.00 0.273 18.67 16.09 -17.18 54.51 
 
Table 2.B. Bacterial colocalisation with mucins in ileal and bladder sections. 
T-test for mean number of bacteria in 10 high power fields. Shaded areas indicate significant differences 
between adhesion in bladder and ileal sections.  
 
Western Blotting analysis of strains for GroEL 
All strains showed GroEL expression on Western Blot, which correspond in size with the 
interacting protein in Far Western Blot, (Fig. 5.) 
 
Von Kóssa staining of sections 
Von Kóssa staining showed a precipitation of phosphate salts, mainly on bacteria. Bacteria were 
found in the intestinal crypts, mainly at the top of the crypts (Fig.1.C.). In these parts of the 
crypts the epithelium mainly stained positive for MUC2 and less for MUC5AC. Agglomerations 
of these precipitates were observed, which almost blocked the crypts. Where crypts were 
blocked, large deposits of bacteria accumulated at the luminal side of the crypts. Precipitation 
was observed in all samples, and could be well distinguished from background staining. Bacteria 
in crypts, without invasion of epithelial cells stained positive in Von Kóssa staining and negative 
with routine immunostaining and enabled an evaluation of the bacterial load as homogenous and 
diffuse over the entire crypt.  
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   Pearson 
correlation 
p-value 
Bacteria in epithelium vs. Bacteria with MUC2 P = 0.964 p < 0.001 
Bacteria in epithelium vs. Bacteria in lamina propria P = 0.525 p = 0.037 
Bacteria with MUC5AC vs. Bacteria without MUC5AC P = 0.671 p = 0.004 
Bacteria in epithelium  vs. Bacteria with MUC5AC P = 0.989 p < 0.001 
Bacteria in epithelium  vs. Bacteria without MUC5AC P = 0.773 p < 0.001 
 
Table 2.C. Colocalisation in Immunohistochemical doublestaining for 1 infected bowel tissue 
section, infected with 16 P.mirabilis strains. Only significant correlations are presented. 
Correlations are significant at the p<0.05 level. 
 
 
MUC2 
(p-value) 
MUC5AC 
(p-value) 
MUC2 vs. 
MUC5AC 
(p-value)a 
Patient urine 16(<0.01) † 16(<0.01) † - 
Patient urine + periodate 0(<0.01) † 16(<0.01) † ≤0.001* 
Patient urine + neuraminidase 10(<0.45) 5(<0.21) 0.302 
Patient urine + MUC3 block 0(<0.01) † 14(<0.01) † ≤0.001* 
Patient urine + hydrolyzed MUC3 block 1(<0.01) † 10(<0.45) 0.004* 
Patient urine + sialic acid block 0(<0.01) † 16(<0.01) † ≤0.001* 
   Normal urine 0(<0.01) † 16(<0.01) † ≤0.001* 
Table 3. Far-Western analysis of 16 P.mirabilis strains.  
Positive staining lanes with the mucin binding capsule protein bands were counted 
a p-values from McNemar test 
†=Significant p-values by binomial distribution within groups of 16 strains (p<0.01) 
*=Differences between MUC2 and MUC5AC interaction are significant in Wilcoxon Signed 
Ranks and McNemar test (p≤ 0.005), and significant in Mann-U-Whitney test (p≤0.001) 
Competitive inhibition of sialic acid with MUC5AC and MUC2, achieved by neuraminidase 
treatment of patient urine showed a  Pearson correlation of –0.595 (p=0.021) between MUC5AC 
and MUC2 interaction. Differences between the AB and U strains were significant for the 
competitive sialic acid block in a Mann-U-Whitney test (p=0.046) 
Strains isolated from enterocystoplasties preferentially bind MUC2 compared to MUC5AC 
(p<0.001) 
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MUC2 MUC5AC
Untreated
Neuraminidase  
Fig.2. Far-Western Analysis of 16 P.mirabilis.  Top)Transblotted bacterial capsules interacted 
with MUC2 and MUC5AC from untreated enterocystoplasty urine. Bottom) Transblotted 
bacterial capsules overlaid with neuraminidase treated enterocystoplasty urine interacted with 
both the mucin and the free sialic acid, and shows a preference for either MUC2 or MUC5AC in 
the presence of sialic acid and the mucin residue. 
 
1 2 3 4 5 6 7 8  
Fig. 3 . Western Blotting analysis of bacterial strains for GroEL (Cpn60). 1 =  AB129, 2= 
AB142, 3= AB364, 4= AB474, 5= AB520, 6= AB780, 7= AB964, 8= S468. Strains from normal 
urinary bladders showed similar expressions (not shown) 
 
 
Discussion 
Interactions between crystals and the bacterial capsule9 and between crystals and mucins21 have 
been described before. Here we describe the interaction between bacteria and mucins in relation 
to the stone formation process.  
It seems bacterial adhesion to the epithelial surface is tissue type specific and that different tissue 
types have different capabilities to adhere bacteria and crystals. Proteus mirabilis in between the 
intestinal villi gathers phosphate salts on the bacterial capsule. These bacteria are found in the 
intervillous space, filled with sulphated mucins from where they infect the epithelial surface. An 
affinity for goblet cells and enterocytes is expressed. The affinity for goblet cells and MUC2 and 
MUC5AC changes after sialic acid blocking to a enterocyte preference. The high sialic acid 
concentration is necessary to achieve a blocking effect, which could be attributed to an osmolyte 
function of sialic acid in the interaction of GroEL with a protein substrate5,36 
Affinity for goblet cells and  enterocytes disappears after MUC3 blocking. This can be explained 
by the application of competitive substrate for GroEL. 
 After degradation of mucins by sialidase, sialic acid is released to enhance the GroELÙ 
substrate interaction in small amounts of sialic acid and a large free section of the protein core 
with α-β transitions. Interaction between GroEL, MUC2 and MUC 5AC changes in certain 
strains after sialidase (neuraminidase) treatment of  enterocystoplasty urine in a similar manner. 
Common urinary proteins are less glycosylated and become better substrates for GroEL. The 
mucins lose sialic acid as well and GroEL either prefers MUC2 or MUC5AC as a substrate. The 
osmolyte function of saccharides would enhance the blocking capability of urinary proteins and 
mask some available α-β transitions in MUC2. MUC2 interaction is decreased and remaining 
interactions may be explained by remaining free GroEL due to high expression of GroEL. 
MUC5AC binding is increased for certain strains, which were blocked more effectively for 
MUC2. Increased band intensity can be explained by the osmolyte function of sialic acid. In 
some strains interactions disappear for MUC2, but become stronger for MUC5AC, due to a 
preferred interaction with the freed α-β transition in MUC5AC. Von Willibrand factor domains 
could be the general interaction sites with GroEL on the mucin molecules. The repeat domains 
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with large amounts of sialic acid could contain the freed α-β transitions involved in the 
interaction with GroEL.   
 
Bacteria available for antibodies must be free from any significant precipitation that would 
interfere with a bacterial-host interaction. This preferentially occurs in the epithelial cell and 
demonstrates bacterial invasion and infection. Precipitation accumulates after a 3-4 hours period 
at 37˚C in artificial urine when bacterial growth has long reached its lag-phase. Bowel tissue 
seems to be more capable of adhering P.mirabilis. Furthermore, these bacteria seem to be located 
mostly in the epithelial part, where the mucins are located and at the center or upper half of the 
villi where the are produced. This indicates a bacterial binding capability of  mucin producing 
cells. When the bacterial load exceeds the bacterial binding capability, the mucosal barrier is 
breeched. 
 
Human Colonic Mucin is the mature form of MUC2 and is secreted into the urine of 
enterocystoplasty patient in relatively large amount. HGM is the mature form of the secreted 
MUC5AC and is also produced by the veru montanum of the normal urogenital tract in boys4.  In 
enterocystoplasties in children the bladder is usually enlarged to relieve a compromised kidney 
and the bladder trigonum remains. The normal bladder urine was acquired from healthy male 
subjects and it is therefore not very surprising that MUC5AC appears in the normal urine Far-
Western. MUC5AC and other urinary (glyco)proteins may interact with the epithelial surface of 
the pouch and for infection of sections enterocystoplasty urine was used to allow for these 
interactions to take place.  
 
It seems the interaction between mucins and P.mirabilis is not a random event induced by the 
“stickiness” of the sialated mucins, but is a specific interaction between host and bacteria, which 
can be blocked by high concentrations of sialic acid and aspecifically by MUC3. This specific 
interaction shifts in preference in the presence of neuraminidase.  MUC2, the most prominent 
secretory mucin type in large bowel33 , important in enterocystoplasties plays an important 
barrier and adhesion role for P.mirabilis. In the presence of other bacteria, producing 
neuraminidase, the interaction preference can change to involve other mucins as well.   
 
Other sugar residues besides sialic acid and encapsulation of the bacteria by the mucin molecule 
may play a role in interaction inhibition. Similarly Streptococci have also been observed to bind 
to sialic acid residues on mucins30. The differences in binding characteristics of the different 
P.mirabilis strains may be more dependent on conformation or glycosylation then actual amino 
acid differences. Neuraminidase is also known as sialidase and is very effective at low 
concentrations. It has been known that bacterial pathogens target sialic acid residues23, which 
may be conformation dependent.  
 
Maybe we should therefore compare the interaction with sialic acid residues we found for 
P.mirabilis with the interactions seen in other urease producing bacteria such as H.pylori, which 
also shows a strain specific interaction with sialic acid3 and interacts with MUC2 and 
MUC5AC35. In MUC2 intact sugar O-rings and therefore glycosylation seems to be important 
for the adhesion of P.mirabilis.  The disappearance of interaction with GroEL can be explained 
by a masking effect of the available interaction site. 
 
The idea that the formation of infection stones is related to the production of urinary urokinase 
and sialidase has been proposed6,7. However sialidase was thought to enhance the formation of a 
mineral matrix from uromucoid. Uromucoid and probably uromodulin27 are identical to Tamm-
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Horsfall protein which can be found in collecting tubule casts present in normal urine and which 
can trap Type I fimbriated E.Coli25 . It now seems that the sialidase pre-treatment of mucins also 
changes the targeting capabilities of the interaction between bacteria and host. Bacteria which do 
not produce urease, but do produce neuraminidase such as E.Coli and Staphylococcus could 
therefore influence the bacterial adhesion of P.mirabilis and therefore contribute directly to 
bacterial strain selection on the basis of MUC2 adhesion and  the formation of an infection stone, 
besides influencing urinary protein excretion.  
  
It seems that mucin production inhibitors can decrease the number of epithelial internalized 
bacteria37, which may play a role in P.mirabilis infection2,24. Alkalisation18 and urease10 have 
been involved in the formation of stones and since usually both of these events are related the 
knowledge that intermittent catheterizing patient who rinse their bladder still produce stones1 
presents a therapeutical possibility. Sialic acid, MUC3 or similarly acting substances may prove 
valuable additives for bladder rinsing solutions. 
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Abstract 
Introduction:  
Proteus mirabilis is a known bacterial agent in the pathogenesis of  urinary infection stones. 
Previously we demonstrated that P.mirabilis colocalizes with mucins MUC2 or MUC5AC. 
These mucins are abundant surface molecules at the cellular surface of enterocystoplasty 
epithelial cells. Here we prove that P.mirabilis interacts with mucins, MUC2 and MUC5AC, and 
identify the bacterial counterpart in the interaction. 
 
Materials and methods:  
Two previously described  P.mirabilis strains  (AB780, AB474) were evaluated by sequential 
Far-Western analysis of  bacterial lysates and fractionated bacterial lysates. Urine from 
enterocystoplasty patients were used in Far-Western analysis to provide fresh mucins. Two 
dimensional gel electrophoresis, ms-ms mass spectrometry, electron microscopy and Western 
blotting analysis were carried out to identify the bacterial adhesin.  
 
Results:  
Bacterial lysates and fractionated samples derived from bacterial lysates contained a MUC2 and 
MUC5AC interacting molecule by Far Western analysis, which was identified by ms-ms mass 
spectrometry as GroEL after separating the samples of interest from contaminants and co-
migrating molecules in 2D-gel electrophoresis. Electron microscopy showed GroEL localization 
at the bacterial surface. Furthermore western blot analysis of outer membrane fractions, also 
demonstrated the presence of GroEL at the bacterial surface. Using purified GroEL interaction 
with MUC2 and MUC5AC was confirmed in Far-Western analysis. 
 
Discussion:  
GroEL from P.mirabilis interacts with MUC2 and MUC5AC present in urine derived from 
enterocystoplasties.  These interactions may be of importance during enterocystoplasty infection 
with P. mirabilis in stressed conditions such as antimicrobial treatment of a hostile urine 
environment. 
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Introduction 
 
Proteus mirabilis has been designated the most important bacterial agent in the formation of 
infection stones, both in normal and augmented bladders1-3. Enterocystoplasties have been an 
adequate surgical intervention for almost 50 years4. In children, the intention is to enlarge small 
non-compliant bladders with an intestinal pouch to create a continent urinary diversion, usually 
an ileal reservoir. Nevertheless, in the last few decades, several adaptations of the augmentation 
method were necessary to achieve a satisfactory result4. At this time there are still morbidity 
risks related to enterocystoplasties. Complications and morbidity can often be related to mucus 
production, infection and catheterization1.  
Stone formation is one of the important complications in children. In the period following 
augmentation of the bladder the pH rises and often stones are formed consisting of ammonium 
magnesium phosphate, calcium phosphate and calcium apatite. The formation of these stones has 
in most cases been attributed to the rise in pH as a result of the size of the incorporated intestinal 
segment and urea splitting by urease 5,6. When the pH of urine rises crystals will form in vitro in 
normal human urine as well as in-vitro in artificial urine above pH 7.37,8 . 
Urease producing organisms and other bacteria encounter a pivotal step in symptomatic 
infection. P.mirabilis requires adhesion to the cellular surface of the augmented bladder as the 
first step of infection of the enterocystoplasty.  
Some adhesion factors have been described for P.mirabilis, such as Non-agglutinating fimbriae 
(NAF)9, mannose resistant pili (MR/P and MR/K)10 and urothelial cell adhesions (UCA)11. These 
adhesion molecules are thought to interact with the bladder epithelium. In the enterocystoplasty, 
a large portion of the augmented bladder consists of intestinal epithelium, secreting intestinal 
mucins of the MUC family12. To date there are approximately 16 mucin types (MUC1-13, and 
MUC16-18) of which 14 have been approved by the Human Genome Organization Gene 
Nomenclature Committee (http:/www.hugo-international.org/hugo/)13. MUC2 is the most 
abundant mucin type in the small intestine and colon14, whereas MUC5AC can be found 
preferentially in gastric mucus15, but also in the duodenum16. MUC5AC is also produced by the 
veru montanum of the bladder trigonum17, which often remains in the augmented bladder. These 
mucins are secreted by the intestinal epithelium and appear in the enterocystoplasty urine. 
Although P.mirabilis may adhere to mucins such as MUC2 and MUC5AC18, it is not clear which 
bacterial molecule is involved in this interaction. To identify the bacterial adhesin used a 
procedure of Far-Western interaction studies, 2D electrophoresis, and ms/ms mass-
spectrometry19 and finally with Transmission electron microscopy. In this order this method can 
identify the unknown interacting molecule of one cell with the known molecule of another. 
 
Materials and Methods 
The methods described here are adaptations of a previously described method for the evaluation 
of protein-protein interactions by Pasquali et al.19 using Far-Western blotting, 2D-electrophoresis 
and mass-spectrometry for the identification of interacting molecules. 
 
Bacterial Strains 
Two previously described Proteus mirabilis strains AB474 and AB78018 were isolated from 
children with an enterocystoplasty and identified using the API- system (BioMerieux, France) 
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and Gram staining. Bacteria were stored in 15% glycerol at -80°C until needed and cultured in 
Luria broth 0.05% glycerol until late log-fase growth before use.  
 
Bacterial Capsule preparation 
Bacterial capsules were isolated from an overnight culture of P.mirabilis and grown in Luria 
broth at 37°C until late log-phase (3-4hours). Bacteria were collected by centrifugation at 3000x 
g for 10 minutes at 4˚C in an Eppendorf 5804R centrifuge and transferred to 25 ml 1 M TRIS-
HCl pH 8.5, for every 100 ml broth. The bacteria were sonicated for 3 minutes at a peak to peak 
amplitude of 9 micron in a Soniprep sonicator. After sonication, bacterial capsules were 
separated from intact bacteria by differential centrifugation at 900x g rpm for 20 minutes, 
removing the bacterial pellet, followed by centrifugation at 1700x g for 1 hour to isolate the 
bacterial capsules. The capsular rich material was resuspended in 1 ml PBS. This crude capsular 
material was used for Far-Western blotting and for further fractionation over a sucrose gradient 
before Western and Far-Western analysis.  
 
Fractionation of  bacterial capsular material  
The samples were prepared according to an abridged version of  a  method previously described 
by R.A. de Maagd e.a.20 Shortly described the method is as follows. Cells were grown overnight 
in Luria broth as described above and harvested. After being harvested cells were resuspended 
into 50 mM Tris (pH8.5) – 20% sucrose – 0.2 mM dithiotreitol (Sigma) supplemented with 0.2 
mg. RNAse T1 (Boehringer Mannheim, GmbH, Germany) per ml. The cells were broken by 
sonication in a Soniprep sonicator at a wave to wave amplitude of 9 microns for 5 minutes. After 
sonication whole cells were separated from broken cells by centrifugation at 900 x g  for 20 
minutes. The supernatant fluid was transferred to a new tube and supplemented with  KCl to a 
final concentration of  0.2 M and centrifuged for 2 hours at 100 000 x g. The pellet was 
resuspended in 0.5 to 1.0 ml  of 20% (wt/wt) sucrose- 5 mM EDTA – 0.2 mM dithiotreitol 
(pH7.5) and layer on top of a discontinuous density gradient of 60%  to 25% sucrose in 5 mM 
EDTA in 5% increments of 0.5 ml each. The gradient was centrifuged for 17 hours at 58 000 x g 
in a Beckman SW50 rotor. The fractions were collected in fractions of 0.5 ml and the small 
residue was resuspended in 20% sucrose 5mM EDTA. Malate Dehydrogenase activity in the 
separate fractions was determined according to Kitto to distinguish intracellular from outer 
membrane fractions.21 The fractions were used for Western and Far-Western Blotting. 
 
Western Blotting analysis of fractionated samples 
Western Blotting was used to evaluate GroEL (Cpn60) in different fractions. Gel electrophoresis, 
transblotting and blocking was performed similar to Far-Western Blotting. Anti-GroEL (Hsp60/ 
Cpn60) antibody (Sanbio BV, Stressgen) was used as a primary antibody  in PBS/0.1 %Tween 
20/ 2% skimmed milk at a 1:1500 dilution and incubated for 1 hour. After that the membrane 
was washed 3 times in PBS/0.1 % Tween 20/ 1 % skimmed milk and the second HRP labeled 
anti-rabbit-antibody was applied in PBS/0.1 % Tween 20 / 2 % skimmed milk and incubated for 
45-60 minutes. Horse radish peroxidase labeled antibodies were visualized by 
chemiluminescence using BM Chemiluminescence Blotting Substrate (POD) (Roche 
Diagnostics GmbH, Mannheim) and exposure to film. 
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Far-Western Analysis 
Far Western analysis was used to evaluate specific bacterial capsule-mucin interactions. Protein 
solutions were diluted to concentrations of approximately 750 µg/ml. Bacterial capsule proteins 
were solubilized in Laemli sample buffer without dithiotreitol (DTT) or mercaptoethanol. The 
bacterial capsule proteins were separated on a 35 cm 4% stacking/ 10% separating SDS-PAGE. 
A small strip was stained with Coomassie Brilliant Blue. The major part remained unstained. 
Another small strip of gel was transblotted at 100 mV for 1 hour to a nitrocellulose transfer 
membrane (Protran® BA 85,  Schleicher&Schuell), washed in PBS/0.1%Tween 20 three times 
and blocked for 1 hour in PBS/ 0.1%Tween 20/ 2% skimmed milk. The transfer membrane was 
overlaid for 45-60 minutes with 5 ml PBS/0.1 % Tween 20/ 2 % skimmed milk supplemented 
with 5 ml urine from enterocystoplasty patients after centrifugation at 1500x g for 10 minutes. 
After washing the nitrocellulose membrane 3 times for 10 minutes in PBS/0.1 %Tween 20/ 1 % 
skimmed milk the first antibody was applied. Rabbit polyclonal antibodies against Human 
Colonic Mucin or Human Gastric Mucin in PBS/0.1 %Tween 20/ 2% skimmed milk at a 1:1000 
dilution were used and incubated for 1 hour. Anti-HCM and anti-HGM characteristics were 
previously described by Tytgat et.al.22. Anti-HCM (Human Colonic Mucin) is a rabbit polyclonal 
antibody raised against purified human colonic mucin. It recognizes the mature, fully 
glycosylated MUC2. Anti-HGM (Human Gastric Mucin) is a rabbit polyclonal antibody raised 
against purified human gastric mucin it recognizes mainly the mature, fully glycosylated 
MUC5AC. The first antibody must be able to recognize the mature protein, therefore anti-HCM 
was used to show MUC2, and anti-HGM was used to show MUC5AC. After that the membrane 
was washed 3 times in PBS/0.1 % Tween 20/ 1 % skimmed milk and the second HRP labeled 
anti-rabbit-antibody was applied in PBS/0.1 % Tween 20 / 2 % skimmed milk and incubated for 
45-60 minutes. Horse radish peroxidase labeled antibodies were visualized by 
chemiluminescence using BM Chemiluminescence Blotting Substrate (POD) (Roche 
Diagnostics GmbH, Mannheim) and exposure to film.  
To induce gel shift of GroEL in Far-Western  analysis, residual fractions were incubated for 30 
minutes with polyclonal rabbit-anti-GroEL before application to 4% stacking/ 10% separating 
SDS-PAGE. Purified recombinant GroEL (Sanbio BV, Stressgen) was used for Far-Western 
analysis. 
 
Sample elution from 1D gel 
Gels were aligned to identify the section of the Coomassie Brilliant Blue stained gel containing 
the positive band in Far-Western analysis. The unstained gel was cut out to isolate the 
appropriate region of the positive band. 
The unstained gel fragment was sliced to 1mm3 pieces and excess 100 mM NH4HCO3 was 
added. Elution of proteins was allowed overnight at 4°C. The supernatant was collected and the 
elution was repeated. Pooled supernatants were freeze-dried and redissolved in solubilization 
fluid: 9M Urea, 100mM DTT, 0.5% (v/v) Pharmalytes pH 3-10 (Amersham), 5% (v/v) Triton X-
100, 5mg Pefabloc (Merck) per 25 ml. 
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2D Gel electrophoresis of eluted samples. 
First dimension: IPG-strips pH 4-7, 17 cm (Bio-Rad) were rehydrated with 250 µl solubilization 
fluid with sample at 16°C overnight. Rehydrated strips were focused for 3 hours at 500 V and 
overnight at 3000 V. 
Second dimension: Focused strips were applied to a 12-20% acrylamide gradient gel and a 
prestained molecular weight marker was added. Gels were run at 118 V 300 mA overnight. Gels 
were fixated in 4:1:5 methanol/ acetic acid/ water for 10 minutes and stained in Cypro Orange 
(Bio-Rad) for 3 hours. Spots were detected on a UV transluminator. Abundant spots were cut out 
and processed for Nanoscale LC-MS. 
 
Mass spectrometric analysis 
Spots of interest were punched out from the gel and sliced in 1 mm3 pieces. 
Slices were then washed three times with water, shrunk with acetonitril, swollen again with 100 
mM ammonium bicarbonate and dried under vacuum.  
The proteins in the slices were digested with modified trypsin (Promega) at a temperature of 37 
oC for 15h. The resulting peptides were extracted with 5% formic acid and subsequently 
analyzed by nano-HPLC-MS/MS23. 
The resulting spectra were interpreted and compared to derived peptide patterns of the Swissprott 
database. (http://www.matrixscience.com) [ Electrophoresis, 20(18) 3551-67 (1999)]  
 
Transmission Electron Microscopy of P.mirabilis 
Bacterial strains were cultured overnight, grown in Luria broth and suspended in PBS similar to 
the bacterial capsule preparation. Bacterial strains were washed three times in PBS and 
resuspended in 0.5% BSA/ PBS/ 0.1%Tween 20. Bacteria were divided in two equal batches and 
centrifuged at 1500 g x 10 minutes at 4°C and resuspended in PBS/ 0.1%Tween 20 
supplemented with rabbit-anti-GroEL (Hsp60) antibody (Sanbio BV, Stressgen)  at a 1:160 
dilution or without a primary antibody and incubated for 1 hour. Bacteria were washed in PBS/ 
0.1%Tween 20 twice and incubated with a secondary gold-labeled anti-mouse antibody for 1 
hour. Gold-labeled bacteria suspensions were applied to the grids and air-dried. Bacteria were 
viewed under a Philips Morgagni ™ 268 transmission electron microscope connected to a CCD 
camera (Mega view II). 
 
Results 
SDS-PAGE and Western analysis of fractions 
Western analysis for GroEL showed a constant band between 50 and 64 kDa, present in residual 
fractions and more in low sucrose fractions then in high sucrose fractions. Most of the GroEL 
was present in the residual fraction and in the fractions of 30-45% sucrose (Fig1A). Most of the 
proteins were found in the residual fractions and in the fractions of 30-35% sucrose (Fig.2.). The 
latter showed low levels of Malate dehydrogenase (MDH) activity whereas the residual fractions 
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showed high levels of MDH activity (Fig.3.). We interpret the levels of MDH activity as the 
presence of intracellular material in the residual fraction and the 30-45% sucrose fractions as 
fractionated capsular material. 
 
 
Fig1.A. AB780: Western blot of fractionated samples showing GroEL in both the 
residue and the fractions with lower sucrose concentration, but less in the 60- 50% 
sucrose fraction. B, Far Western analysis of fractionated samples showing an 
identical profile with the GroEL Western Blot. A similar profile was found for AB474 
(not shown). 1, residue, 2, 60% sucrose, 3, 55% sucrose, 4, 50% sucrose, 5, 45% 
sucrose, 6, 40% sucrose, 7, 35% sucrose,  8, 30% sucrose, 9, 25 % sucrose. 
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Fig2. AB780: Coomassie stained SDS-PAGE of fractionated samples by 
discontinuous sucrose gradients  
 
Far-Western Analysis 
Far-Western analysis of fractionated samples showed interaction of bands corresponding with 
GroEL in Western analysis. Most of the interactions were present in the residual fraction and in 
the fractions of 30-45% sucrose (Fig1.B.). Purified GroEL interacts with MUC2 (Fig.4.B.) and 
MUC5AC (Fig.4.A.). This band is also present in the residual fractions and in the 35% and 40% 
sucrose fractions. Gel shift of GroEL in the residual fractions could be induced in Far-Western 
analysis and interacted with both MUC2 and MUC5AC. 
Far-Western analysis reveals a constant band at approximately 56 kDa that interacts with both 
MUC2 and MUC5AC. Several other weak bands are visible as a smear Fig.5. A stronger signal 
can be found for MUC5AC adhesion then in MUC2 adhesion. The section indicated by an 
asterisk in Fig.5. was used for elution of the interacting protein band and 2D electrophoresis.  
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Fig3. Malate dehydrogenase activity in sucrose fractions and residue as a measure of 
intercellular contamination. Sample 1 = AB780, Sample4= AB474 
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Fig4.A. Far-Western Blot experiments. MUC5AC interaction B. Far-Western Blot experiments. 
MUC2 interaction. 1, purified recombinant GroEL, 2, residue in 20% sucrose, 3, 40% sucrose 
fraction, 4, 35% sucrose fraction, 5, gel-shift of GroEL in diluted residue by rabbit-anti-GroEL, 
the original band disappears and shifts upwards. 
 
2D Gel electrophoresis of eluted samples. 
Many spots were visible in 2 D-electrophoresis after reduction of the isolated sample. The most 
intense spots were approximately 56 kDa. The pattern of the spots was very similar between the 
2D electrophoresis gels of proteins that comigrate with the Far-Western MUC2 and MUC5AC 
positive bands Fig.6. Many contaminants were separated from the predominant protein mixture. 
The 10 most intense spots are indicated with approximately similar mass and pH (1-5) from 
either gel and were evaluated in mass spectrometry. 
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Mass spectrometric analysis 
Most of the 10 processed samples were identified as a Heat Shock Protein. Half of the samples 
could be identified as GroEL (Hsp60/ Cpn60). GroEL (Hsp60/ Cpn60) also fits the molecular 
weight found on gel in contrast to other identifications. Identifications are presented in Table 1. 
Almost all the identifications which correspond with the molecular weight found on gel 
correspond with GroEL (Cpn60). Trigger Factor was not regarded as a suitable adhesion 
molecule option since it does not occur in samples derived from both MUC2 and MUC5AC 
adhesive bands, but only in samples from  MUC5AC adhesive bands. Furthermore, the mascot 
score and percentage of matched peptides is lower then scores and percentages found for other 
proteins. Identifications of samples 6-10 of both 2D-gels revealed mostly enolase contamination 
with relatively low molecular weights. The identified amino acid sequences used for a database 
search are presented in Fig.7. MUC2 and MUC5AC adhesion molecules in P.mirabilis seem to 
be identical in mass spectrometry. 
Transmission Electron Microscopy 
To confirm the identification of GroEL as the adhesion molecule for MUC2 and MUC5AC and 
the expression or presence of GroEL on the bacterial surface Transmission electron microscopy 
imaging was used. GroEL could be determined on P.mirabilis. Many of the bacteria were 
negative. Positive bacteria were found both as clusters and single bacteria. Negative controls 
without a primary antibody showed no staining Fig.8.  
 
Sample 
code 
Mol. weigh
On gel (kDa
Mol. weight 
Found(kDa) Result MASCOT search 
Score 
MASCOT 
Matched 
peptides 
MUC2-1 44-77 57.5 (NC_000907) heat shock protein (GroEL) 414 16% 
MUC2-2 44-77 61.1 30S ribosomal protein S1 (P02349) 638 20% 
MUC2-3 44-77 68.9 
Chaperone protein dnaK (Heat shock 
protein 70) (Heat shock 70 kDa 
protein)(Q8ZIM7) 
420 11% 
MUC2-4 44-77  Only keratin   
MUC2-5 44-77 56.3 60 kDa chaperonin (Protein Cpn60) (GroEL protein) (O66214) 603 19% 
MUC5AC-1 44-77 57.5 
60 kDa chaperonin (Protein Cpn60) 
(GroEL protein 
(P43733) 
337 19% 
MUC5AC-2 44-77 56.3 
60 kDa chaperonin (Protein Cpn60) 
(GroEL protein) 
(O66198) 
434 15% 
MUC5AC-3 44-77 56.3 60 kDa chaperonin (Protein Cpn60) (GroEL protein) 583 17% 
MUC5AC-4 44-77 43.1 Elongation factor Tu (EF-Tu) (P-43) 368 21% 
MUC5AC-5 44-77 56.3 Trigger factor (TF) (P22257) 267 9% 
 
Table 1. Results of MASCOT search with ms-ms results. Five samples with highest intensity were 
analyzed. Best samples according to molecular weight on both Far-Western and 2D-gel are 
shaded grey.  
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Fig5.Far-western blot for MUC2 (left) and corresponding Coomassie 
stained gel, Far-western blot for MUC5AC (right) and corresponding 
Coomassie stained gel. Bar and asterisk indicate the section used for 
sample elution and 2D electrophoresis. 
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Fig.6. 2D-electrophoresis. Spots 1-10 were analyzed. 1-5 were considered to be of importance as 
the possible MUC2 and MUC5AC adhesion molecule, 6-10 were considered contaminants and 
comigrating molecules, and were excluded based on molecular weight. The most intense spots 
were chosen. MUC2 indicates the 2D gel from the eluted sample of the positive band in MUC2 
Far-Western analysis. MUC5AC indicates the 2D gel from the eluted sample of the positive band 
in MUC2 Far-Western analysis. 
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 H.influenza Cpn60 (GroEL) 
 
1  M A A K D V K F G N     D A R V K M L K G V      N V L A D A V K V T      L G P K G R H V I L   D K S F G A P T I T  
5 1   K D G V S V A R E I   E L E D K F E N M G    A Q M V K E V A S K      A N D A A G D G T T      T A T V L A Q A I V  
1 0 1  N E G L K A V A A G   M N P M D L K R G I    D K A V S A V V S E   L K N L S K P C E T   A K E I E Q V G T I  
1 5 1  S A N S D S I V G Q   L J S Q A M E K V G    K E G V I T V E D G   T G L E D E L D V V   E G M Q F D R G Y L  
2 0 1  S P Y F I N K P E T   A T V E L D N P Y L    L L V D K K I S N I   R E L L P V L E G V     A K A G K P L L I I  
2 5 1  A E D V E G E A L A   T L V V N T M R G I    V K V A A V K A P G      F G D R R K A M L Q     D I A I L T A G T V  
3 0 1  I S B E I G M E L E   K A T L E D L G Q A        K R V V I N K D N T   T I I D G I G D E A   Q I K G R V A Q I R  
3 5 1  Q Q I E E S T S D Y   D K E K L Q E R V A    K L A G G V A V I K      V G A A T E V E M K     E K K D R V D D A L  
4 0 1  H A T R A A V B E G   I V A G G G V A L V    R A A A K V A A S L  K G D N E E Q N V G     I K L A L R A M E A  
4 5 1  P L R Q I V T N A G  E E A S V V A S A V    K N G E G N F G Y N      A G T E Q Y G D M I      E M G I L D P T K V  
5 0 1  T R S A L Q F A A S  V A G L M I T T E C   M V T D L P K D D K      A D L G A A G M G G     M G G M G G M M  
 
 Bold = peptide fragments from ms/ms 
 Gray = peptide fragments different from P.mirabilis GroEL 
 Black = peptide fragments identical to P.mirabilis GroEL 
 Underlined = Identified in mascot search as GroEL from  R.ornitholytica, 
 otherwise the peptides where  identified as GroEL from Haemophilus Influenza 
 
 P.mirabilis Cpn60 (GroEL) 
 
1      A T V L A Q A I I A   E G L K A V A A G M   N P M D L K R G I D  K A V V G A V E E L  K K L S V P C S D T  
5 1   K A I A Q V G T I S   A N S D E T V G T L   I A Q A M E K V G K   E G V I T V E E G T   G L E D E L D V V E   
1 0 1  G M Q F D R G Y L S   P Y F I N K P E T G   T A E L E N P F I L   L V D K K V S N I R   E L L P V L E G V A   
1 5 1  K A N K P L L I I A   E D V E G E A L A T   L V V N N M R G I V   K V A A V  
 
Underlined = Identified in mascot search as GroEL, corresponding with  
proposed P.mirabilis GroEL  
 
Fig.7. Sequence homology between GroEL from Haemophilus influenza and Proteus mirabilis. 
The similarity between GroEL from Haemophilus Influenza and Proteus mirabilis is very high. 
The known sequence of Proteus mirabilis GroEL corresponds for 85% with Haemophilus 
Influenza. 
 
Discussion 
Bacterial adhesion by uropathogens in the bladder depends on several adhesion molecules. Some 
of these molecules have been described as NAF9, MR/P10, MR/K, or UCA11, but involve 
adhesion to urothelium. In enterocystoplasties the most prominent surface molecules are 
intestinal mucins. MUC2 is the most abundant mucin type secreted by the intestinal pouch14. 
Here we showed that GroEL is involved in the adhesion of P.mirabilis to mucins from 
enterocystoplasties.  
GroEL has been extensively described as an intracellular or membrane bound protein involved in 
protein folding24,25. As most heat shock proteins, GroEL is expressed increasingly in stress 
conditions to help maintain the secondary structure of proteins26. Enterocystoplasties as a 
continent urinary diversion under antibiotic prophylaxis can be considered a stressful 
environment for uropathogens. GroEL has also been described as an extracellular protein, 
associated with the bacterial outer membrane. Examples of GroEL on the bacterial outer 
membrane are found in Legionella pneumophila27, Haemophilus ducreyi28 and Clostridium 
difficile29. In Legionella pneumophila invasion is associated with the expression of GroEL. 
P.mirabilis is also capable of invading epithelial cells18,30, but has so far not been associated with 
GroEL. 
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Fig. 8. Electron Microscopy images of AB780: immunostained with gold-labels to 
identify GroEL on the bacterial exterior. A clustered bacteria, positive for GroEL in 
the center, with a negative P.mirabilis in the top left. B. single P.mirabilis positive for 
GroEL. 
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It is clear that GroEL interacts with MUC2 and MUC5AC from Far-Western experiments. This 
becomes evident with purified GroEL and by gel-shift experiments with GroEL from 
P.mirabilis.   
Salts and osmolytes present in enterocystoplasty urine may play a role in the interaction between 
mucins and GroEL in enterocystoplasties and thereby enhance adhesion or if present in very high 
concentrations inhibit interaction32,31.. High concentrations of osmolytes may mask the protein 
backbone structure of protein precursors or denaturated proteins. 
Often GroEL is associated with other protein fragments or GroES24,25. This may explain a smear 
in separation of proteins on a SDS-PAGE gel. In retrospect The Far-Western analysis of samples 
resembles Western blots of GroEL which have been reported previously33 and correspond with 
our results. GroEL adheres preferentially to the α-β transition in the protein structure24. By 
folding protein precursors or destabilized proteins to their proper 3D structure, GroEL can 
enhance the bacterial survival by increasing the durance of essential proteins. This 3D structure 
is available in mucins such as MUC2 and MUC5AC, but twice as much in MUC5AC13. The α-β 
transition is determined to great extent by the glycosylation of the mucin backbone, creating a 
rigid structure. Where glycosylation is absent or less profound, flexibility of the 3D structure 
occurs and GroEL adhesion can be expected. Some sections in the MUC2 and MUC5AC 
structure such as the Von Willibrand factor like domains and the cysteine rich domains are 
suitable candidates and could explain strong staining for MUC5AC and MUC2 adhesion in Far 
Western analysis. 
In Actinobacillus actinomycetemcomitans GroEL was demonstrated to be present on the bacterial 
surface, but most likely as an extracellular component34. The GroEL-like protein present on the 
bacterial surface has been suggested to play a role in disease initiation. It can not be excluded 
that GroEL expression in P.mirabilis is present on the bacterial surface due to intracellular 
material from lysed cells, which will adhere to the surface of other cells. Altruistic (auto)lysis of 
single cells to enhance the survival of other bacteria in the colony is a possibility in a hostile 
environment such as enterocystoplasties. Expression is nevertheless retained after culturing in 
Luria broth in low concentration and may be increased by environmental factors. Whether 
GroEL is part of an extracellular component or is part of the outer membrane is not clear. The 
possibility remains that GroEL adheres to the bacterial capsule and protein after lysis.  
Nevertheless, P.mirabilis GroEL may be a part of the outer membrane as is determined by the 
method described for outer membrane isolation and may be an integral part of the bacterial 
capsule. 
 
Conclusion 
GroEL is an adhesion molecule for MUC2 and MUC5AC for P.mirabilis.  In 
enterocystoplasties, producing several mucin types, the most likely interacting molecules are 
MUC2 and MUC5AC. P.mirabilis  probably adheres to enterocystoplasties by GroEL. The 
expression of GroEL may be dependent on an external stressor. Far-Western blotting and mass 
spectrometry to identify protein- protein interactions, can be applied for research on protein-
protein interactions extracellular in combination with transmission electron microscopy. 
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Risks and Resistance 
 
The definition of a symptomatic infection “The multiplication and maintenance of pathogenic 
bacteria, fungi, parasites or viruses after contamination, causing local inflammation or systemic 
disease of the host” was evaluated in as many aspects as possible in relation to stone formation in 
enterocystoplasties by P. mirabilis. It seems clear that the differences between a normal bladder 
and an augmented bladder are such that stone formation is enhanced in certain conditions. Most 
prevalent risk factor dominating and connecting all the other risk factors seems to be the 
presence of symptomatic infections (chapter 2). However, prophylactic use of antibiotics seems 
to have little or no effect on the prevention of stone formation. Children with a cloacal 
malformation or a vaginal reconstruction (related to the occurrence of a congenital urinary 
malformation) appear to be at risk for stone formation. It is clear that concomitant surgical 
procedures at the time of augmentation or at a later stage are important risk factors, especially 
continence enhancing procedures to the bladder neck. These children are often treated 
extensively with antibiotics and are often hospitalised. The ambulant patients often encounter 
infections which are treated with antibiotics by general practitioners. The antibiotics that are 
prescribed are usually effective in a normal bladder but in patients who have been exposed to 
antibiotics to such an extent as patients with an enterocystoplasties the effectiveness may be less. 
How this effects the usefulness of existing antimicrobial options and stone formation were 
discussed in the chapter 3. 
From the findings in the comparative study on bacteriological infections of the enterocystoplasty 
and bacteriuria, it becomes clear that community acquired infections should be checked for the 
correct bacteriological strain and treated specifically if symptoms occur instead of the empirical 
treatment, often used in general practice. The use of broad spectrum antibiotics and the 
preferential use of certain antibiotics such as cotrimoxazol and amoxicillin to treat the urinary 
tract infections seen in enterocystoplasties have a tendency to transform the characteristics of a 
community acquired infection into a nosocomial infection due to the increased resistance among 
bacterial strains (chapter 3). Furthermore, the high degree of mixed cultures and low frequency 
of detected P.mirabilis infections may be explained by intracellular infection and increased 
resistance may thus explain the formation of stones; this was discussed in chapter 5.  
In chapter 4 the interaction between the enterocystoplasty and the urine content is discussed in 
relation to bacterial/crystal adhesion and crystal formation as it seems that infection of the 
enterocystoplasty increases the pH level of the urine content conditioned by the 
enterocystoplasty, which correlates with stone formation The high number of mixed cultures 
may mask a number of P.mirabilis infections. Further research has to be done whether a specific 
search for urease producing bacterial strains among patients with an enterocystoplasty will 
benefit stone prevention by more specific antibiotic therapy of these strains. At this point we can 
not advocate a specific search for urease producing bacteria with current laboratory testing to 
identify them in mixed cultures, but clearly identification of uropathogens should preceed 
specific antibiotic treatment of  symptomatic urinary tract infections in enterocystoplasties. 
 
Mucins and bladder stones 
Mucins have been implicated with stone formation due to their ability to act as a framework for 
crystal growth. Furthermore, several compounds such as glycosaminoglycans have been 
correlated with crystal and bacterial evacuation by wrapping particles in the soluble polymer. It 
seems that some mucins are able to act in a similar manner. Many of the mucins secreted by the 
intestinal cells in the enterocystoplasty will remain in the bladder at the surface of the cells. 
Since these molecules are able to agglomerate crystals, they must be able to bind crystals. This is 
described in chapter 3. These mucins are not secreted by P.mirabilis. It seems that P.mirabilis 
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invades the epithelial cells. This phenomenon and its implication on the therapeutic effect of 
antibiotics was discussed in chapter 5. By invading the epithelial cells a safe haven was created 
where the bacteria could retreat and survive in case of antibiotic therapy. The safe haven was 
provided by the double membranes of the cell and a cytoplasmatic layer. The cytoplasmic 
colonies remain at the edge of the cell underneath the double membrane until the epithelial cell 
bursts under the burden of it’s bacterial load. It seems that mucins MUC2 and MUC5AC play a 
role in the formation of crystal agglomerates which may bind to the epithelial cells on MUC2 
and MUC5AC. How these mucins are involved in the adhesion of bacteria was discussed in 
chapter 6. The invasion of epithelial cells and cellular stress are probably involved in a number 
of cellular reactions which may enhance the production of mucins and thereby increase the effect 
of crystal adhesion.  
The effect on antibiotic resistance may play an important role in the persistence of an infection 
but requires a first step of bacterial adhesion in the process of invasion. Mucins seem to have 
certain characteristics that enhance bacterial adhesion. Sialic acid seems to play an important 
role in this process. Adhesion to mucins could be demonstrated for both MUC2 and MUC5AC 
and could also be blocked by other mucin types. Many bacterial strains use mucins as a target for 
cellular infection. Thus mucins and sugar residues may be useful in the prevention and therapy 
of bacterial infections in the augmented bladder.  
P.mirabilis adheres to mucins on the cellular surface and invades epithelial cells after which 
crystals are formed in the epithelial cells. This process can be blocked by MUC3, sialic acid and 
other methods to disable the interaction with certain mucin substructures. The approximately 
50kDa molecule attached to the bacterial capsule still needs to be identified to have a clear idea 
of all the molecules and interactions that play a role in bacterial and crystal adhesion to the 
epithelial surface. In chapter 7 we attempt to identify the bacterial molecule responsible for 
MUC2 and MUC5AC binding. 
 
Closing the circle of interactions 
If GroEL (Hsp60) is indeed the bacterial molecule interacting with mucins, an interaction 
between the different molecules can be described. First, the crystals can agglomerate and adhere 
to mucins (MUC2) on the epithelial cells. Second, crystals can precipitate on the bacterial 
capsule, thus transforming the bacterial surface into a crystal surface. Furthermore, the bacterial 
surface by means of GroEL can interact with mucins (MUC2 and MUC5AC) at the epithelial 
surface. At the epithelial surface a docking process takes place which can preceed cellular 
invasion which enhances bacterial survival. In the epithelial cells crystals can be formed, which 
are small and protected from wash out by micturation. Of course bacterial urease elevates the pH 
of urine which enhances precipitation of crystals. By the combination of these processes an 
infectious bladder stone can be formed which is relatively resistant to antibiotic therapy and is 
securely fixed to the bladder wall, while providing the conditions for the growth of the bladder 
stone until it has reached a diameter that exceeds the diameter of the urethra or catheterisation 
channel. A diagram of the interactions as described above is presented in Fig.1. Crystals 
agglomerate mediated by mucins,  crystals are formed by pH elevation due to urease activity 
from bacteria, while the bacteria find a safe haven inside the cell and fortify their safe haven by 
the precipitation of crystals. These interactions between GroEL and epithelial mucins can be 
inhibited by the addition of MUC3. 
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Fig.1. Interactions between bacteria, mucins and crystals in enterocystoplasties. 
1= free crystal, 2= agglomeration of crystals mediated by mucins secreted by the 
epithelial surface, 3= adherent crystals to the epithelium, 4= free P.mirabilis, 5=  
adherent P.mirabilis, mediated by GroELÙ mucin interaction, 6= invaded bacteria, 
safe from antibiotics, with the possibility to pass the lamina propria or restart the 
cycle after cell lysis, 7=epithelial cell, 8= lamina propria, 9= adherent agglomerate 
of crystals , mucins and bacteria, initiating the formation of an infection stone. 
 


  143
 
 
Summary 
Summary/ Samenvatting 
 144 
 
Samenvatting 
In dit proefschrift wordt de vorming van infectiestenen geëvalueerd in enterocystoplastieken 
onder invloed van P.mirabilis en mucines om de interactie tussen cellen, bacteriën en kristallen 
in dit proces op te helderen. 
Er was bij het begin van dit onderzoek weinig bekend van Proteus mirabilis hechting in 
enterocystoplastieken en hun rol bij steenvorming in enterocystoplastieken werd vrijwel 
uitsluitend toegeschreven aan de aanwezigheid van urease. Er werd hierbij veelal voorbijgegaan 
aan de definitie van een infectie: “Het zich na besmetting handhaven en vermenigvuldigen in 
weefsels van ziekteverwekkende parasieten, schimmels, bacteriën of virussen waardoor 
plaatselijke onsteking of ziekte van het gehele organisme wordt veroorzaakt”. Men richtte zich 
voornamelijk op het symptoom “bacteriurie” i.p.v. de ziekte “symptomatic infection/ cystitis” 
die gecorreleerd was met steenvorming in de condities van een enterocystoplastiek en een 
interactie met cellen verondersteld. Hierin is bacteriële hechting de eerste stap is gevolgd door 
een cellulaire reactie en in relatie staat tot een groot aantal cellulaire, urinaire en bacteriologische 
factoren. De sterke correlatie tussen het symptoom, bacteriurie, en de ziekte, cystitis, in de 
anatomisch normale blaas leidt tot misinterpretaties van gegevens uit de enterocystoplastiek. Het 
onderzoek zou zich gaan ontwikkelen in de richting van bacterie/ crystal/ cel interacties in 
enterocystoplastieken. In enterocystoplastieken lijken voornamelijk mucines als belangrijk 
bestanddeel van mucus en met name gesulfateerde mucines en hun suikerresidu’s een 
belangrijke rol te spelen. Zij zijn een risicofactor in de hechting aan het epitheel van de 
verschillende componenten die samen met urine en intra-epitheliale componenten een therapie 
resistente blaassteen vormen. 
 
Risico factoren en Resistentie 
De belangrijkste risicofactor voor infectiesteenvorming blijkt een symptomatische infectie te 
zijn. Verder blijken ook bijkomende heelkundige ingrepen tijdens of na de blaasaugmentatie van 
invloed te zijn op de kans op steenvorming en infectie (Hoofdstuk 2). Mogelijk geldt dit ook 
voor kinderen met een vaginale reconstructie of cloacale malformatie. Deze en andere 
aandoeningen vereisen in sommige gevallen ingrepen in de blaas die een hogere kans geven op 
zowel infectie als blaassteenvorming (Hoofdstuk 3). Het voorkomen van deze infecties in 
combinatie met profylaxis d.m.v. gangbare antibiotica heeft een toenemend effect op 
resistentievorming en is minder effectief als bescherming tegen steenvorming. De mogelijkheid 
in cellen te penetreren biedt de bacteriën de kans zich terug te trekken uit de vijandige omgeving 
van het blaaslumen en geeft, in dit geval, P.mirabilis de kans om resistent te worden tegen de 
antibiotica in het lumen (Hoofdstuk 5). 
 
De rol van mucines 
Mucines zijn een belangrijk onderdeel van de epitheliale barrière en beschermen het epitheel 
tegen mechanische en chemische beschadiging. Het is echter ook bekend dat sommige mucines 
kunnen functioneren als een belangrijke hechtingsplaats voor zowel pathogene als niet pathogene 
bacteriën. Verder kunnen mucines de vorming van kristallen induceren of bevorderen. Dat 
mucines ook voor agglomeratie van kristallen kunnen zorgen –een veel sneller proces-, is 
beschreven in hoofdstuk 4. Deze mucines, die in een enterocystoplastiek voornamelijk door de 
intestinale  pouch worden gesecreteerd in de urine kunnen zowel een beschermende rol hebben 
als een hechtingsplaats bieden voor bacteriën (Hoofdstuk 6 en 7). Het lijkt erop dat een 
bacterieel proteïne dat gevormd wordt onder invloed van stress, GroEL, een rol speelt in de 
hechting van P.mirabilis, aan het MUC2 en MUC5AC geproduceerd door het epitheel. Deze 
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hechting is weer de eerste stap van de infectie en de bescherming van de bacterie tegen het 
antibioticum. Het is mogelijk deze hechting te inhiberen en daarmee de cyclus te onderbreken. 
 
Het sluiten van de cyclus. 
Als GroEL (Hsp60/Cpn60) inderdaad de bacteriële tegenpool is in de interactie met MUC2 en 
MUC5AC in de enterocystoplastiek, dan wordt een volgorde van interacties duidelijk die kan 
leiden tot de vorming van een infectie steen. In deze interacties spelen mucines een verbindende 
rol tussen de interacties van bacteriën, cellen en kristallen. Er blijft wat betreft kristalvorming tot 
op zekere hoogte een scheiding tussen het intra- en extracellulaire milieu. Kristallen in suspensie 
hebben de mogelijkheid zich te vormen bij het stijgen van de urinaire pH en om te agglomereren 
onder invloed van mucines. Intracellulair kunnen eveneens kristallen worden gevormd op een 
gelijkaardige manier, maar vereist dat de cel niet meer in staat is haar eigen pH te regelen. 
De gevormde kristallen kunnen worden gekoloniseerd door bacteriën. Dit kan direct op het 
kristaloppervlak maar ook indirect door tussenkomst van mucines. De mogelijkheid van 
kristallen om een interactie aan te gaan met mucines betekent tevens dat de mogelijkheid bestaat 
dat kristallen zich direct hechten aan het oppervlak van de epitheelcel die deze mucines 
produceert. 
Proteus mirabilis kan door zich te hechten aan het epitheel en zich terug te trekken in de 
epitheelcel een veilige haven creëren tegen een vijandig milieu. Deze bacteriën kunnen door de 
productie van urease kristallen in stand houden. Tegelijkertijd bezorgen ze de cel veel schade en 
kan cellysis de intracellulaire bacteriën (en kristallen) weer doen vrijkomen in het lumen, wat 
aanleiding kan geven tot meer resistentie tegen veel gebruikte antibiotica. Een lang in stand 
gehouden infectie kan aanleiding geven tot een slecht behandelbare infectiesteen. De eerste stap 
van de infectie is weer de hechting van de bacterie aan het epitheel, waarin mucines MUC2, 
MUC5AC en GroEL waarschijnlijk een belangrijke rol spelen 
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Summary 
In this thesis the formation of infection stones by P.mirabilis and mucins in enterocystoplasties is 
evaluated to clarify the interaction between cells, bacteria and crystals in the stone formation 
process 
Little was known about Proteus mirabilis adhesion to enterocystoplasties at the start of this 
research project and stone formation in enterocystoplasties was almost exclusively contributed to 
the presence of urease. Most often this notion ignored the definition of a symptomatic infection: 
“The multiplication and maintenance of pathogenic bacteria, fungi, parasites or viruses after 
contamination, causing local inflammation or systemic disease of the host”. Researchers 
primarily focused their attention to the symptom “ bacteriuria” rather then the disease 
“symptomatic infection/ cystitis”, which correlated with stone formation in enterocystoplasties 
and suggests an interaction with cells. Bacterial adhesion is the first step in this interaction, 
followed by a cellular reaction which is related to a great number of cellular, urinary and 
bacteriological factors. The strong correlation between the symptom, bacteriuria, and the disease 
cystitis in the anatomically normal bladder leads to misinterpretations of data acquired from 
enterocystoplasties. Research would evolve towards bacterial/ crystal and cellular interactions in 
enterocystoplasties. In enterocystoplasties, mostly mucins seem to play an important role as an 
important component of mucus and in particular the sulfated mucins and their carbohydrate 
residues. They are a risk factor in the adhesion of the several components that in conjunction 
with urine and intra-epithelial components act to form a therapy resistant bladder stone. 
 
Risk factors and Resistance 
The most important risk factor for infection stone formation seems to be a symptomatic 
infection. Furthermore, concomitant surgical procedures during or after bladder augmentation 
appear to influence the risk of stone formation and infection (Chapter 2). Possibly this may also 
apply to children with a vaginal reconstruction or cloacal malformation. These and other 
conditions may sometimes require bladder surgery, which increases the risk for both infection 
and bladder calculi (Chapter 3). The occurrence of these infections combined with the most 
common antibiotic prophylaxis increases resistance and supplies less protection against stone 
formation. The potential to invade cells, provides the bacteria with the opportunity to retreat 
from the hostile bladder lumen into the cells and thus gives P.mirabilis a chance to acquire 
resistance to the antibiotics in the lumen (Chapter 5).  
 
The role of mucins 
Mucins are an important component of the epithelial barrier and protect the epithelium from 
mechanical and chemical erosion. Nevertheless, mucins have been known to act as important 
adhesion molecules for both pathogenic and non-pathogenic bacteria. Furthermore, mucins may 
induce or enhance the formation of crystals. That mucins may cause agglomeration of crystals, a 
much faster process, has been described in Chapter 4. These mucins, which are mostly secreted 
in urine by the intestinal pouch in enterocystoplasties may have both a protective role while 
providing the bacteria with a adhesion site (Chapter 6 and 7) It seems that a bacterial protein, 
expressed under stress, GroEL, contributes to the adhesion of P.mirabilis to the MUC2 and 
MUC5AC, produced by the epithelium. This adhesion is the first step of infection and the 
bacterial protection from the antibiotic. This adhesion can be inhibited and break the cycle. 
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Closing the cycle 
If GroEL (Hsp 60/Cpn60) is indeed the bacterial counterpart in the interaction with MUC2 and 
MUC5AC in enterocystoplasties, a sequence of interactions appears that may lead to the 
formation of an infection stone. In these interactions mucins play a connecting role between the 
interactions of bacteria, cells and crystals. In regard to crystal formation to some extent a 
separation between the intra and extracellular environment remains. Crystals in suspension have 
the opportunity to form due to a rise in the urinary pH level and agglomerate mediated by 
mucins. Crystals may also form intracellular in a similar fashion, but requires a loss of cellular 
pH regulation. 
The crystals may be colonized by bacteria. This may occur directly on the crystal surface or 
indirectly by the mediation of mucins. The capability of crystals to interact with mucins implies 
the possibility for crystals to adhere directly to the epithelial surface, producing these mucins. 
Proteus mirabilis may create a safe haven from a hostile environment by epithelial adhesion and 
invasion. These bacteria can maintain crystals by the production of urease. At the same time they 
exert a lot of damage to the cell and cause cellular lysis liberating intracellular bacteria (and 
crystals), which may lead to an increased resistance to common antibiotics. A persisting 
infection can give rise to therapy resistant infection stones. Again the first step of an infection is 
adhesion of the bacteria to the epithelium with a probably important role for the mucins MUC2, 
MUC5AC and GroEL 
 
 
 
 

 149
 
 
Acknowledgement, Publications and CV 
 
Aknowledgement, Publications and CV 
150 
Dankwoord 
Velen zijn gekomen en weer gegaan in de periode die dit proefschrift beslaat. Dit proefschrift is 
het gevolg van de prettige samenwerking met en de inzet van vele mensen en verschillende 
afdelingen. Velen die terloops een helpende hand hebben toegestoken, logistieke en morele steun 
hebben gegeven zou ik hier willen vermelden. Ik zou hier iedereen willen bedanken die direct of 
indirect een bijdrage heeft geleverd aan dit proefschrift. Met het gevaar toch namen over te 
slaan zou echter een aantal mensen met name willen noemen: 
In de eerste plaats natuurlijk mijn directe begeleider en co-promotor Dik Kok. De nonchalante, 
relaxte manier waarmee jij onderzoekers begeleidde was onterecht een doorn in het oog van 
velen. Zelfs ik begreep in het begin niet wat ik met jou aan moest tot Dr. Rien Nijman mij op het 
hart drukte iets meer relaxed te zijn, en hij had gelijk. Ik heb veel gehad aan jouw steun en inzet. 
De echte waardering kwam toen wij het onderzoeksvoorstel voor de Nierstichting schreven en 
we in 3 maanden tijd een groot deel van het onderzoek moesten verwoorden om het op de 
valreep in te kunnen dienen. De waardering groeide voor je geduld, de manier waarop je het 
beste uit mensen naar boven wist te halen en de enthousiaste manier waarop je nieuwe ideeën 
benaderde . Ik heb nog steeds zeer goede herinneringen aan de congressen waar we samen heen 
zijn geweest en de discussies die we hebben gevoerd. Je stond altijd open voor een nieuw idee en 
gaf mij de vrijheid ze uit te werken. Drie hoofdstukken waren eigenlijk het resultaat van een 
middag in de zomerzon op een terras een wandeling langs Lake Michigan en een parkbankje in 
Chicago wachtend op het begin van de laatste lezing.  
Dr.Nijman, beste Rien, jij bent jarenlang de stille, maar altijd aanwezige kracht geweest achter 
de schermen en de directe verbinding naar de kliniek. Als student ben ik bij jou begonnen en heb 
jij mij wegwijs gemaakt op de afdeling, voorzien van de nodige morele steun of advies en werd 
de kans geboden het onderzoek op te zetten, waarvoor nog altijd dank. Toen was het nog Dr. 
Nijman, na een paar jaar werd het langzaam Rien en sinds kort professor Nijman. Het 
onmisbare klinisch oordeel dat u gaf vond zij weerslag in het gehele proefschrift. 
 
Verder wil ik m’n promotoren Prof. Verbrugh en in het bijzonder Prof. Schröder bedanken voor 
hun persoonlijke inzet bij de totstandkoming van dit proefschrift en de nodige correcties.De 
Stichting Urologisch Wetenschappelijk Onderzoek en de afdeling Klinische Microbiologie en 
Infectieziekten wil ik bij deze bedanken voor de jarenlange financiële ondersteuning zonder 
welke dit onderzoek niet mogelijk was geweest.  
 
Beste Kees, ook jouw invloed is duidelijk aanwezig in dit proefschrift. Ik heb nog steeds moeite 
om zonder verdere test met enkel de koloniemorfologie, de geur en verkleuring van de plaat te 
bepalen welke bacterie is gekweekt, maar dat komt misschien nog wel. Je hebt me altijd terzijde 
gestaan met je opgewekte persoonlijkheid, logistieke en morele steun en een kritische blik voor 
methoden en interpretaties van bacteriologische gegevens. Meestal was de manier om een 
kritisch oordeel op een manuscript uit te lokken de vermelding: “ Laatste versie”. Hierop volgde 
veelal mijn verongelijkte antwoord “Dat weet jij toch ook?”. Duidelijk is het mede dankzij jou 
geworden. 
 
Lieve Sandra en Ingrid, jullie waren met de kennis over mucines en met name MUC2 en 
MUC5AC een belangrijke vraagbaak bij de afwezigheid van Jan Dekker. Sandra, het inzicht dat 
jij wist te verschaffen en de open manier waarop je met onderzoeksvragen omgaat maakte dat 
het laboratorium kindergeneeskunde uitnodigde tot meer. Er zouden meer vrouwelijke UHD’s 
moeten komen en meer zoals jou. Lieve Ingrid, AJAX Rules! Theo bedankt voor de prettige sfeer 
en plek waar ik altijd heen kon met een idee. Ik wil jou bedanken voor je inzet, gewiekste 
opmerkingen en je onmisbare kennis op het gebied van gelelectrophoresis.  
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Pim, Ton en Piet, jullie EM foto’s waren essentieel voor m’n onderzoek. Het was erg moeilijk 
kiezen uit alle mooie foto’s, het is mij niet gelukt, vandaar het kaftje. Ik hoop dat jullie het toch 
mooi vinden. 
 
Dear Mazen, you were the last one to leave the laboratory every evening to finish your work on 
Wilm’s tumors. The long discussions and your inspiring drive to reach for the best have led to 
many joint manuscripts and publications and I’m very happy to hear about your upcoming 
promotion. I wish you the best of luck and hope to stay in touch. 
 
Ad de Jong, Hugo Meijring en Jan ten Hove, bij deze wil ik jullie bedanken voor de gastvrijheid 
en de identificatie van GroEL tussen de bedrijven door. Jullie kennis van massaspectrometrie 
was van grote waarde en zonder de trips naar Bilthoven was dit proefschrift nooit zo mooi 
geworden. 
 
Ik zou verder iedereen van het laboratorium Klinische Microbiologie en BAClab willen 
bedanken voor hun steun, advies, geduld en de prettige sfeer; met name Anton, Mariëlle, 
Marieke, Wim, Diana, Roel, Will, Alex, en bovenal Cindy van der Schee voor alle hulp op het 
moleculair biologisch vlak. Rood haar blijft mooi. 
 
Iedereen van het Experimenteel Urologisch Lab, de Steengroep en de Kinderurologie en de 
afdeling Pathologie van het Josephine Nefkens Instituut zou ik bij deze willen bedanken. Met 
name Hans Romijn, Wytske van Weerden, Guido Jenster, Carl Verkoelen en Paul Verhagen, 
Ellen Zwarthoff, Winand Dinjens, Robert Kraaij, Gert-Jan Steenbrugge, Katja Wolffenbuttel, 
Ellen van den Berg en Brigitte van de Graaf, maar ook Arnold Hekman, Burt van der Boom, 
Niels-Peter Buchholz en Saima, Ruud de Water en Cindy, Karel van Wely, Nico en alle anderen 
die reeds vertrokken zijn. Alle analisten van het lab wil ik bij deze bedanken, in het bijzonder 
Joke en Laura, Monique Oomen en Corrina, Wilma, Sigrun (het zonnetje), en Angelique, alsook 
de AIO’s, en de vele studenten die op het lab hebben gewerkt. Marieke en Marino, succes met 
jullie promotie.  
 
Bij deze wil ik mijn paranimfen, mijn broer Anil en m’n goede vriend Reinout Haverkamp, 
bedanken voor hun steun, hun luisterend oor en hun bereidheid mij ook nu terzijde te staan. 
M’n ouders en broer wil ik bij deze bedanken voor hun vertrouwen, steun en advies wanneer het 
even tegen zat. 
Papa, mama, het boekje is af. Ik hoop dat jullie het mooi en de moeite waard vinden. Nog 2 jaar 
studeren en dan ben ik klaar 
 
Rejiv 
 
 
Y  
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